2919 genotypes with 4207 annotations displayed
of selected term and subterms
|
Searched Term: increased inflammatory response
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/Jdk)
|
insulitis
|
J:137009
|
5730403I07Rikem8Gpt/5730403I07Rikem8Gpt
(involves: C57BL/6JGpt)
|
increased inflammatory response
|
J:329871
|
9030622O22Rikem1Eem/9030622O22Rik+ Foxa2tm1.1Khk/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
respiratory system inflammation
|
J:284174
|
9030622O22Rikem1Eem/9030622O22Rikem1Eem
(involves: C57BL/6 * CD-1)
|
lung inflammation
|
J:284174
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(Myh6-2A)#Know/0
(involves: BALB/c * C57BL/6 * FVB/N)
|
heart inflammation
|
J:128060
|
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka)
|
stomach inflammation
|
J:184485
|
AA467197em1Nyam/AA467197em1Nyam
(C57BL/6J-AA467197em1Nyam)
|
kidney inflammation
|
J:347271
|
liver inflammation
|
J:347271
|
lung inflammation
|
J:347271
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
glomerulonephritis
|
J:64390
|
uterus inflammation
|
J:64390
|
Abcb1atm1Bor/Abcb1atm1Bor
(FVB.129P2-Abcb1atm1Bor/TacImx)
|
colitis
|
J:51190
|
large intestinal inflammation
|
J:51190
|
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
|
bile duct inflammation
|
J:15531,
J:21232
|
liver inflammation
|
J:15531
|
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N)
|
bile duct inflammation
|
J:175015
|
liver inflammation
|
J:175015
|
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
|
bile duct inflammation
|
J:105357
|
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c)
|
bile duct inflammation
|
J:168123
|
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
|
increased susceptibility to induced colitis
|
J:117326
|
intestinal inflammation
|
J:117326
|
small intestinal inflammation
|
J:117326
|
Abcd1tm1Kds/Y Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
increased inflammatory response
|
J:94583
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:132952
|
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB)
|
liver inflammation
|
J:201884
|
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)
|
liver inflammation
|
J:199570
|
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J)
|
lung inflammation
|
J:72875
|
AbmmDBA/2J/?
(involves: BALB/cByJ * DBA/2J)
|
myocarditis
|
J:52296
|
Acantm2Afos/Acantm2Afos
(involves: C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:122102
|
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc)
|
brain inflammation
|
J:299448
|
Ace2em1(ACE2)Yowa/Ace2em1(ACE2)Yowa
(C57BL/6-Ace2em1(ACE2)Yowa)
|
interstitial pneumonia
|
J:288243
|
Ace2em1Cya/Y
(C57BL/6J-Ace2em1Cya/Cya)
|
increased susceptibility to induced colitis
|
J:299383
|
intestinal inflammation
|
J:299383
|
Ace2em2(ACE2)Gpt/Y
(C57BL/6JGpt-Ace2em2(ACE2)Gpt/Gpt)
|
lung inflammation
|
J:302150
|
Ace2em#Yngh/Y
(involves: Kunming)
|
increased susceptibility to induced colitis
|
J:221616
|
Ace2tm1a(KOMP)Wtsi/Y Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac)
|
lung inflammation
|
J:282139
|
Ace2tm1a(KOMP)Wtsi/Ace2tm1a(KOMP)Wtsi Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac)
|
lung inflammation
|
J:282139
|
Ace2tm1Cof/Ace2tm1Cof
(involves: 129S6/SvEvTac * C57BL/6)
|
increased incidence of corneal inflammation
|
J:289503
|
Ace2tm1Lex/Ace2tm1Lex
(B6;129S5-Ace2tm1Lex/Mmucd)
|
lung inflammation
|
J:264991
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
heart inflammation
|
J:124548
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd)
|
lung inflammation
|
J:282139,
J:100334
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
lung inflammation
|
J:277074
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd)
|
lung inflammation
|
J:282139,
J:100334
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6J)
|
lung inflammation
|
J:277074
|
Acetm1Keb/Acetm1Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
kidney inflammation
|
J:33018
|
Acetm1Mcf/Acetm1Mcf
(Not Specified)
|
kidney inflammation
|
J:32114
|
tubulointerstitial nephritis
|
J:32114
|
Acetm1Unc/Acetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
kidney inflammation
|
J:25284
|
Acetm9Keb/Acetm9Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
kidney inflammation
|
J:185888
|
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi)
|
skin inflammation
|
J:235775
|
Ackr1tm1Scp/Ackr1tm1Scp
(involves: 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:64222
|
Ackr2tm1Gjg/Ackr2tm1Gjg
(involves: 129/Sv * C57BL/6)
|
dermatitis
|
J:97607
|
increased inflammatory response
|
J:97806
|
Ackr3tm1Jgo/Ackr3+
(involves: 129S/SvEvBrd * C57BL/6)
|
lung inflammation
|
J:136246
|
Ackr3tm1Jgo/Ackr3tm1Jgo
(involves: 129S/SvEvBrd * C57BL/6)
|
lung inflammation
|
J:136246
|
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J)
|
liver inflammation
|
J:174942
|
Acox2em1Jynz/Acox2em1Jynz
(involves: C57BL/6N)
|
liver inflammation
|
J:323193
|
Acvr1tm1Emsh/Acvr1+
(chimera involves: BALB/c * C57BL/6 * CD-1)
|
increased inflammatory response
|
J:194134
|
Adatm1Mw/Adatm1Mw Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
lung inflammation
|
J:73418
|
Adam8tm1.1Mdz/Adam8tm1.1Mdz
(DBA/1LacJ-Adam8tm1.1Mdz)
|
decreased susceptibility to induced arthritis
|
J:155243
|
Adam17m1Btlr/Adam17m1Btlr
(C57BL/6J-Adam17m1Btlr)
|
increased susceptibility to induced colitis
|
J:166602
|
Adam17tm1.1Srj/Adam17tm1.1Srj
(involves: 129S/SvEv * C57BL/6 * SJL)
|
increased susceptibility to induced colitis
|
J:163380
|
skin inflammation
|
J:163380
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl Il17atm1Yiw/Il17atm1Yiw Sox9tm3(cre)Crm/Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL)
|
dermatitis
|
J:229771
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl Il23atm1Dnax/Il23atm1Dnax Sox9tm3(cre)Crm/Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL)
|
dermatitis
|
J:229771
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl Sox9tm3(cre)Crm/Sox9+
(B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl)
|
dermatitis
|
J:229771
|
Adam17tm1Imx/Adam17tm1Imx
(involves: 129 * C57BL/6)
|
increased incidence of corneal inflammation
|
J:51053
|
Adam17woe/Adam17woe
(C57BL/6-Adam17woe)
|
dermatitis
|
J:160781
|
increased incidence of corneal inflammation
|
J:160781
|
Adam29em1Otin/Adam29em1Otin
(C57BL/6-Adam29em1Otin)
|
increased inflammatory response
|
J:353244
|
Adamdec1tm1Dgen/Adamdec1+
(B6.129P2-Adamdec1tm1Dgen)
|
increased susceptibility to induced colitis
|
J:301741
|
Adamdec1tm1Dgen/Adamdec1tm1Dgen
(B6.129P2-Adamdec1tm1Dgen)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:301741
|
increased susceptibility to induced colitis
|
J:301741
|
intestinal inflammation
|
J:301741
|
Adamts5tm1.1Eam/Adamts5+
(involves: 129S5/SvEvBrd)
|
decreased susceptibility to induced arthritis
|
J:97590
|
Adamts5tm1.1Eam/Adamts5tm1.1Eam
(involves: 129S5/SvEvBrd)
|
decreased susceptibility to induced arthritis
|
J:97590
|
Adamts5tm1Lex/Adamts5tm1Lex Tg(CMV-cre)1Cgn/0
(involves: 129S5/SvEvBrd * BALB/cJ)
|
osteoarthritis
|
J:105138
|
Adamts5tm2.2Lex/Adamts5tm2.2Lex
(B6.129S5-Adamts5tm2.2Lex)
|
decreased susceptibility to induced arthritis
|
J:175366
|
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dermatitis
|
J:271185
|
Adamts18tm1.1Wzha/Adamts18tm1.1Wzha
(involves: 129 * C57BL/6)
|
increased acute inflammation
|
J:258487
|
increased susceptibility to induced colitis
|
J:258487
|
Adcy7tm1.1Pcst/Adcy7tm1.1Pcst Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
peritoneal inflammation
|
J:191067
|
Adm2em1Zhan/Adm2em1Zhan
(Not Specified)
|
increased inflammatory response
|
J:266495
|
liver inflammation
|
J:266495
|
Admtm1Tfjt/Adm+
(involves: C57BL/6 * CBA)
|
blood vessel inflammation
|
J:102946
|
Adora2btm1Till/Adora2btm1Till
(B6.129P2-Adora2btm1Till)
|
increased susceptibility to type I hypersensitivity reaction
|
J:125297
|
Adtrptm1.1Clu/Adtrptm1.1Clu
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased inflammatory response
|
J:295059
|
Aec1NOD/Uf/Aec1NOD/Uf Aec2NOD/Uf/Aec2NOD/Uf
(B6.NOD-Aec2NOD/Uf Aec1NOD/Uf)
|
lacrimal gland inflammation
|
J:129282
|
salivary gland inflammation
|
J:129282
|
Agnm1MRL/MpJ/Agnm1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
glomerulonephritis
|
J:97786
|
Agnm2C3H/HeJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
glomerulonephritis
|
J:97786
|
Agnm2MRL/MpJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
glomerulonephritis
|
J:97786
|
Agnm3C3H/HeJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
glomerulonephritis
|
J:97786
|
Agnm3MRL/MpJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
glomerulonephritis
|
J:97786
|
Agp1NZB/Agp1NZB
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agp1NZB/Agp1NZW
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agp2NZB/Agp2NZW
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agp2NZW/Agp2NZW
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
brown adipose tissue inflammation
|
J:186035
|
liver inflammation
|
J:186035
|
Agr2tm1.1Lpkn/Agr2tm1.1Lpkn Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
colitis
|
J:156704
|
Agr2tm1.2Erle/Agr2tm1.2Erle
(involves: 129S4/SvJae * FVB/N)
|
increased susceptibility to induced colitis
|
J:148339
|
Agr2tm1.2Lpkn/Agr2tm1.2Lpkn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
colitis
|
J:156704
|
ileum inflammation
|
J:156704
|
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA)
|
tubulointerstitial nephritis
|
J:46506
|
Agttm1Unc/Agttm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
tubulointerstitial nephritis
|
J:24156
|
Agtr1atm1Unc/Agtr1atm1Unc Agtr1btm1Cof/Agtr1btm1Cof
(involves: 129P2/OlaHsd * C57BL/6)
|
kidney inflammation
|
J:137944
|
Ahi1tm1Jgg/Ahi1tm1Jgg Tg(TCF/Lef1-lacZ)34Efu/0
(involves: 129S1/Sv * 129X1/SvJ)
|
kidney inflammation
|
J:154321
|
Ahrb-1/Ahrb-1
(C57BL/6J)
|
increased inflammatory response
|
J:5244,
J:5387
|
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra/J)
|
lung inflammation
|
J:118646,
J:100359
|
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
bile duct inflammation
|
J:25048
|
colitis
|
J:44690
|
folliculitis
|
J:44690
|
heart inflammation
|
J:44690
|
increased inflammatory response
|
J:25048
|
Ahrtm1Yfk/Ahrtm1Yfk
(involves: 129S/SvEv * C57BL/6J)
|
urinary bladder inflammation
|
J:179919
|
Aif1tm1Nsib/Aif1tm1Nsib
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:204462
|
Aim2tm1.2Arte/Aim2tm1.2Arte Dnase2atm1Osa/Dnase2atm1Osa Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129 * BALB/c * C57BL/6 * C57BL/6J)
|
rheumatoid arthritis
|
J:238323
|
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6)
|
stomach inflammation
|
J:119475
|
Airetm1.1Doi/Airetm1.1Doi
(B6.129S2-Airetm1.1Doi/Doi)
|
increased incidence of corneal inflammation
|
J:107432
|
lung inflammation
|
J:107432
|
salivary gland inflammation
|
J:107432
|
stomach inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi)
|
increased incidence of corneal inflammation
|
J:107432
|
liver inflammation
|
J:107432
|
lung inflammation
|
J:107432
|
ovary inflammation
|
J:107432
|
pancreas inflammation
|
J:107432
|
prostate gland inflammation
|
J:107432
|
salivary gland inflammation
|
J:107432
|
stomach inflammation
|
J:107432
|
thyroid gland inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi)
|
increased incidence of corneal inflammation
|
J:107432
|
liver inflammation
|
J:107432
|
lung inflammation
|
J:107432
|
ovary inflammation
|
J:107432
|
prostate gland inflammation
|
J:107432
|
salivary gland inflammation
|
J:107432
|
stomach inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi)
|
liver inflammation
|
J:107432
|
lung inflammation
|
J:107432
|
ovary inflammation
|
J:107432
|
pancreas inflammation
|
J:107432
|
prostate gland inflammation
|
J:107432
|
salivary gland inflammation
|
J:107432
|
stomach inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6 * NOD)
|
liver inflammation
|
J:107432
|
lung inflammation
|
J:107432
|
pancreas inflammation
|
J:107432
|
salivary gland inflammation
|
J:107432
|
stomach inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2-Airetm1.1Doi)
|
chronic pancreas inflammation
|
J:135154
|
insulitis
|
J:135154
|
lacrimal gland inflammation
|
J:135154
|
lung inflammation
|
J:135154
|
salivary gland inflammation
|
J:135154
|
stomach inflammation
|
J:135154
|
thyroid gland inflammation
|
J:135154
|
uveitis
|
J:135154
|
Airetm1.1Doi/Airetm1.1Doi H2b/H2b
(NOD.Cg-Airetm1.1Doi H2b/Doi)
|
stomach inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi Idd3C57BL/6/Idd3C57BL/6 Idd5C57BL/10SnJ/Idd5C57BL/10SnJ
(NOD.Cg-Idd3C57BL/6 Idd5C57BL/10SnJ Airetm1.1Doi/Doi)
|
stomach inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi Il1r1tm1Imx/Il1r1+
(involves: 129S2/SvPas * 129S7/SvEvBrd * NOD)
|
keratoconjunctivitis
|
J:163691
|
lacrimal gland inflammation
|
J:163691
|
Airetm1.1Doi/Airetm1.1Doi Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S2/SvPas * 129S7/SvEvBrd * NOD)
|
keratoconjunctivitis
|
J:163691
|
lacrimal gland inflammation
|
J:163691
|
Airetm1Mand/Aire+
(involves: 129P2/OlaHsd * C57BL/6)
|
lacrimal gland inflammation
|
J:135154
|
salivary gland inflammation
|
J:135154
|
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand)
|
chronic pancreas inflammation
|
J:135154
|
CNS inflammation
|
J:135154
|
increased inflammatory response
|
J:188686
|
insulitis
|
J:135154
|
lacrimal gland inflammation
|
J:135154
|
salivary gland inflammation
|
J:135154
|
thyroid gland inflammation
|
J:135154
|
Airetm1Mand/Airetm1.1Doi
(NOD.129-Airetm1Mand/Airetm1.1Doi)
|
chronic pancreas inflammation
|
J:135154
|
insulitis
|
J:135154
|
lacrimal gland inflammation
|
J:135154
|
lung inflammation
|
J:135154
|
salivary gland inflammation
|
J:135154
|
stomach inflammation
|
J:135154
|
thyroid gland inflammation
|
J:135154
|
uveitis
|
J:135154
|
Airetm1Mand/Airetm1Mand
(involves: 129P2/OlaHsd * C57BL/6)
|
eye inflammation
|
J:135154
|
lacrimal gland inflammation
|
J:135154
|
salivary gland inflammation
|
J:135154
|
Airetm1Mmat/Airetm1Mmat
(involves: C57BL/6 * CBA)
|
lacrimal gland inflammation
|
J:96580
|
pancreas inflammation
|
J:96580
|
parotid gland inflammation
|
J:96580
|
stomach inflammation
|
J:96580
|
submandibular gland inflammation
|
J:96580
|
Airetm1Mmat/Airetm1Mmat
(C.Cg-Airetm1Mmat)
|
stomach inflammation
|
J:96580
|
Airetm1Mmat/Airetm1Mmat
(B6.Cg-Airetm1Mmat)
|
salivary gland inflammation
|
J:96580
|
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
|
liver inflammation
|
J:77873
|
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn)
|
liver inflammation
|
J:115076
|
Airetm1Ptsn/Airetm1Ptsn
(C57BL/6-Airetm1Ptsn)
|
parotid gland inflammation
|
J:145910
|
sublingual gland inflammation
|
J:145910
|
uveitis
|
J:145910
|
vitreous body inflammation
|
J:145910
|
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn)
|
stomach inflammation
|
J:174653
|
Ak7Gt(OST434404)Lex/Ak7Gt(OST434404)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
rhinosinusitis
|
J:185566
|
Ak7Tg(tetO-Hmox1)67Sami/Ak7Tg(tetO-Hmox1)67Sami
(FVB/N-Ak7Tg(tetO-Hmox1)67Sami)
|
respiratory system inflammation
|
J:186062
|
rhinitis
|
J:186062
|
Akap12tm1Ihg/Akap12tm1Ihg
(involves: 129S4/SvJae * C57BL/6)
|
liver inflammation
|
J:138882
|
Aknatm1Mak/Aknatm1Mak
(B6.129P2-Aknatm1Mak)
|
alveolitis
|
J:233952
|
increased acute inflammation
|
J:233952
|
lung inflammation
|
J:233952
|
Akr1b8tm1Dgen/Akr1b8tm1Dgen
(Not Specified)
|
increased susceptibility to induced colitis
|
J:301852
|
Akr1c21em1Wany/Akr1c21em1Wany
(involves: C57BL/6)
|
increased acute inflammation
|
J:322353
|
lung inflammation
|
J:322353
|
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6N)
|
kidney inflammation
|
J:276210
|
liver inflammation
|
J:276210
|
lung inflammation
|
J:276210
|
peritoneal inflammation
|
J:276210
|
Aldh18a1tm1a(KOMP)Wtsi/Aldh18a1+
(C57BL/6N-Aldh18a1tm1a(KOMP)Wtsi/Wtsi)
|
skin inflammation
|
J:232539
|
Aldobtm1(KOMP)Vlcg/Aldobtm1(KOMP)Vlcg
(C57BL/6NTac-Aldobtm1(KOMP)Vlcg)
|
liver inflammation
|
J:220330
|
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
tubulointerstitial nephritis
|
J:100403
|
Alox5aptm1Jdm/Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm)
|
decreased susceptibility to induced arthritis
|
J:100736
|
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm)
|
decreased susceptibility to induced arthritis
|
J:100736
|
Alox8tm1a(KOMP)Wtsi/Alox8tm1a(KOMP)Wtsi
(C57BL/6N-Alox8tm1a(KOMP)Wtsi/MbpMmucd)
|
lung inflammation
|
J:277623
|
Alox15tm1Fun/Alox15tm1Fun
(B6.129S2-Alox15tm1Fun/J)
|
dermatitis
|
J:119405
|
Als2tm1Jei/Als2tm1Jei
(involves: 129P2/OlaHsd * C57BL/6J)
|
CNS inflammation
|
J:104446
|
amdA/J/amdA/J
(involves: A/J * C57BL/6J)
|
myocarditis
|
J:2843,
J:11025
|
amdDBA/2J/amdDBA/2J
(B10.D2-H8b/(57N)SnJ)
|
myocarditis
|
J:11025
|
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm)
|
liver inflammation
|
J:221247
|
Ampd3tm1Tm/Ampd3tm1Tm
(Not Specified)
|
lung inflammation
|
J:201211
|
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
glomerulonephritis
|
J:199427
|
Ankank/Ankank
(involves: C3HeB/FeJ * C57BL/6J * JGBF/LeJ)
|
autoimmune arthritis
|
J:63420
|
Ano5em1Huyi/Ano5em1Huyi
(C57BL/6N-Ano5em1Huyi)
|
periodontium inflammation
|
J:294237
|
Ano5em2Huyi/Ano5em2Huyi
(C57BL/6-Ano5em2Huyi)
|
osteomyelitis
|
J:336715
|
Anta/Anta+
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
glomerulonephritis
|
J:169366
|
Anxa1tm1Rjf/Anxa1+
(Not Specified)
|
increased inflammatory response
|
J:81498
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified)
|
increased inflammatory response
|
J:81498
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: BALB/c)
|
increased susceptibility to induced colitis
|
J:142735
|
Anxa7tm1Pll/Anxa7+
(Not Specified)
|
pancreas inflammation
|
J:58572
|
Aod1aA/J/?
(involves: A/J * C57BL/6J)
|
ovary inflammation
|
J:83714
|
Aod1bC57BL/6J/?
(involves: A/J * C57BL/6J)
|
ovary inflammation
|
J:83714
|
Aod3A/J/?
(A/J)
|
ovary inflammation
|
J:78005
|
aol/aol
(involves: C3H * C57BL/6)
|
osteoarthritis
|
J:115238
|
Ap3b1pe/Ap3b1pe Hps1ep/Hps1ep
(involves: C3H/He * C3HeB/FeJ * C57BL/6J)
|
lung inflammation
|
J:85431
|
ApcMin/Apc+ Esr2tm1Mma/Esr2tm1Mma
(involves: 129S2/SvPas * C57BL/6J)
|
colitis
|
J:118600
|
Apctm1Tno/Apc+ Ptentm2Mak/Ptentm2Mak Tg(Cyp1a1-cre/ERT)1Dwi/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)
|
peritoneal inflammation
|
J:143082
|
Apctm2.1Cip/Apctm2.1Cip Lect2tm1Ymg/Lect2tm1Ymg Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
liver inflammation
|
J:184496
|
Apctm2.1Cip/Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
liver inflammation
|
J:184496
|
Apcstm1Mpe/Apcs+
(B6.Cg-Apcstm1Mpe)
|
glomerulonephritis
|
J:90502
|
Apcstm1Mpe/Apcstm1Mpe
(B6.Cg-Apcstm1Mpe)
|
glomerulonephritis
|
J:90502
|
Apcstm1Mpe/Apcstm1Mpe
(129.Cg-Apcstm1Mpe)
|
glomerulonephritis
|
J:90502
|
Apex1tm1Ecf/Apex1+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
heart inflammation
|
J:70397
|
myocarditis
|
J:70397
|
pericarditis
|
J:70397
|
Apoa4tm1Bres/Apoa4tm1Bres
(B6.129S4-Apoa4tm1Bres)
|
increased susceptibility to induced colitis
|
J:91357
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
aortitis
|
J:227165
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
blood vessel inflammation
|
J:91058
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:83615
|
Apoetm1Unc/Apoetm1Unc Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr)
|
glomerulonephritis
|
J:121671
|
Apoetm1Unc/Apoetm1Unc Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc)
|
blood vessel inflammation
|
J:91058
|
kidney inflammation
|
J:200141
|
Apoetm1Unc/Apoetm1Unc Gja5tm1Mchn/Gja5tm1Mchn Tg(TIE2-lacZ)182Sato/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
alveolitis
|
J:162224
|
Apoetm1Unc/Apoetm1Unc Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
lung inflammation
|
J:83615
|
Apoetm1Unc/Apoetm1Unc Klf15tm2Jain/Klf15tm2Jain Tg(Tagln-cre)1Jjl/0
(involves: 129P2/OlaHsd * FVB/N)
|
blood vessel inflammation
|
J:203920
|
Apoetm1Unc/Apoetm1Unc Soat1tm1Far/Soat1tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
skin inflammation
|
J:61147
|
Apoetm1Unc/Apoetm1Unc Tg(MSR1-Plau)1Ddi/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
heart inflammation
|
J:101486
|
Apptm2.1Ldad/Apptm2.1Ldad
(involves: 129 * C57BL/6J)
|
myositis
|
J:166989
|
Apptm3.1Tcs/Apptm3.1Tcs Mapttm1.1(MAPT)Tcs/Mapttm1.1(MAPT)Tcs
(involves: 129S/SvEv * C57BL/6)
|
CNS inflammation
|
J:278451
|
Aprttm1Dwm/Aprttm1Dwm
(129P2/OlaHsd-Aprttm1Dwm)
|
pyelonephritis
|
J:38450
|
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * Black Swiss)
|
kidney inflammation
|
J:33255
|
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * C57BL/6J)
|
kidney inflammation
|
J:33255
|
Aprttm1Vri/Aprttm1Vri
(involves: 129P2/OlaHsd * C57BL/6)
|
kidney inflammation
|
J:50874
|
Aqp3m1Btlr/Aqp3m1Btlr
(C57BL/6J-Aqp3m1Btlr)
|
increased susceptibility to induced colitis
|
J:153279
|
Aqp12tm1Rai/Aqp12tm1Rai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to induced pancreatitis
|
J:155920
|
Artm1Verh/Y Rnase10tm1(cre)Hht/Rnase10+
(involves: 129S7/SvEvBrd * C57BL/6)
|
testis inflammation
|
J:173897
|
Aregtm1Dle/Aregtm1Dle Egftm1Dle/Egftm1Dle Tgfatm1Unc/Tgfatm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
dermatitis
|
J:54980
|
Arhgap17Gt(RRN062)Byg/Arhgap17Gt(RRN062)Byg
(B6.129P2-Arhgap17Gt(RRN062)Byg)
|
increased susceptibility to induced colitis
|
J:277297
|
Arhgap25tm1a(KOMP)Wtsi/Arhgap25tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
increased acute inflammation
|
J:240521
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA)
|
tubulointerstitial nephritis
|
J:57995
|
Arid5bGt(ROSA)75Sor/Arid5bGt(ROSA)75Sor
(involves: 129S4/SvJaeSor)
|
kidney inflammation
|
J:117491
|
Arih2tm1Mak/Arih2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
dermatitis
|
J:191066
|
heart inflammation
|
J:191066
|
increased inflammatory response
|
J:191066
|
liver inflammation
|
J:191066
|
lung inflammation
|
J:191066
|
Arih2tm1Mak/Arih2tm1Mak
(B6.129P2-Arih2tm1Mak)
|
increased inflammatory response
|
J:191066
|
Arl3Gt(OST263303)Lex/Arl3Gt(OST263303)Lex
(involves: 129S5/SvEvBrd)
|
bile duct inflammation
|
J:107331
|
Arpc4tm1c(EUCOMM)Wtsi/Arpc4tm1c(EUCOMM)Wtsi Krt14tm1(cre)Wbm/Krt14+
(B6.Cg-Arpc4tm1c(EUCOMM)Wtsi Krt14tm1(cre)Wbm)
|
dermatitis
|
J:253986
|
Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6)
|
increased acute inflammation
|
J:112607
|
increased susceptibility to endotoxin shock
|
J:112607
|
asa/asa
(either: A/J or BALB/c or DBA/2J)
|
myocarditis
|
J:2843
|
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
|
lung inflammation
|
J:285931
|
Ash1lGt(AL0395)Wtsi/Ash1lGt(AL0395)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J)
|
blepharitis
|
J:227516
|
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu)
|
glomerulonephritis
|
J:208213
|
increased susceptibility to endotoxin shock
|
J:208213
|
increased susceptibility to induced arthritis
|
J:208213
|
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf/Il6tm1Kopf
(B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf)
|
increased susceptibility to induced arthritis
|
J:208213
|
Asm2MRL/MpJ/?
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
salivary gland inflammation
|
J:66459
|
Asq1IQI/Asq1IQI
(involves: IQI * C57BL/6CrSlc)
|
salivary gland inflammation
|
J:127310
|
Atf2tm1Glm/Atf2tm1Glm
(involves: 129S2/SvPas)
|
eye inflammation
|
J:30611
|
Atf2tm1Glm/Atf2tm1Glm
(C.Cg-Atf2tm1Glm)
|
increased susceptibility to endotoxin shock
|
J:67176
|
Atf3tm1Dron/Atf3tm1Dron
(involves: 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:140112
|
Atg5tm1Myok/Atg5tm1Myok Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
glomerulonephritis
|
J:235399
|
Atg7tm1Tchi/Atg7tm1Tchi Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
glomerulonephritis
|
J:235399
|
Atg7tm1Tchi/Atg7tm1Tchi Xbp1tm2Glm/Xbp1tm2Glm Tg(Defa6-icre)1Rsb/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
small intestinal inflammation
|
J:206084
|
Atg7tm1Tchi/Atg7tm1Tchi Xbp1tm2Glm/Xbp1tm2Glm Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
ileum inflammation
|
J:206084
|
intestinal inflammation
|
J:206084
|
Atg16l1tm1Aki/Atg16l1tm1Aki
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to induced colitis
|
J:141420
|
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi Tcrdtm1Mom/Tcrdtm1Mom Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N * SJL)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:340266
|
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi Tg(Defa6-icre)1Rsb/0
(involves: C57BL/6)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:340266
|
increased susceptibility to induced colitis
|
J:340266
|
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi Tg(Vil1-cre)997Gum/?
(involves: C57BL/6J * C57BL/6N * SJL)
|
cecum inflammation
|
J:221019
|
Atg16l1tm1Kuv/Atg16l1tm1Kuv Tg(Vil1-cre)997Gum/0
(B6.Cg-Atg16l1tm1Kuv Tg(Vil1-cre)997Gum)
|
increased susceptibility to induced colitis
|
J:269933
|
small intestinal inflammation
|
J:269933
|
Atg16l1tm1Kuv/Atg16l1tm1Kuv Tg(Vil1-cre)997Gum/0 Xbp1tm2Glm/Xbp1tm2Glm
(B6.Cg-Atg16l1tm1Kuv Xbp1tm2Glm Tg(Vil1-cre)997Gum)
|
small intestinal inflammation
|
J:269933
|
Atg16l1tm1Kuv/Atg16l1tm1Kuv Xbp1tm2Glm/Xbp1tm2Glm Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
ileum inflammation
|
J:206084
|
intestinal inflammation
|
J:206084
|
Atl1tm1.2Cbla/Atl1tm1.2Cbla Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6.Cg-Reep1Gt(OST398247)Tigm Atl1tm1.2Cbla)
|
increased susceptibility to otitis media
|
J:334532
|
Atp7aMo-blo/Y
(B6.Cg-Atp7aMo-blo/J)
|
osteoarthritis
|
J:36378
|
Atrtm1Bal/Atrtm2Bal Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
kidney inflammation
|
J:123200
|
Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J)
|
blepharitis
|
J:308387
|
eye inflammation
|
J:308387
|
Awat2tm1.2Golc/Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J)
|
blepharitis
|
J:308387
|
eye inflammation
|
J:308387
|
Axltm1Grl/Axltm1Grl Mertktm1Grl/Mertktm1Grl Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
joint inflammation
|
J:70420
|
B2mtm1Jae/B2mtm1Jae Foxp3sfOtcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
dermatitis
|
J:20865
|
B2mtm1Jae/B2mtm1Jae Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
B2mtm1Unc/B2mtm1Unc
(involves: 129P2/OlaHsd * NOD/Lt)
|
insulitis
|
J:93557
|
B2mtm1Unc/B2mtm1Unc Il2tm1Hor/Il2tm1Hor
(involves: 129 * C57BL/6)
|
colitis
|
J:39981,
J:51450
|
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J)
|
increased susceptibility to induced colitis
|
J:123826
|
B3gnt6tm1Lx/B3gnt6tm1Lx C1galt1tm1.1Rpmc/C1galt1tm1.1Rpmc Tg(Vil1-cre)997Gum/0
(involves: 129S1/Sv * C57BL/6J * SJL)
|
small intestinal inflammation
|
J:239765
|
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
glomerulonephritis
|
J:117891
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
colitis
|
J:123547
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
colitis
|
J:169839
|
liver inflammation
|
J:169839
|
lung inflammation
|
J:169839
|
B9d2/Tgfb1tm1Flv/B9d2+ Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
colitis
|
J:169839
|
liver inflammation
|
J:169839
|
lung inflammation
|
J:169839
|
Bag4tm1Yeh/Bag4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:83559
|
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm2Sjk Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
autoimmune arthritis
|
J:100463
|
glomerulonephritis
|
J:100463
|
Bap1tm1.1Geno/Bap1tm1.1Geno Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
heart inflammation
|
J:187380
|
Bbaa10C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa11C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa12C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa13C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa14C3H/HeJ/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa16C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa17C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa18C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa20C3H/HeJ/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa22C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bbaa23C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased inflammatory response
|
J:73060
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:292505
|
Bcas1tm1Himo/Bcas1tm1Himo
(C57BL/6-Bcas1tm1Himo)
|
brain inflammation
|
J:242041
|
Bcl2l11tm1.1Ast/Bcl2l11+
(involves: 129S1/Sv * C57BL/6)
|
glomerulonephritis
|
J:58641
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
glomerulonephritis
|
J:58641
|
increased inflammatory response
|
J:58641
|
Bcl6tm1Gdba/Bcl6tm1Gdba Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
white adipose tissue inflammation
|
J:271078
|
Bcl6tm1Htno/Bcl6tm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:55952
|
myocarditis
|
J:55952
|
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv)
|
heart inflammation
|
J:40769
|
increased inflammatory response
|
J:40769
|
liver inflammation
|
J:40769
|
lung inflammation
|
J:40769
|
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
|
heart inflammation
|
J:40769
|
increased inflammatory response
|
J:40769
|
liver inflammation
|
J:40769
|
lung inflammation
|
J:40769
|
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas)
|
increased susceptibility to endotoxin shock
|
J:23804
|
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp)
|
liver inflammation
|
J:273501
|
Becn1tm1Ebr/Becn1tm1Ebr Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
glomerulonephritis
|
J:235399
|
Best3tm1.1Zhoj/Best3tm1.1Zhoj Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * SJL)
|
aortitis
|
J:338981
|
Bgntm1Mfy/Y
(involves: 129S4/SvJae * C57BL/6)
|
osteoarthritis
|
J:76203
|
Bgntm1Mfy/Y Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
osteoarthritis
|
J:76203
|
Bgntm1Mfy/Y Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
accelerated temporomandibular joint osteoarthritis
|
J:112779,
J:117908
|
Bgntm1Mfy/Bgntm1Mfy
(involves: 129S4/SvJae)
|
osteoarthritis
|
J:222369
|
Bgntm1Mfy/Bgntm1Mfy Epyctm1Mhok/Epyctm1Mhok
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
osteoarthritis
|
J:222369
|
Bgntm1Mfy/Bgntm1Mfy Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
accelerated temporomandibular joint osteoarthritis
|
J:117908
|
Bin1tm1Gcp/Bin1tm2Gcp Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
endometrium inflammation
|
J:117330
|
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6)
|
liver inflammation
|
J:133313
|
lung inflammation
|
J:133313
|
Bld/Bld+
(involves: BALB/cCi)
|
increased incidence of corneal inflammation
|
J:5076
|
Blmhtm1Geh/Blmhtm1Geh
(either: (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
dermatitis
|
J:54585
|
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J)
|
lung inflammation
|
J:4098
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
increased incidence of corneal inflammation
|
J:110697
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
lung inflammation
|
J:17712
|
Bmp7tm1.1Dgra/Bmp7tm1.1Dgra Tg(Prrx1-cre)1Cjt/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * SJL/J)
|
joint inflammation
|
J:221175
|
osteoarthritis
|
J:221175
|
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
stomach inflammation
|
J:163367
|
Bmpr1atm2.1Bhr/Bmpr1atm2.2Bhr Tg(Gdf5-cre,-ALPP)1Kng/0
(involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng)
|
osteoarthritis
|
J:97780
|
Bmxtm1Ali/Bmxtm1Ali
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to induced arthritis
|
J:173099
|
Bpitm1.1Buls/Bpitm1.1Buls
(involves: BALB/cJ * C57BL/6J)
|
increased susceptibility to induced colitis
|
J:346703
|
Bpifa1m1Ingm/Bpifa1m1Ingm
(involves: C3HeB/FeJ)
|
increased susceptibility to otitis media
|
J:221346
|
lung inflammation
|
J:195535
|
Braftm1Mmcm/Braftm1Mmcm Cd207tm2.1(cre)Bjec/Cd207+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
liver inflammation
|
J:211690
|
lung inflammation
|
J:211690
|
Braftm1Mmcm/Braftm1Mmcm Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
cytokine storm
|
J:211690
|
increased inflammatory response
|
J:211690
|
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
|
dermatitis
|
J:155810
|
Brf1tm1Arte/Brf1tm1Arte Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA)
|
liver inflammation
|
J:285667
|
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas * C57BL/6J)
|
interstitial pneumonia
|
J:46376
|
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129/Sv * 129S2/SvPas)
|
interstitial pneumonia
|
J:46376
|
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas)
|
glomerulonephritis
|
J:287636
|
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
|
increased susceptibility to induced colitis
|
J:92639
|
Btnl2em1Wche/Btnl2em1Wche
(C57BL/6-Btnl2em1Wche)
|
large intestinal inflammation
|
J:321348
|
Btrctm1Paga/Btrctm1Paga Fbxw11tm1Ybn/Fbxw11tm1Ybn Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
intestinal inflammation
|
J:206654
|
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd)
|
glomerulonephritis
|
J:145903
|
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ X/Yaa
(B10.BXSB-(D13Mit3-D13Mit78) Yaa)
|
glomerulonephritis
|
J:145049
|
C1galt1ptl1/C1galt1ptl1
(C57BL/6-C1galt1ptl1)
|
glomerulonephritis
|
J:115272
|
kidney inflammation
|
J:115272
|
C1galt1ptl1/C1galt1ptl1 Rag1tm1Bal/Rag1tm1Bal
(involves: 129S4/SvJae * C57BL/6)
|
kidney inflammation
|
J:115272
|
C1qatm1Mjw/C1qatm1Mjw
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
|
glomerulonephritis
|
J:47315
|
C1qtnf3tm1Yiw/C1qtnf3tm1Yiw
(involves: C57BL/6NSlc)
|
increased susceptibility to induced arthritis
|
J:211893
|
joint inflammation
|
J:211893
|
C1qtnf4em1Smoc/C1qtnf4em1Smoc
(C57BL/6J-C1qtnf4em1Smoc/Smoc)
|
increased susceptibility to endotoxin shock
|
J:302282
|
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
|
increased susceptibility to induced arthritis
|
J:227217
|
increased susceptibility to type III hypersensitivity reaction
|
J:227217
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
liver inflammation
|
J:30152
|
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr)
|
brain inflammation
|
J:123658
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae)
|
glomerulonephritis
|
J:44715
|
C3tm1Crr/C3tm1Crr Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6)
|
insulitis
|
J:122114
|
C3tm1Pkna/C3tm1Pkna
(D1.129P2-C3tm1Pkna)
|
decreased susceptibility to induced arthritis
|
J:88872
|
C3ar1tm1Raw/C3ar1tm1Raw
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:68807
|
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
increased susceptibility to type I hypersensitivity reaction
|
J:80071
|
C3ar1tm1Raw/C3ar1tm1Raw Cpn1tm1Raw/Cpn1tm1Raw
(B6.129-C3ar1tm1Raw Cpn1tm1Raw)
|
increased acute inflammation
|
J:148315
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
liver inflammation
|
J:30152
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J)
|
glomerulonephritis
|
J:111811
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae)
|
glomerulonephritis
|
J:44715
|
C5ar2tm1Cge/C5ar2tm1Cge
(B6.129S1-C5ar2tm1Cge)
|
increased inflammatory response
|
J:104092
|
C9orf72tm1.1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
|
dermatitis
|
J:240357
|
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
brain inflammation
|
J:240357
|
dermatitis
|
J:240357
|
liver inflammation
|
J:240357
|
C9orf72tm1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
|
dermatitis
|
J:240357
|
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
|
dermatitis
|
J:240357
|
Cacna1ctm2Itl/Cacna1c+
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
dermatitis
|
J:201506
|
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
|
rhinitis
|
J:92396
|
Camk2gtm1.1Irt/Camk2gtm1.1Irt
(involves: C57BL/6J)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:243363
|
increased susceptibility to induced colitis
|
J:243363
|
Camptm1Rlg/Camptm1Rlg
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of corneal inflammation
|
J:199719
|
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
eye inflammation
|
J:234044
|
Car2tm1(KOMP)Vlcg/Car2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
pyelonephritis
|
J:216402
|
Card11m1Btlr/Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
|
dermatitis
|
J:149767,
J:139069
|
Card11tm1.1Litt/Card11tm1.1Litt Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
respiratory system inflammation
|
J:180410
|
Card11tm1Xav/Card11tm1Xav
(involves: 129 * C57BL/6)
|
lung inflammation
|
J:132226
|
Card11unm/Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu)
|
dermatitis
|
J:84042
|
erythroderma
|
J:84042
|
increased inflammatory response
|
J:84042
|
Card14em1Tshu/Card14em1Tshu
(C57BL/6-Card14em1Tshu)
|
decreased susceptibility to chemically induced skin inflammation
|
J:289239
|
Card14em2Tshu/Card14+
(involves: C57BL/6)
|
skin inflammation
|
J:289239
|
Card14em3Tshu/Card14+
(involves: C57BL/6)
|
skin inflammation
|
J:289239
|
Card14em9Lutzy/Card14+
(C57BL/6J-Card14em9Lutzy/J)
|
skin inflammation
|
J:262723
|
Card14tm1Lex/Card14tm1Lex
(B6.129S-Card14tm1Lex)
|
decreased susceptibility to chemically induced skin inflammation
|
J:253409
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del
(B6.129S2-Casp1tm1Flv)
|
increased susceptibility to induced colitis
|
J:173245
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del Slc11a1s/Slc11a1s
(B6.129S2-Casp1tm1Flv)
|
cecum inflammation
|
J:124378
|
Casp8tm1.1Raz/Casp8tm1.1Raz Ripk3tm1Vmd/Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased inflammatory response
|
J:170815
|
Casp8tm1Clie/Casp8tm1Clie Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
liver inflammation
|
J:218665
|
Casp8tm1Hed/Casp8tm1Hed Tg(KRT14-cre)1Efu/0
(Not Specified)
|
dermatitis
|
J:167299
|
Casp12tm1Dwni/Casp12tm1Dwni
(involves: 129S1/SvImJ * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:144912
|
CasrNuf/CasrNuf
(involves: 102/El * C3H/He)
|
tongue inflammation
|
J:92612
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
lung inflammation
|
J:87282
|
Cav1tm1Mls/Cav1tm1Mls Cav3tm1Mls/Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
heart inflammation
|
J:77372
|
Cbfa2t2tm1Swh/Cbfa2t2tm1Swh
(either: B6.129S6-Cbfa2t2tm1Swh or (involves: 129S6/SvEvTac * C57BL/6))
|
small intestinal inflammation
|
J:102172
|
Cbfbtm1Itan/Cbfbtm1Itan Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
lung inflammation
|
J:125953
|
Cbltm1.1Hua/Cbltm1.1Hua Lattm1Les/Lattm1Les
(involves: 129P2/OlaHsd)
|
liver inflammation
|
J:91369
|
lung inflammation
|
J:91369
|
Cbltm1.1Hua/Cbltm1.1Hua Lcp2tm1Gak/Lcp2tm1Gak
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
liver inflammation
|
J:91369
|
lung inflammation
|
J:91369
|
Cbltm2Hua/Cbltm2Hua Cblbtm1Hua/Cblbtm1Hua Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
dermatitis
|
J:80427
|
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
liver inflammation
|
J:101303
|
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm)
|
increased susceptibility to otitis media
|
J:147413
|
sinus inflammation
|
J:147413
|
Ccl3tm1Unc/Ccl3tm1Unc
(involves: 129P2/OlaHsd)
|
cecum inflammation
|
J:107677
|
Ccl3tm1Unc/Ccl3tm1Unc Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
CNS inflammation
|
J:90687
|
Ccl21atm1Yout/Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
lacrimal gland inflammation
|
J:244640
|
Ccl25tm1.1Mal/Ccl25tm1.1Mal Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
intestinal inflammation
|
J:136667
|
Ccl27aem1Nax/Ccl27aem1Nax Ccl27alem1Nax/Ccl27alem1Nax Ccl27bem1Nax/Ccl27bem1Nax
(involves: C57BL/6)
|
increased susceptibility to chemically induced skin inflammation
|
J:330550
|
Ccl27aem1Nax/Ccl27aem1Nax Ccl27alem1Nax/Ccl27alem1Nax Ccl27bem1Nax/Ccl27bem1Nax Ccr10tm1.1Nax/Ccr10+
(involves: C57BL/6)
|
uterus inflammation
|
J:330550
|
Ccl28tm1Takna/Ccl28tm1Takna
(C57BL/6J-Ccl28tm1Takna)
|
increased susceptibility to induced colitis
|
J:256896
|
Ccm2tm1Kwhi/Ccm2tm1.1Kwhi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/?
(involves: C57BL/6 * CBA)
|
CNS inflammation
|
J:173947
|
Ccnt1Gt(RRR115)Byg/Ccnt1Gt(RRR115)Byg
(involves: 129P2/OlaHsd)
|
lacrimal gland inflammation
|
J:130071
|
salivary gland inflammation
|
J:130071
|
Ccpg1tm1a(EUCOMM)Hmgu/Ccpg1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ccpg1tm1a(EUCOMM)Hmgu)
|
pancreas inflammation
|
J:256708
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae)
|
glomerulonephritis
|
J:115119
|
increased susceptibility to type IV hypersensitivity reaction
|
J:115119
|
lung inflammation
|
J:43569
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
|
cecum inflammation
|
J:107677
|
Ccr1tm1Gao/Ccr1tm1Gao
(B6.129S4-Ccr1tm1Gao)
|
bronchiolitis
|
J:162707
|
Ccr2tm1Blck/Ccr2tm1Blck Faslpr/Faslpr
(MRL.Cg-Ccr2tm1Blck Faslpr)
|
glomerulonephritis
|
J:113343
|
kidney inflammation
|
J:113343
|
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR)
|
liver inflammation
|
J:111517
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to induced colitis
|
J:110814
|
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae)
|
bronchiolitis
|
J:162707
|
Ccr5tm1Brv/Ccr5tm1Brv
(either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR))
|
increased susceptibility to type IV hypersensitivity reaction
|
J:46941
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz)
|
bronchiolitis
|
J:162707
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor)
|
increased inflammatory response
|
J:110910
|
lacrimal gland inflammation
|
J:110910
|
parotid gland inflammation
|
J:110910
|
salivary gland inflammation
|
J:110910
|
submandibular gland inflammation
|
J:110910
|
Ccr9tm1.1Mal/Ccr9tm1.1Mal Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
intestinal inflammation
|
J:136667
|
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
myocarditis
|
J:126220
|
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
lung inflammation
|
J:177038
|
Cd1d1tm1Crw/Cd1d1tm1Crw
(B6.129S4-Cd1d1tm1Crw)
|
decreased susceptibility to induced arthritis
|
J:99107
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc)
|
glomerulonephritis
|
J:121187
|
kidney inflammation
|
J:121187
|
Cd2apem1Irgu/Cd2apem1Irgu
(C57BL/6-Cd2apem1Irgu)
|
kidney inflammation
|
J:294238
|
Cd3etm1Mal/Cd3etm1Mal Nlrp1aNeut1/Nlrp1aNeut1
(involves: C57BL/6)
|
skin inflammation
|
J:191055
|
Cd4tm1Mak/Cd4tm1Mak
(PL.129S2(B6)-Cd4tm1Mak/Rdgz)
|
brain inflammation
|
J:92227
|
Cd4tm1Mak/Cd4tm1Mak
(SJL.129S2(B6)-Cd4tm1Mak/Rdgz)
|
brain inflammation
|
J:92227
|
Cd4tm1Mak/Cd4tm1Mak Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Cd19tm1(cre)Cgn/Cd19+ Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
arteritis
|
J:147840
|
glomerulonephritis
|
J:147840
|
kidney inflammation
|
J:147840
|
Cd28tm1Jmg/Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg)
|
increased susceptibility to type I hypersensitivity reaction
|
J:149888
|
Cd28tm1Ltu/Cd28tm1Ltu Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
skin inflammation
|
J:194503
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:149888
|
Cd28tm1Mak/Cd28tm1Mak
(B6.129S2-Cd28tm1Mak/J)
|
brain inflammation
|
J:57613
|
Cd28tm1Mak/Cd28tm1Mak Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak)
|
insulitis
|
J:93421
|
Cd28tm1Mak/Cd28tm1Mak Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
esophageal inflammation
|
J:205692
|
Cd36obl/Cd36obl
(C57BL/6-Cd36obl)
|
endophthalmitis
|
J:96018
|
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ)
|
insulitis
|
J:108097
|
Cd40tm1Kik/Cd40tm1Kik Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
|
glomerulonephritis
|
J:113556
|
Cd44tm1Hbg/Cd44+ Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
ileum inflammation
|
J:145626
|
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ)
|
increased acute inflammation
|
J:131974
|
Cd44tm1Hbg/Cd44tm1Hbg Tg(TNF)197Gkl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
autoimmune arthritis
|
J:97992
|
Cd44tm1Mak/Cd44tm1Mak
(B6.129P2-Cd44tm1Mak)
|
liver inflammation
|
J:69351
|
lung inflammation
|
J:111216,
J:108245
|
Cd44tm1Mak/Cd44tm1Mak
(D1.129P2-Cd44tm1Mak)
|
increased susceptibility to induced arthritis
|
J:95275
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
peritoneal inflammation
|
J:155691
|
Cd44tm2Kmz/Cd44tm2Kmz
(DBA/1LacJ-Cd44tm2Kmz)
|
decreased susceptibility to induced arthritis
|
J:74268
|
Cd55tm1Song/Cd55tm1Song Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm)
|
myositis
|
J:113567
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129)
|
increased susceptibility to induced arthritis
|
J:146711
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
lung inflammation
|
J:123582
|
myositis
|
J:113567
|
Cd69tm1Naka/Cd69tm1Naka
(C.129P2-Cd69tm1Naka)
|
decreased susceptibility to induced arthritis
|
J:84940
|
Cd72c/Cd72c Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
liver inflammation
|
J:204782
|
lung inflammation
|
J:204782
|
Cd72tm1Tsub/Cd72tm1Tsub
(involves: C57BL/6J)
|
glomerulonephritis
|
J:204782
|
lung inflammation
|
J:204782
|
Cd72tm1Tsub/Cd72tm1Tsub Faslpr/Faslpr
(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)
|
glomerulonephritis
|
J:204782
|
liver inflammation
|
J:204782
|
lung inflammation
|
J:204782
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr)
|
brain inflammation
|
J:57613
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * NOD)
|
insulitis
|
J:61905
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(involves: 129S4/SvJae * FVB/N * NOD)
|
insulitis
|
J:113109
|
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs)
|
increased inflammatory response
|
J:209990
|
increased susceptibility to endotoxin shock
|
J:209990
|
Cd109tm1Mat/Cd109tm1Mat
(involves: 129S6/SvEvTac * C57BL/6J)
|
skin inflammation
|
J:188696
|
Cd151tm1Nki/Cd151tm1Nki
(involves: 129P2/OlaHsd * FVB/N)
|
tubulointerstitial nephritis
|
J:114988
|
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
lung inflammation
|
J:233977
|
Cd180tm1Kmiy/Cd180tm1Kmiy Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
blood vessel inflammation
|
J:137066
|
glomerulonephritis
|
J:137066
|
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods)
|
increased susceptibility to induced arthritis
|
J:65982
|
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(involves: C57BL/6)
|
increased inflammatory response
|
J:217719
|
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6)
|
urinary bladder inflammation
|
J:288225
|
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
|
increased susceptibility to induced arthritis
|
J:165841
|
Cd276tm1Lpc/Cd276tm1Lpc
(B6.129-Cd276tm1Lpc)
|
increased susceptibility to type I hypersensitivity reaction
|
J:237700
|
Cd276tm1Lpc/Cd276tm1Lpc
(D1J.129-Cd276tm1Lpc)
|
decreased susceptibility to induced arthritis
|
J:237700
|
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:84973
|
Cd276tm1Mak/Cd276tm1Mak
(C.129P2-Cd276tm1Mak)
|
increased inflammatory response
|
J:84973
|
Cd300lftm1Toki/Cd300lftm1Toki
(Not Specified)
|
increased susceptibility to type I hypersensitivity reaction
|
J:190979
|
respiratory system inflammation
|
J:190979
|
Cdcs1C3H/HeJBir/Cdcs1C57BL/6J
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn)
|
colitis
|
J:72978
|
Cdcs2C3H/HeJBir/Cdcs2C3H/HeJBir
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
|
intestinal inflammation
|
J:72978
|
Cdcs2C3H/HeJBir/Cdcs2C57BL/6J
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
|
intestinal inflammation
|
J:72978
|
Cdcs3C3H/HeJBir/Cdcs3C3H/HeJBir
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
|
intestinal inflammation
|
J:72978
|
Cdcs4C3H/HeJBir/Cdcs4C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
|
intestinal inflammation
|
J:72978
|
Cdcs4C57BL/6J/Cdcs4C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
|
intestinal inflammation
|
J:72978
|
Cdcs5C57BL/6J/Cdcs5C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
|
intestinal inflammation
|
J:72978
|
Cdcs6C57BL/6J/?
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
|
intestinal inflammation
|
J:72978
|
Cdcs7C3H/HeJBir/Cdcs7C3H/HeJBir
(involves: C3H/HeJBir * C57BL/6J)
|
intestinal inflammation
|
J:78917
|
Cdcs8C57BL/6J/Cdcs8C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
|
intestinal inflammation
|
J:78917
|
Cdcs9C3H/HeJBir/Cdcs9C3H/HeJBir
(involves: C3H/HeJBir * C57BL/6J)
|
intestinal inflammation
|
J:78917
|
Cdcs9C3H/HeJBir/Cdcs9C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
|
intestinal inflammation
|
J:78917
|
Cdcs10C3H/HeJBir/Cdcs10C3H/HeJBir
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn)
|
intestinal inflammation
|
J:78917
|
Cdcs10C3H/HeJBir/Cdcs10C57BL/6J
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn)
|
intestinal inflammation
|
J:72978
|
Cdh17M1Btlr/Cdh17M1Btlr
(C57BL/6J-Cdh17M1Btlr)
|
increased susceptibility to induced colitis
|
J:272090
|
Cdkn1atm1Led/Cdkn1atm1Led Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
|
glomerulonephritis
|
J:76041
|
increased inflammatory response
|
J:76041
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J)
|
decreased susceptibility to induced arthritis
|
J:108569
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
glomerulonephritis
|
J:60292,
J:70894
|
Cdsntm1.1Ics/Cdsntm1.1Ics Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S2/SvPas)
|
skin inflammation
|
J:153292
|
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
liver inflammation
|
J:136134
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
glomerulonephritis
|
J:25215
|
Cebpbtm3Nerl/Cebpbtm3Nerl
(either: B6.129P2-Cebpbtm3Nerl or (involves: 129P2/OlaHsd * C57BL/6))
|
myositis
|
J:153686
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
colitis
|
J:76024
|
conjunctivitis
|
J:76024
|
increased inflammatory response
|
J:76024
|
lung inflammation
|
J:76024
|
osteomyelitis
|
J:76024
|
peritoneal inflammation
|
J:76024
|
rhinitis
|
J:76024
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac)
|
colitis
|
J:76024
|
conjunctivitis
|
J:76024
|
increased inflammatory response
|
J:76024
|
lung inflammation
|
J:76024
|
osteomyelitis
|
J:76024
|
peritoneal inflammation
|
J:76024
|
pleuritis
|
J:76024
|
rhinitis
|
J:76024
|
Celsr1ctb-2J/Celsr1ctb-2J
(STOCK Celsr1ctb-2J/GrsrJ)
|
increased susceptibility to otitis media
|
J:229303
|
Celsr1ctb/Celsr1ctb
(CByJ.Cg-Celsr1ctb/GrsrJ)
|
increased susceptibility to otitis media
|
J:229303
|
Ces2atm1(KOMP)Vlcg/Ces2atm1(KOMP)Vlcg
(C57BL6/N-Ces2atm1(KOMP)Vlcg)
|
liver inflammation
|
J:335459
|
Cfbtm1Pkna/Cfbtm1Pkna
(D1.129P2-Cfbtm1Pkna)
|
decreased susceptibility to induced arthritis
|
J:88872
|
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129/Sv * C57BL/6)
|
glomerulonephritis
|
J:78193
|
increased susceptibility to type III hypersensitivity reaction
|
J:78193
|
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129)
|
glomerulonephritis
|
J:131403
|
Cfmq1129X1/SvJ/Cfmq1C57BL/6J Cftrtm1Unc/Cftrtm1Unc
(involves: 129X1/SvJ * C57BL/6J)
|
intestinal inflammation
|
J:101842
|
Cfmq2129X1/SvJ/Cfmq2129X1/SvJ Cftrtm1Unc/Cftrtm1Unc
(involves: 129X1/SvJ * C57BL/6J)
|
intestinal inflammation
|
J:101842
|
Cfmq3129X1/SvJ/Cfmq3C57BL/6J Cftrtm1Unc/Cftrtm1Unc
(involves: 129X1/SvJ * C57BL/6J)
|
intestinal inflammation
|
J:101842
|
Cfptm1Song/Cfptm1Song
(involves: 129 * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:165497
|
Cfptm2.1Song/Cfptm2.1Song Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased susceptibility to induced arthritis
|
J:165497
|
Cftrtm1Bay/Cftrtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
acute pancreas inflammation
|
J:15244
|
Cftrtm1Cam/Cftrtm1Cam
(involves: 129S/SvEv)
|
peritoneal inflammation
|
J:23850
|
Cftrtm1Hgu/Cftrtm1Hgu
(involves: 129P2/OlaHsd)
|
lung inflammation
|
J:24119
|
Cftrtm1Kth/Cftrtm1Kth
(involves: 129S7/SvEvBrd * C57BL/6J)
|
peritoneal inflammation
|
J:29074
|
Cftrtm1Kth/Cftrtm1Kth
(B6.129S7-Cftrtm1Kth)
|
lung inflammation
|
J:112450
|
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc/J)
|
lung inflammation
|
J:58571,
J:112450
|
Cftrtm1Unc/Cftrtm1Unc
(involves: 129P2/OlaHsd)
|
peritoneal inflammation
|
J:2079
|
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc)
|
lung inflammation
|
J:44904
|
Cftrtm1Unc/Cftrtm1Unc Tg(FABPCFTR)1Jaw/0 Tg(Scgb1a1-Scnn1b)6608Bouc/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)
|
respiratory system inflammation
|
J:191673
|
Cftrtm2Cam/Cftrtm2Cam
(involves: 129S/SvEv)
|
peritoneal inflammation
|
J:27734
|
Cftrtm2Mrc/Cftrtm2Mrc
(B6.129S6-Cftrtm2Mrc)
|
lung inflammation
|
J:112450
|
Cftrtm3Hgu/Cftrtm3Hgu
(involves: 129P2/OlaHsd)
|
gallbladder inflammation
|
J:32766
|
peritoneal inflammation
|
J:32766
|
Cftrtm3Mrc/Cftrtm3Mrc
(B6.129S6-Cftrtm3Mrc)
|
lung inflammation
|
J:112450
|
Cgnz1NZM2328/J/Cgnz1NZM2328/J
(involves: C57L/J * NZM2328/J)
|
kidney inflammation
|
J:71397
|
Chchd10em8Lutzy/Chchd10+
(C57BL/6NJ-Chchd10em8Lutzy/J)
|
increased susceptibility to otitis media
|
J:272524
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
arteritis
|
J:146176
|
heart inflammation
|
J:146176
|
interstitial pneumonia
|
J:146743
|
liver inflammation
|
J:146743
|
myocarditis
|
J:146743
|
Chd7Flo/Chd7+
(involves: C3HeB/FeJ)
|
keratoconjunctivitis sicca
|
J:104123
|
Chd7Looper/Chd7+
(BALB/c-Chd7Looper)
|
blepharitis
|
J:252089
|
conjunctivitis
|
J:252089
|
Chd7Ome/Chd7+
(involves: BALB/cByJ * C57BL/6J)
|
increased susceptibility to otitis media
|
J:187200
|
Chd7Trooper/Chd7+
(BALB/c-Chd7Trooper)
|
blepharitis
|
J:262283
|
conjunctivitis
|
J:262283
|
Chd7Whi/Chd7+
(involves: C3HeB/FeJ)
|
keratoconjunctivitis sicca
|
J:104123
|
Chrna3tm1Bay/Chrna3tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
urinary bladder inflammation
|
J:54994
|
Chrnb2tm1Mdb/Chrnb2tm1Mdb Chrnb4tm1Mdb/Chrnb4tm1Mdb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
urinary bladder inflammation
|
J:73590
|
Chsy1skt/Chsy1skt Pde6b+/Pde6b+
(mixed)
|
kidney inflammation
|
J:286529
|
Chsy1tm1Lex/Chsy1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
autoimmune arthritis
|
J:171883
|
Chuktm1Mpa/Chuktm1Mpa Ikbkbtm2Cgn/Ikbkbtm2Cgn Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to endotoxin shock
|
J:137861
|
Chuktm2Yhu/Chuktm2Yhu
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
skin inflammation
|
J:197037
|
Chuktm2Yhu/Chuktm2Yhu Tg(Lor-CHUK)8Yhu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
lung inflammation
|
J:197037
|
Cia2DBA/1J/Cia2DBA/1J
(involves: DBA/1J * FVB/N)
|
increased susceptibility to induced arthritis
|
J:116665
|
Cia5bRIIIS/J/?
(involves: C57BL/10 * RIIIS/J)
|
decreased susceptibility to induced arthritis
|
J:101767
|
Cia5bRIIIS/J/Cia5bRIIIS/J Cia32B10.RIII/Cia32RIIIS/J
(involves: C57BL/10 * RIIIS/J)
|
decreased susceptibility to induced arthritis
|
J:101767
|
Cia5cRIIIS/J/?
(involves: C57BL/10 * RIIIS/J)
|
decreased susceptibility to induced arthritis
|
J:101767
|
Cia7DBA/1J/Cia7C57BL/10SnSg
(involves: B10.Q * DBA/1)
|
increased inflammatory response
|
J:57012
|
Cia7DBA/1J/Cia7DBA/1J
(involves: B10.Q * DBA/1)
|
increased inflammatory response
|
J:57012
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia8DBA/1J/Cia8DBA/1J
(involves: B10.Q * DBA/1)
|
increased inflammatory response
|
J:57012
|
Cia9C57BL/10SnSg/Cia9NOD/ShiLtJ
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd)
|
increased inflammatory response
|
J:69981
|
Cia26RIIIS/J/Cia26RIIIS/J Cia30B10.RIII/?
(involves: B10.RIII * RIIIS/J)
|
autoimmune arthritis
|
J:95848
|
Cia30RIIIS/J/Cia30RIIIS/J Cia5B10.RIII/Cia5B10.RIII
(involves: B10.RIII * RIIIS/J)
|
decreased susceptibility to induced arthritis
|
J:95848
|
Cia31B10.RIII/Cia31RIIIS/J Cia5B10.RIII/Cia5B10.RIII
(involves: B10.RIII * RIIIS/J)
|
autoimmune arthritis
|
J:95848
|
Cia31B10.RIII/Cia31RIIIS/J Cia5RIIIS/J/Cia5RIIIS/J
(involves: C57BL/10 * RIIIS/J)
|
decreased susceptibility to induced arthritis
|
J:101767
|
Cia32B10.RIII/Cia32RIIIS/J Cia5B10.RIII/Cia5B10.RIII
(involves: B10.RIII * RIIIS/J)
|
autoimmune arthritis
|
J:95848
|
Cia34DBA/1J/Cia34DBA/1J
(involves: C57BL/10 * DBA/1J)
|
decreased susceptibility to induced arthritis
|
J:122130
|
Cia35C57BL/10SnSg/Cia35C57BL/10SnSg Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1)
|
decreased susceptibility to induced arthritis
|
J:122130
|
Cia35C57BL/10SnSg/Cia35DBA/1J
(involves: C57BL/10 * DBA/1J)
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia35C57BL/10SnSg/Cia35DBA/1J Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1)
|
decreased susceptibility to induced arthritis
|
J:122130
|
Cia35DBA/1J/Cia35DBA/1J Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1)
|
decreased susceptibility to induced arthritis
|
J:122130
|
Cia36DBA/1J/Cia36DBA/1J
(involves: C57BL/10 * DBA/1J)
|
decreased susceptibility to induced arthritis
|
J:122130
|
Cia37C57BL/10SnSg/Cia37DBA/1J
(involves: C57BL/10 * DBA/1J)
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia38DBA/1J/Cia38DBA/1J
(involves: C57BL/10 * DBA/1J)
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia39C57BL/10Sn/Cia39C57BL/10Sn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r)
|
decreased susceptibility to induced arthritis
|
J:97801
|
Cia39RIII/WySn/Cia39RIII/WySn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r)
|
autoimmune arthritis
|
J:97801
|
Cia40C57BL/10SnSg/Cia40C57BL/10SnSg
(involves: C57BL/10SnSg * DBA/1J * NFS/N)
|
increased susceptibility to induced arthritis
|
J:106522
|
Cia43DBA/1J/Cia43FVB/N
(involves: DBA/1J * FVB/N)
|
increased susceptibility to induced arthritis
|
J:146242
|
Cia43FVB/N/Cia43FVB/N
(involves: DBA/1J * FVB/N)
|
increased susceptibility to induced arthritis
|
J:146242
|
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
|
insulitis
|
J:107051
|
pancreas inflammation
|
J:106081
|
periinsulitis
|
J:106081
|
Cishtm1.1Cdon/Cishtm1.1Cdon Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased susceptibility to type I hypersensitivity reaction
|
J:204829
|
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
increased susceptibility to type I hypersensitivity reaction
|
J:204829
|
lung inflammation
|
J:204829
|
Clca1tm1.1Lex/Clca1tm1.1Lex
(involves: 129S/SvEvBrd)
|
increased inflammatory response
|
J:125158
|
lung inflammation
|
J:125158
|
Clcnkam1Btlr/Clcnkam1Btlr
(C57BL/6J-Clcnkam1Btlr)
|
increased susceptibility to induced colitis
|
J:271974
|
Clec2htm1.1Apma/Clec2htm1.1Apma
(B6(Cg)-Clec2htm1.1Apma)
|
kidney inflammation
|
J:322835
|
Clec2htm1.1Apma/Clec2htm1.1Apma Rag1tm1Mom/Rag1tm1Mom
(B6.Cg-Rag1tm1Mom Clec2htm1.1Apma)
|
kidney inflammation
|
J:322835
|
Clec4a2tm1.1Cfg/Clec4a2tm1.1Cfg
(involves: C57BL/6)
|
increased inflammatory response
|
J:217719
|
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
enthesitis
|
J:217720
|
increased inflammatory response
|
J:217720
|
increased susceptibility to induced arthritis
|
J:217720
|
joint inflammation
|
J:217720
|
salivary gland inflammation
|
J:217720
|
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6)
|
lung inflammation
|
J:203221
|
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:203159
|
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe)
|
liver inflammation
|
J:200968
|
Clec5atm1Cua/Clec5atm1Cua
(involves: C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:158811
|
Clec7atm1Gdb/Clec7atm1Gdb
(B6.129S6-Clec7atm1Gdb)
|
lung inflammation
|
J:179011
|
Clec10am1/Clec10am1
(NC/Nga)
|
dermatitis
|
J:283174
|
Clec10atm1Hed/Clec10atm1Hed
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
dermatitis
|
J:283174
|
Clec12atm1Jrld/Clec12atm1Jrld
(B6J.129-Clec12atm1Jrld)
|
increased inflammatory response
|
J:210326
|
ClppGt(IST11134F10)Tigm/ClppGt(IST11134F10)Tigm
(involves: C57BL/6N)
|
dermatitis
|
J:203140
|
ClppGt(IST13563G11)Tigm/ClppGt(IST13563G11)Tigm
(involves: C57BL/6N)
|
dermatitis
|
J:203140
|
Clutm1Jakh/Clutm1Jakh
(involves: Black Swiss * FVB/N)
|
heart inflammation
|
J:65660
|
myocarditis
|
J:65660
|
Cmastm1.1Bwei/Cmastm1.1Bwei Tg(NPHS2-cre)295Lbh/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
tubular nephritis
|
J:286022
|
Cmklr1tm1Dgen/Cmklr1tm1Dgen
(B6.Cg-Cmklr1tm1Dgen)
|
increased susceptibility to endotoxin shock
|
J:157190
|
lung inflammation
|
J:157190
|
Cmtm4tm1d(EUCOMM)Wtsi/Cmtm4tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased susceptibility to chemically induced skin inflammation
|
J:333836
|
Col1a1Aga2/Col1a1+
(C3HeB/FeJ-Col1a1Aga2)
|
lung inflammation
|
J:185988
|
Col1a1M1Jrt/Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ)
|
osteoarthritis
|
J:216423
|
Col1a1M1Jrt/Col1a1+
(involves: C57BL/6 * FVB/N)
|
autoimmune arthritis
|
J:228439
|
Col1a1tm1(tetO-Fos)Wag/Col1a1+ Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
skin inflammation
|
J:201145
|
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI)
|
liver inflammation
|
J:210545
|
Col2a1tm1Prc/Col2a1+ Col9a1tm1Jae/Col9a1tm1Jae
(involves: 129/Sv * 129S2/SvPas)
|
osteoarthritis
|
J:117910
|
Col3a1m1Btlr/Col3a1m1Btlr
(C57BL/6J-Col3a1m1Btlr)
|
increased susceptibility to induced colitis
|
J:271973
|
Col3a1Tsk2/Col3a1+
(C3H101H-Col3a1Tsk2/H)
|
adipose tissue inflammation
|
J:31216
|
skin inflammation
|
J:31216
|
Col4a1tm1.1Ics/Col4a1+
(involves: 129S2/SvPas * C57BL/6)
|
kidney inflammation
|
J:240798
|
Col4a1tm1.1Ics/Col4a1tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
kidney inflammation
|
J:240798
|
Col4a3tm1.1Rkl/Col4a3+
(involves: C57BL/6)
|
glomerulonephritis
|
J:167404
|
Col4a3tm1Dec/Col4a3tm1Dec
(involves: 129X1/SvJ * C57BL/6)
|
glomerulonephritis
|
J:37963
|
Col4a3tm1Dec/Col4a3tm1Dec
(129-Col4a3tm1Dec/J)
|
glomerulonephritis
|
J:158731
|
Col4a3tm1Dec/Col4a3tm1Dec
(B6.129X1-Col4a3tm1Dec)
|
glomerulonephritis
|
J:167404
|
Col4a3tm1Dec/Col4a3tm1Dec Itga1tm1Gdnr/Itga1tm1Gdnr
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c)
|
tubular nephritis
|
J:71378
|
Col4a3tm1Dec/Col4a3tm1Dec Sostdc1tm1Myan/Sostdc1tm1Myan
(involves: 129X1/SvJ)
|
glomerulonephritis
|
J:158731
|
Col4a3tm1Jhm/Col4a3tm1Jhm
(involves: 129S1/Sv * 129X1/SvJ)
|
glomerulonephritis
|
J:37017
|
Col4a3tm1Jhm/Col4a3tm1Jhm Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
glomerulonephritis
|
J:63137
|
Col4a4bwk/Col4a4bwk
(NON;NZO-Col4a4bwk/J)
|
kidney inflammation
|
J:223185
|
tubulointerstitial nephritis
|
J:223185
|
Col4a4bwk/Col4a4bwk
(D2.NON(NZO)-Col4a4bwk/GrsrJ)
|
kidney inflammation
|
J:223185
|
Col4a4bwk/Col4a4bwk
(129S1.NON(NZO)-Col4a4bwk/PgnJ)
|
kidney inflammation
|
J:223185
|
Col4a5tm1Yseg/Y
(B6.Cg-Col4a5tm1Yseg)
|
tubulointerstitial nephritis
|
J:102306
|
Col9a1tm1Jae/Col9a1tm1Jae
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL))
|
osteoarthritis
|
J:18628
|
Col9a1tm1Jae/Col9a1tm1Jae
(involves: 129S2/SvPas)
|
osteoarthritis
|
J:117910
|
Col11a1cho/Col11a1+
(involves: C57BL/6Fr)
|
osteoarthritis
|
J:106282
|
Col13a1tm1Pih/Col13a1tm1Pih
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
myositis
|
J:71939
|
Col17a1em1Dcr/Col17a1em1Dcr Lamc2jeb/Lamc2jeb
(B6.Cg-Lamc2jeb Col17a1em1Dcr/Dcr)
|
ear inflammation
|
J:352187
|
Col17a1em2Dcr/Col17a1em2Dcr Lamc2jeb/Lamc2jeb
(C57BL/6J-Col17a1em2Dcr/Dcr)
|
ear inflammation
|
J:352187
|
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6)
|
skin inflammation
|
J:220622
|
Comptm1Mbri/Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
osteoarthritis
|
J:125086
|
Copatm1.1Shum/Copa+
(B6(CBA)-Copatm1.1Shum)
|
bronchiolitis
|
J:288425
|
lung inflammation
|
J:288425
|
Coro1aLmb3-C57BL/6Scr/Coro1aLmb3-C57BL/6Scr
(MRL.Cg-Coro1aC57BL/6Scr Faslpr)
|
glomerulonephritis
|
J:125557
|
Coro1atm1Achn/Coro1atm1Achn Coro1btm1.1Nfoe/Coro1btm1.1Nfoe
(involves: 129X1/SvJ * C57BL/6N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:177785
|
Cox4i2tm1Hutt/Cox4i2+
(B6.129-Cox4i2tm1Hutt)
|
lung inflammation
|
J:187640
|
Cox4i2tm1Hutt/Cox4i2tm1Hutt
(B6.129-Cox4i2tm1Hutt)
|
lung inflammation
|
J:187640
|
Cptm1Hrs/Cptm1Hrs Hephsla/Y
(involves: 129X1/SvJ * C57BL/6)
|
eye inflammation
|
J:136925
|
Cpa1tm1.1Satom/Cpa1tm1.1Satom
(involves: C57BL/6NCrl * FVB/N)
|
pancreas inflammation
|
J:300042
|
Cpa3tm3(icre)Hrr/Cpa3+ Fgfr1tm1Upir/Fgfr1tm1Upir Fgfr2tm1Dor/Fgfr2tm1Dor Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
|
skin inflammation
|
J:221184
|
Cpb2tm1Nok/Cpb2tm1Nok
(involves: 129P2/OlaHsd * BALB/c)
|
increased inflammatory response
|
J:93733
|
Cpn1tm1Raw/Cpn1tm1Raw
(B6.129S1-Cpn1tm1Raw)
|
increased acute inflammation
|
J:148315
|
Cr1ltm1Hmo/Cr1ltm1Hmo
(involves: 129X1/SvJ)
|
increased inflammatory response
|
J:59432
|
Crim1Gt(KST264)Byg/Crim1Gt(KST264)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
kidney inflammation
|
J:172334
|
Crlf2tm1Jni/Crlf2tm1Jni
(involves: 129P2/OlaHsd)
|
respiratory system inflammation
|
J:187770
|
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: BALB/c)
|
lung inflammation
|
J:107431
|
Crlf2tm1Wjl/Crlf2tm1Wjl
(Not Specified)
|
colitis
|
J:175844
|
Crocctm1Tili/Crocctm1Tili
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:98885
|
Crotem1Akw/Crotem1Akw Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Crotem1Akw Ldlrtm1Her)
|
blood vessel inflammation
|
J:331161
|
Crsl/Crsl+
(involves: C3HeB/FeJ)
|
keratoconjunctivitis sicca
|
J:104123
|
Cry1tm1Jhjh/Cry1tm1Jhjh Cry2tm1Jhjh/Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:159504
|
Csf1op/Csf1op Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
interstitial pneumonia
|
J:19089
|
lung inflammation
|
J:19089
|
Csf1op/Csf1op Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
liver inflammation
|
J:117880
|
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:18747
|
Csf2tm1Dran/Csf2tm1Dran Ifngtm1Ts/Ifngtm1Ts Il3tm1Glli/Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased inflammatory response
|
J:83086
|
Csf2tm1Dran/Csf2tm1Dran Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli)
|
glomerulonephritis
|
J:83086
|
lung inflammation
|
J:67404
|
Csf2tm1Dran/Csf2tm1Dran Il3tm1Glli/Il3tm1Glli
(C.129S2-Csf2tm1Dran Il3tm1Glli)
|
lung inflammation
|
J:67404
|
Csf2raem1Szut/Csf2raem1Szut
(C57BL/6-Csf2raem1Szut)
|
lung inflammation
|
J:322934
|
Csf2rbtm1Cgb/Csf2rbtm1Cgb
(involves: 129S1/Sv * C57BL/6)
|
lung inflammation
|
J:29737
|
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:35829
|
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd)
|
lung inflammation
|
J:24122
|
Csf2rbtm1Mur/Csf2rbtm1Mur Il3tm1Tyb/Il3tm1Tyb
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
lung inflammation
|
J:35829
|
Csgalnact1tm1.1Migar/Csgalnact1tm1.1Migar
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
periodontium inflammation
|
J:269621
|
Csktm1Tara/Csktm2Tara Elanetm1(cre)Roes/Elane+
(involves: 129P2/OlaHsd * CB20 * C57BL/6)
|
increased acute inflammation
|
J:89716
|
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased incidence of corneal inflammation
|
J:50587
|
uveitis
|
J:50587
|
ctl/ctl
(A/WySnJ-ctl/GrsrJ)
|
autoimmune arthritis
|
J:91389
|
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD)
|
increased acute inflammation
|
J:109887
|
Ctla4tm1All/Ctla4tm1All Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD * SJL)
|
increased acute inflammation
|
J:109887
|
insulitis
|
J:109887
|
Ctla4tm1Saka/Ctla4tm1Saka Foxp3tm1(cre)Saka/Y
(involves: BALB/c)
|
increased inflammatory response
|
J:140085
|
lung inflammation
|
J:140085
|
myocarditis
|
J:140085
|
salivary gland inflammation
|
J:140085
|
stomach inflammation
|
J:140085
|
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
joint inflammation
|
J:30393
|
lung inflammation
|
J:30393
|
myocarditis
|
J:30393
|
pancreas inflammation
|
J:30393
|
salivary gland inflammation
|
J:30393
|
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6)
|
conjunctivitis
|
J:71744
|
increased inflammatory response
|
J:71744
|
increased susceptibility to otitis media
|
J:71744
|
keratoconjunctivitis sicca
|
J:71744
|
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+ Tg(CMV-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased inflammatory response
|
J:71744
|
increased susceptibility to otitis media
|
J:71744
|
keratoconjunctivitis sicca
|
J:71744
|
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * FVB/N)
|
pancreas inflammation
|
J:119908
|
Ctrb1em1Toth/Ctrb1em1Toth
(C57BL/6N-Ctrb1em1Toth)
|
increased susceptibility to induced pancreatitis
|
J:294171,
J:294035
|
Ctrcm1/Ctrcm1
(C57BL/6-Ctrcm1)
|
increased susceptibility to induced pancreatitis
|
J:291240
|
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde)
|
insulitis
|
J:153355
|
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde)
|
insulitis
|
J:153355
|
salivary gland inflammation
|
J:153355
|
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6)
|
dermatitis
|
J:108745
|
Ctslnkt/Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))
|
dermatitis
|
J:54856
|
increased inflammatory response
|
J:54856
|
liver inflammation
|
J:54856
|
lymph node inflammation
|
J:54856
|
Ctslnkt/Ctslnkt
(B6.Cg-Ctslnkt)
|
dermatitis
|
J:78460
|
Ctslnkt/Ctslnkt
(C.Cg-Ctslnkt)
|
dermatitis
|
J:78460
|
Ctsltm1Alpk/Ctsltm1Alpk
(involves: 129P2/OlaHsd * C57BL/6)
|
dermatitis
|
J:99755
|
folliculitis
|
J:99755
|
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr)
|
insulitis
|
J:153355
|
Ctsltm1Cptr/Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr)
|
salivary gland inflammation
|
J:153355
|
Ctsstm1Eae/Ctss+
(NOD.D1-Ctsstm1Eae)
|
insulitis
|
J:153355
|
Ctsstm1Eae/Ctsstm1Eae
(involves: C57BL/6 * DBA/1LacJ)
|
decreased susceptibility to induced arthritis
|
J:53399
|
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae)
|
insulitis
|
J:153355
|
salivary gland inflammation
|
J:153355
|
Cuedc2tm1Qxia/Cuedc2tm1Qxia
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased susceptibility to induced colitis
|
J:211782
|
Cux1tm2Ejn/Cux1tm2Ejn
(involves: 129S4/SvJae * C57BL/6)
|
rhinitis
|
J:74660
|
Cuzd1tm1Ljm/Cuzd1tm1Ljm
(involves: 129S6/SvEvTac * Black Swiss)
|
increased susceptibility to induced pancreatitis
|
J:80980
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
brain inflammation
|
J:129712
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl)
|
CNS inflammation
|
J:87076
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J)
|
decreased susceptibility to induced arthritis
|
J:142880
|
Cxcr3tm1Raks/Cxcr3tm1Raks
(B6.129P2-Cxcr3tm1Raks)
|
kidney inflammation
|
J:152790
|
Cxcr3tm1Wwh/Y
(B6.Cg-Cxcr3tm1Wwh)
|
lung inflammation
|
J:91359
|
Cxcr3tm1Wwh/Cxcr3tm1Wwh
(B6.Cg-Cxcr3tm1Wwh)
|
lung inflammation
|
J:91359
|
Cxcr4tm1Yiw/Cxcr4tm1Yiw Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
decreased susceptibility to induced arthritis
|
J:164872
|
Cybanmf333/Cybanmf333
(A.B6 Tyr+-Cybanmf333/J)
|
increased inflammatory response
|
J:132359
|
lung inflammation
|
J:132359
|
Cybbtm1Din/Y
(involves: 129S/SvEv * C57BL/6)
|
increased inflammatory response
|
J:22868
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din)
|
increased acute inflammation
|
J:110181
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
|
glomerulonephritis
|
J:235399
|
Cyldtm1.1Mpa/Cyldtm1.1Mpa Faddtm1Mpa/Faddtm1Mpa Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Cyldtm1.1Mpa Tg(Vil1-cre)997Gum)
|
cecum inflammation
|
J:175865
|
Cyldtm1.1Mpa/Cyldtm1.1Mpa Ikbkgtm1.1Mpa/Y Tg(Vil1-cre)997Gum/0
(B6.Cg-Cyldtm1.1Mpa Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum)
|
colitis
|
J:175865
|
Cyldtm1.1Mpa/Cyldtm1.1Mpa Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum/0
(B6.Cg-Cyldtm1.1Mpa Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum)
|
colitis
|
J:175865
|
Cyldtm1Lex/Cyldtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to induced colitis
|
J:114972
|
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2c70em1Utr)
|
liver inflammation
|
J:302190
|
Cyp2ctm1104Arte/Cyp2ctm1104Arte
(B6NTac(Cg)-Cyp2ctm1104Arte/Arte)
|
liver inflammation
|
J:241121
|
Cyp2ctm1897.1(Alb-CYP2C9)Arte/Cyp2ctm1897.1(Alb-CYP2C9)Arte
(B6(Cg)-Cyp2ctm1897.1(Alb-CYP2C9)Arte/Arte)
|
liver inflammation
|
J:241121
|
Cyp2g1tm1(rtTA)Lane/Cyp2g1+ Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: 129 * C57BL/6 * SJL)
|
rhinitis
|
J:157842
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
kidney inflammation
|
J:92438
|
salivary gland inflammation
|
J:92438
|
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv)
|
lacrimal gland inflammation
|
J:216958
|
salivary gland inflammation
|
J:216958
|
Cys1cpk/Cys1cpk
(129.B6-Cys1cpk)
|
liver inflammation
|
J:116210
|
Cysltr1tm1Ykn/Cysltr1tm1Ykn
(involves: C57BL/6)
|
respiratory system inflammation
|
J:88647
|
Cytl1tm1Chun/Cytl1tm1Chun
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:175377
|
DbaclC57BL/6Jcl/DbaclC57BL/6Jcl
(NOD.B6-(D4Mit193-D4Mit17))
|
insulitis
|
J:144964
|
Dcntm1Ioz/Dcntm1Ioz
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
tubular nephritis
|
J:75298
|
Ddctm1.1Rhrs/Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn/0
(involves: 129 * C57BL/6 * SJL)
|
tubulointerstitial nephritis
|
J:175630
|
Ddctm1.1Rhrs/Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn/0
(129.Cg-Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn)
|
tubulointerstitial nephritis
|
J:175630
|
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
|
white adipose tissue inflammation
|
J:214136
|
Defb3tm1Xen/Defb3tm1Xen
(involves: C57BL/6)
|
increased incidence of corneal inflammation
|
J:199719
|
Del(1Aim2-Ifi205)1Stsn/+ Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
heart inflammation
|
J:234263
|
increased inflammatory response
|
J:234263
|
kidney inflammation
|
J:234263
|
myositis
|
J:234263
|
stomach inflammation
|
J:234263
|
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
stomach inflammation
|
J:234263
|
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
heart inflammation
|
J:234263
|
increased inflammatory response
|
J:234263
|
kidney inflammation
|
J:234263
|
myositis
|
J:234263
|
stomach inflammation
|
J:234263
|
Del(6Ephb6-Trpv6)1Mhed/+
(involves: 129S/SvEv)
|
dermatitis
|
J:133151
|
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed
(involves: 129S/SvEv)
|
dermatitis
|
J:133151
|
Del(6Snca)1Slab/Del(6Snca)1Slab Tg(Th-SNCA*)1Mgsp/0
(involves: C57BL/6J * C57BL/6JOlaHsd * CBA/Ca)
|
brain inflammation
|
J:108310
|
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae)
|
osteoarthritis
|
J:72926
|
Del(10Prmt2-Col6a1)1Yah/+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
lung inflammation
|
J:167506
|
respiratory system inflammation
|
J:167506
|
Del(14Ltb4r2-Ltb4r1)1Bodd/+
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:131779
|
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:131779
|
Del(19Poll-Dcpd)1Nmt/Del(19Poll-Dcpd)1Nmt
(involves: 129P2/OlaHsd)
|
sinus inflammation
|
J:75779
|
Derm1NC/Nga/Derm1NC/Nga
(involves: MSM/Ms * NC/Nga)
|
dermatitis
|
J:68698
|
DermsBALB/cByJ/?
(involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
dermatitis
|
J:80574
|
DermsDBA/2J/?
(involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
dermatitis
|
J:80574
|
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:293120
|
Dh/Dh+ H2d/H2d
(NZB.Cg-Dh)
|
glomerulonephritis
|
J:12036
|
Diaph1tm1Asal/Diaph1tm1Asal
(involves: 129S1/Sv * C57BL/6)
|
dermatitis
|
J:124319
|
Dicer1tm1Bdh/Dicer1tm1Bdh Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
blood vessel inflammation
|
J:138683
|
liver inflammation
|
J:138683
|
lung inflammation
|
J:138683
|
Dicer1tm1Bdh/Dicer1tm1Bdh Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ)
|
blood vessel inflammation
|
J:138683
|
liver inflammation
|
J:138683
|
lung inflammation
|
J:138683
|
Dicer1tm1Bdh/Dicer1tm1Bdh Tg(Foxp3-EGFP/icre)1aJbs/0
(involves: 129 * NOD/ShiLt)
|
liver inflammation
|
J:138808
|
lung inflammation
|
J:138808
|
Dicer1tm1Tara/Dicer1tm1Tara Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
increased susceptibility to induced arthritis
|
J:180783
|
Dido1tm3Cmar/Dido1tm3.1Cmar Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
liver inflammation
|
J:328215
|
Dkc1tm1Ppp/Y
(involves: 129S1/Sv)
|
lung inflammation
|
J:81054
|
Dlk1tm1.1Jvs/Dlk1+ Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
increased inflammatory response
|
J:167124
|
Dmbt1tm1Janm/Dmbt1tm1Janm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to induced colitis
|
J:130258
|
Dmdem1Eno/Y
(involves: C57BL/6J)
|
myositis
|
J:253191
|
Dmdem4Eno/Y
(C57BL/6-Dmdem4Eno)
|
myositis
|
J:285447
|
Dmdem4Eno/Dmdem4Eno
(C57BL/6-Dmdem4Eno)
|
myositis
|
J:285447
|
Dmdmdx/Y
(involves: C57BL/10ScSn)
|
diaphragmitis
|
J:140282
|
myositis
|
J:140282
|
Dmdmdx/Y Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
myositis
|
J:167294
|
Dmdmdx/Y Tg(DMD*)#Spc/0
(involves: 129P2/OlaHsd * C57BL/10ScSn * DBA/2)
|
myositis
|
J:280218
|
Dmdmdx/Y Utrntm1Jrs/Utrn+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
diaphragmitis
|
J:140282
|
myositis
|
J:140282
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx/J)
|
myositis
|
J:226314
|
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx/J)
|
heart inflammation
|
J:226314
|
myositis
|
J:226314
|
Dmdmdx/Dmdmdx Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn)
|
myositis
|
J:162340
|
Dmdtm1.1Know/Dmdtm1.1Know
(involves: C3H)
|
myocarditis
|
J:207775
|
Dmdtm1Kmf/Y
(involves: C57BL/6)
|
myositis
|
J:233298
|
Dnaaf5em1Slb/Dnaaf5em1Slb
(C57BL/6-Dnaaf5em1Slb)
|
sinus inflammation
|
J:342770
|
Dnaaf5em1Slb/Dnaaf5em2Slb
(C57BL/6-Dnaaf5em1Slb Dnaaf5em2Slb)
|
sinus inflammation
|
J:342770
|
Dnah5Tg1Htz/Dnah5Tg1Htz
(involves: C57BL/6 * CBA/J)
|
increased susceptibility to otitis media
|
J:76189
|
sinus inflammation
|
J:76189
|
Dnai1tm1.1Leo/Dnai1tm1.1Leo Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6)
|
rhinosinusitis
|
J:155730
|
Dnajc3m1Btlr/Dnajc3m1Btlr
(C57BL/6J-Dnajc3m1Btlr)
|
increased susceptibility to induced colitis
|
J:265248
|
Dnase1tm1Tmo/Dnase1+
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:62549
|
kidney inflammation
|
J:62549
|
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:62549
|
kidney inflammation
|
J:62549
|
Dnase1tm2092.1Arte/Dnase1tm2092.1Arte
(involves: C57BL/6)
|
glomerulonephritis
|
J:277126
|
Dnase2atm1Osa/Dnase2atm1Osa Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
joint inflammation
|
J:238323,
J:114982
|
rheumatoid arthritis
|
J:238323,
J:114982
|
Dnase2atm1Osa/Dnase2atm2Osa Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)
|
joint inflammation
|
J:114982
|
rheumatoid arthritis
|
J:114982
|
Dock2m1Hsd/Dock2m1Hsd Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd)
|
glomerulonephritis
|
J:144035
|
Dock8tm1Ysfk/Dock8tm1Ysfk Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
dermatitis
|
J:305132
|
Dpcd/PollGt(OST280355)Lex/Dpcd/PollGt(OST280355)Lex
(involves: 129S5/SvEvBrd * C57BL/6Brd)
|
increased susceptibility to otitis media
|
J:185566
|
Dpp4em1Rba/Dpp4+
(C57BL/6J-Dpp4em1Rba)
|
lung inflammation
|
J:279834
|
Dpp4em1Rba/Dpp4em1Rba
(C57BL/6J-Dpp4em1Rba)
|
lung inflammation
|
J:279834
|
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
interstitial pneumonia
|
J:223728
|
lung inflammation
|
J:223728
|
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
lung inflammation
|
J:238079
|
pleuritis
|
J:238079
|
Dpp4tm1.1(DPP4)Pbmj/Dpp4tm1.1(DPP4)Pbmj
(involves: C57BL/6 * C57BL/6NTac)
|
lung inflammation
|
J:242025
|
Drd1tm1Jcd/Drd1tm1Jcd Drd2tm1Ebo/Drd2+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
small intestinal inflammation
|
J:91781
|
Droshatm1Litt/Droshatm1.1Litt Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
blood vessel inflammation
|
J:138683
|
liver inflammation
|
J:138683
|
lung inflammation
|
J:138683
|
Droshatm1Litt/Droshatm1.1Litt Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
blood vessel inflammation
|
J:138683
|
liver inflammation
|
J:138683
|
lung inflammation
|
J:138683
|
Droshatm1Litt/Droshatm1.1Litt Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
intestinal inflammation
|
J:138683
|
liver inflammation
|
J:138683
|
lung inflammation
|
J:138683
|
Dsc1tm1Dga/Dsc1tm1Dga
(involves: C57BL/6J)
|
dermatitis
|
J:73102
|
Dsg2m1Btlr/Dsg2m1Btlr
(C57BL/6J-Dsg2m1Btlr)
|
increased susceptibility to induced colitis
|
J:271975
|
Dsg2m2Btlr/Dsg2m2Btlr
(C57BL/6J-Dsg2m2Btlr)
|
increased susceptibility to induced colitis
|
J:271976
|
Dsg2m3Btlr/Dsg2m3Btlr
(C57BL/6J-Dsg2m3Btlr)
|
increased susceptibility to induced colitis
|
J:271977
|
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
heart inflammation
|
J:235770
|
Dsg2tm3.1Leu/Dsg2tm3.1Leu Tg(Vil1-cre)20Syr/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:302333
|
increased susceptibility to induced colitis
|
J:302333
|
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
|
conjunctivitis
|
J:219200
|
Dsg3tm1Stan/Dsg3tm1Stan
(involves: 129X1/SvJ * C57BL/6J)
|
conjunctivitis
|
J:40804
|
Dsg4lah-J/Dsg4lah-J
(involves: DBA/1LacJ)
|
dermatitis
|
J:83117
|
Dsg4lah/Dsg4lah
(LAH/Pas)
|
dermatitis
|
J:33849
|
Dspptm1Kul/Dspptm1Kul
(B6;129-Dspptm1Kul/Mmnc)
|
periodontium inflammation
|
J:241990
|
Dssc1C3H/HeJ/Dssc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
colitis
|
J:52852
|
Dssc1C57BL/6J/Dssc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
colitis
|
J:52852
|
Dssc2C3H/HeJ/Dssc2C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
colitis
|
J:52852
|
Dssc2C3H/HeJ/Dssc2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
colitis
|
J:52852
|
DstTg4/DstTg4
(involves: C57BL/6 * CD-1)
|
conjunctivitis
|
J:209161
|
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
|
glomerulonephritis
|
J:151605
|
liver inflammation
|
J:151605
|
lung inflammation
|
J:151605
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas)
|
lung inflammation
|
J:118832
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:118833
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * various)
|
increased susceptibility to type I hypersensitivity reaction
|
J:125919
|
Dusp1tm1Brv/Dusp1tm1Brv
(C3.129S2-Dusp1tm1Brv)
|
lung inflammation
|
J:164929
|
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:126383
|
increased susceptibility to induced arthritis
|
J:126383
|
Dusp2tm1Cmac/Dusp2tm1Cmac
(B6.Cg-Dusp2tm1Cmac)
|
decreased susceptibility to induced arthritis
|
J:112609
|
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac)
|
increased susceptibility to type I hypersensitivity reaction
|
J:92104
|
Dusp11Gt(BB0198)Wtsi/Dusp11Gt(BB0198)Wtsi
(B6.129P2-Dusp11Gt(BB0198)Wtsi)
|
increased susceptibility to endotoxin shock
|
J:301503
|
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht)
|
increased inflammatory response
|
J:213253
|
kidney inflammation
|
J:213253
|
liver inflammation
|
J:213253
|
lung inflammation
|
J:213253
|
Dysfim/Dysf+ Large1myd/Large1myd
(involves: C57BL/6 * SJL/J)
|
myositis
|
J:221523
|
Dysfim/Dysfim Fktntm1Ttd/Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)
|
myositis
|
J:221523
|
Dysfim/Dysfim Large1myd/Large1myd
(involves: C57BL/6 * SJL/J)
|
myositis
|
J:221523
|
Dysftm1Kcam/Dysftm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myositis
|
J:171870
|
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
insulitis
|
J:93708
|
salivary gland inflammation
|
J:93708
|
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
glomerulonephritis
|
J:76318
|
increased inflammatory response
|
J:76318
|
liver inflammation
|
J:76318
|
lung inflammation
|
J:76318
|
E2f2tm1Zubi/E2f2tm1Zubi Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased inflammatory response
|
J:76318
|
E2f3tm1Lees/E2f3tm1Lees
(involves: 129S2/SvPas * C57BL/6)
|
lung inflammation
|
J:75765
|
E2f4tm1Lees/E2f4tm1Lees
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to otitis media
|
J:64193
|
rhinitis
|
J:64193
|
Eae2B10.RIII/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
autoimmune arthritis
|
J:95848
|
Eae2RIIIS/J/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
decreased susceptibility to induced arthritis
|
J:95848
|
Eae2bC57BL/10SnSg/Eae2bC57BL/10SnSg
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae7B10.S/DvTe/Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae7B10.S/DvTe/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae7SJL/J/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae16SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased inflammatory response
|
J:67840
|
Eae21SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased inflammatory response
|
J:67840
|
Eae22SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased inflammatory response
|
J:67840
|
Eae23SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased inflammatory response
|
J:67840
|
Eae25SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased inflammatory response
|
J:69083
|
Eae27C57BL/10SnSg/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae27RIIIS/J/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae39C57BL/10SnSg/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae39RIIIS/J/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae41C57BL/10SnSg/Eae41C57BL/10SnSg
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae44aB10.S/DvTe/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae44aSJL/J/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow Eaf2tm1Zhow/Eaf2tm1Zhow Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * DBA/2)
|
prostate gland inflammation
|
J:288972
|
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow Tg(Pbsn-cre)4Prb/0
(B6(Cg)-Eaf1tm1.1Zhow Tg(Pbsn-cre)4Prb)
|
prostate gland inflammation
|
J:288972
|
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd)
|
prostate gland inflammation
|
J:288972
|
Eamcd1A/WySn/Eamcd1A/WySn
(B10.A-(D1Mit65-D1Mit334))
|
myocarditis
|
J:145043
|
Eamcd2A/WySn/Eamcd2A/WySn
(involves: A.SW-H2s/J * B10.S-H2s/J)
|
myocarditis
|
J:96562
|
Ebi3Gt716Lex/Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:286951
|
EdaTa-6J/Y
(C57BL/6J Aw-J-EdaTa-6J/J)
|
blepharitis
|
J:99510
|
conjunctivitis
|
J:99510
|
corneal limbitis
|
J:99510
|
eye inflammation
|
J:99510
|
increased incidence of corneal inflammation
|
J:99510
|
Edil3Tg(lacZ)1Tq/Edil3Tg(lacZ)1Tq
(Not Specified)
|
increased susceptibility to induced arthritis
|
J:254384
|
Ednrbtm1Nrd/Ednrbtm1Nrd Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)
|
large intestinal inflammation
|
J:233811
|
Efstm1Kale/Efs+
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
|
increased inflammatory response
|
J:103757
|
small intestinal inflammation
|
J:103757
|
Efstm1Kale/Efstm1Kale
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
|
increased inflammatory response
|
J:103757
|
kidney inflammation
|
J:103757
|
liver inflammation
|
J:103757
|
lung inflammation
|
J:103757
|
small intestinal inflammation
|
J:103757
|
Egfrtm1Dwt/Egfrtm1Dwt Sox9tm3(cre)Crm/Sox9+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
dermatitis
|
J:229771
|
Egr1tm1Jmi/Egr1tm1Jmi
(B6.129-Egr1tm1Jmi)
|
liver inflammation
|
J:128421
|
Egr1tm1Jmi/Egr1tm1Jmi Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1*)1Eli/?
(involves: 129 * C57BL/6)
|
lung inflammation
|
J:92469
|
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:66112
|
Eif2ak3tm1.1Drc/Eif2ak3tm1.1Drc Tg(Ela1-cre)16Eps/0
(involves: 129S6/SvEvTac)
|
acute pancreas inflammation
|
J:129974
|
Eif4btm1.1Smoc/Eif4btm1.1Smoc Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6)
|
increased susceptibility to induced colitis
|
J:311140
|
lung inflammation
|
J:311140
|
Elac2em1Afi/Elac2em1Afi
(C57BL/6N-Elac2em1Afi)
|
prostate gland inflammation
|
J:336403
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo)
|
increased susceptibility to endotoxin shock
|
J:184388
|
increased susceptibility to induced colitis
|
J:184388
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:184388
|
Elavl1tm1Lix/Elavl1tm1Lix Tg(Scgb1a1-rtTA)2Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6)
|
lung inflammation
|
J:204952
|
Elovl3tm1Jaco/Elovl3tm1Jaco
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
dermatitis
|
J:88477
|
Elp1tm1.1Id/Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
|
conjunctivitis
|
J:188923
|
Elp1tm1.2Id/Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
|
conjunctivitis
|
J:188923
|
Enpp1asj/Enpp1asj
(C57BL/6J-Enpp1asj/GrsrJ)
|
increased susceptibility to otitis media
|
J:251638
|
joint inflammation
|
J:174912
|
osteoarthritis
|
J:174912
|
osteomyelitis
|
J:174912
|
Enpp1ttw/Enpp1ttw
(involves: ICR)
|
osteoarthritis
|
J:19124,
J:37369
|
Enpp3tm1Ktak/Enpp3tm1Ktak
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6))
|
increased susceptibility to type I hypersensitivity reaction
|
J:223825
|
intestinal inflammation
|
J:223825
|
lung inflammation
|
J:223825
|
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
|
liver inflammation
|
J:163795
|
Entpd8tm1Ktak/Entpd8tm1Ktak
(C.Cg-Entpd8tm1Ktak)
|
increased susceptibility to induced colitis
|
J:311564
|
Epcamtm1.1Mcu/Epcamtm1.1Mcu Tg(CD207-cre)1Dhka/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL/J)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:182665
|
Epcamtm1.2Msiv/Epcamtm1.2Msiv
(involves: C57BL/6 * FVB/N * SJL)
|
small intestinal inflammation
|
J:210901
|
Epha1tm1Sld/Epha1tm1Sld
(involves: 129 * C57BL/6J)
|
endometrium inflammation
|
J:142722
|
vaginal inflammation
|
J:142722
|
Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+ Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * CBA/J * SJL)
|
pancreas inflammation
|
J:107545
|
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
dermatitis
|
J:213427
|
Epyctm1Mhok/Epyctm1Mhok
(involves: 129S7/SvEvBrd * C57BL/6J)
|
osteoarthritis
|
J:222369
|
Erbb3tm1.1Dwt/Erbb3tm2.1Dwt Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
increased susceptibility to induced colitis
|
J:152703
|
Erbb4tm1Grl/Erbb4tm1Grl Tg(Myh6-ERBB4)HT2Gass/0
(involves: 129S1/Sv * 129X1/SvJ)
|
lung inflammation
|
J:132190
|
Eregtm1Dwt/Eregtm1Dwt
(129S6/SvEvTac-Eregtm1Dwt)
|
increased susceptibility to induced colitis
|
J:93327
|
Eregtm1Sawa/Eregtm1Sawa
(involves: 129X1/SvJ * C57BL/6J)
|
dermatitis
|
J:92618
|
Ergtm1.1Iwamo/Ergtm1.1Iwamo Tg(Gdf5-cre,-ALPP)1Kng/?
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
increased susceptibility to induced arthritis
|
J:243715
|
osteoarthritis
|
J:243715
|
Ern1tm2.1Tiw/Ern1tm2.1Tiw Xbp1tm2Glm/Xbp1tm2Glm Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
|
small intestinal inflammation
|
J:206084
|
Ern2m1Btlr/Ern2m1Btlr
(C57BL/6J-Ern2m1Btlr)
|
increased susceptibility to induced colitis
|
J:216045
|
Ern2M2Btlr/Ern2M2Btlr
(C57BL/6J-Ern2M2Btlr)
|
increased susceptibility to induced colitis
|
J:234237
|
Ern2m3Btlr/Ern2m3Btlr
(C57BL/6J-Ern2m3Btlr)
|
increased susceptibility to induced colitis
|
J:236686
|
Ern2tm1Dron/Ern2tm1Dron
(either: 129S6/SvEvTac-Ern2tm1Dron or B6.129S6-Ern2tm1Dron)
|
increased susceptibility to induced colitis
|
J:67934
|
Errfi1tm1Gvw/Errfi1tm1Gvw
(Not Specified)
|
accelerated temporomandibular joint osteoarthritis
|
J:100927
|
osteoarthritis
|
J:100927
|
Errfi1tm1Gvw/Errfi1tm1Gvw Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
osteoarthritis
|
J:100927
|
Errfi1tm3.1Gvw/Errfi1tm3.1Gvw Tg(CMV-cre)1Cgn/0
(involves: 129 * 129S4/SvJaeSor * BALB/cJ)
|
osteoarthritis
|
J:206807
|
Errfi1tm3.1Gvw/Errfi1tm3.1Gvw Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6 * CBA)
|
osteoarthritis
|
J:206807
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
glomerulonephritis
|
J:88156
|
Esr1tm1Ksk/Esr1tm1Ksk Inhatm1Bay/Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)
|
liver inflammation
|
J:84989
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
colitis
|
J:107308
|
urinary bladder inflammation
|
J:122274
|
exf/exf
(involves: C3H/HeN(MTV-))
|
conjunctivitis
|
J:5649
|
Exph5tm1Tiz/Exph5tm1Tiz
(B6NJcl.Cg-Exph5tm1Tiz/Tiz)
|
increased susceptibility to type I hypersensitivity reaction
|
J:313415
|
Eya4tm1Jse/Eya4tm1Jse
(involves: 129S6/SvEvTac * CBA/J)
|
increased susceptibility to otitis media
|
J:131873
|
F2tm2Jld/F2+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
|
decreased susceptibility to induced arthritis
|
J:174629
|
F2rtm1Ajc/F2rtm1Ajc F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:132733
|
F2rl1tm1Bpd/F2rl1tm1Bpd
(involves: 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:96196
|
increased susceptibility to induced pancreatitis
|
J:96196
|
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6)
|
glomerulonephritis
|
J:124303
|
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:81119
|
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd)
|
liver inflammation
|
J:102762
|
F11tm1Gjb/F11tm1Gjb Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:67398
|
F11rtm1.1Dej/F11rtm1.1Dej
(Not Specified)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:92592
|
Faddtm1Mpa/Faddtm1Mpa Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
liver inflammation
|
J:118336
|
Faddtm1Mpa/Faddtm1Mpa Myd88tm1Aki/Myd88tm1Aki Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Myd88tm1Aki Tg(Vil1-cre)997Gum)
|
cecum inflammation
|
J:175865
|
Faddtm1Mpa/Faddtm1Mpa Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Tg(Vil1-cre)997Gum)
|
cecum inflammation
|
J:175865
|
colitis
|
J:175865
|
Faddtm1Mpa/Faddtm1Mpa Tnftm1Gkl/Tnftm1Gkl Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Tnftm1Gkl Tg(Vil1-cre)997Gum)
|
cecum inflammation
|
J:175865
|
colitis
|
J:175865
|
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J)
|
dermatitis
|
J:153293
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * PT)
|
kidney inflammation
|
J:77295
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
|
liver inflammation
|
J:27735
|
Fahtm1Mgo/Fahtm1Mgo Hgdaku/Hgd+
(involves: 129S7/SvEvBrd * NB)
|
kidney inflammation
|
J:77295
|
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
liver inflammation
|
J:164184
|
Fam3dem1Wko/Fam3dem1Wko
(C57BL/6-Fam3dem1Wko)
|
colitis
|
J:300819
|
increased susceptibility to colitis induced morbidity/mortality
|
J:300819
|
increased susceptibility to induced colitis
|
J:300819
|
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi)
|
white adipose tissue inflammation
|
J:258290
|
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi Tg(Col1a1-cre)2Bek/0
(involves: 129S6/SvEvTac * CD-1)
|
dental pulp inflammation
|
J:225679
|
periodontium inflammation
|
J:225679
|
Fam210bem1Cya/Fam210bem1Cya
(involves: C57BL/6N)
|
glomerulonephritis
|
J:351618
|
Fan1tm1a(KOMP)Wtsi/Fan1tm1a(KOMP)Wtsi
(129S1.B6-Fan1tm1a(KOMP)Wtsi)
|
tubulointerstitial nephritis
|
J:242198
|
Faslpr/Fas+ Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp)
|
liver inflammation
|
J:72817
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
blood vessel inflammation
|
J:28885
|
glomerulonephritis
|
J:27634,
J:13757,
J:28885
|
lacrimal gland inflammation
|
J:18512
|
salivary gland inflammation
|
J:18512
|
submandibular gland inflammation
|
J:21965
|
thyroid gland inflammation
|
J:28171
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
|
CNS inflammation
|
J:14151
|
conjunctivitis
|
J:123192
|
glomerulonephritis
|
J:92084,
J:122315,
J:127199,
J:7454
|
salivary gland inflammation
|
J:92084
|
Faslpr/Faslpr
(involves: C3H * MRL/Mp)
|
increased susceptibility to type III hypersensitivity reaction
|
J:34296
|
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
|
brain inflammation
|
J:120427
|
CNS inflammation
|
J:120427
|
Faslpr/Faslpr
(MRL-Faslpr)
|
glomerulonephritis
|
J:126261
|
Faslpr/Faslpr
(MRL.Cg-Irf1tm1Mak Faslpr)
|
glomerulonephritis
|
J:114771
|
Faslpr/Faslpr
(C3.MRL-Faslpr/J)
|
glomerulonephritis
|
J:7454
|
Faslpr/Faslpr
(B6.MRL-Faslpr)
|
glomerulonephritis
|
J:135036,
J:7454
|
Faslpr/Faslpr
(AK.MRL-Faslpr)
|
glomerulonephritis
|
J:7454
|
Faslpr/Faslpr
(C3.MRL-Faslpr)
|
lacrimal gland inflammation
|
J:1028
|
salivary gland inflammation
|
J:1028
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr)
|
blood vessel inflammation
|
J:137066
|
glomerulonephritis
|
J:125114,
J:132514,
J:137066
|
Faslpr/Faslpr
(involves: 129P2/OlaHsd * MRL)
|
glomerulonephritis
|
J:45448
|
kidney inflammation
|
J:45448
|
Faslpr/Faslpr Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
arteritis
|
J:106188
|
glomerulonephritis
|
J:106188
|
Faslpr/Faslpr Ifnar1tm1Agt/Ifnar1tm1Agt
(MRL.Cg-Ifnar1tm1Agt Faslpr)
|
glomerulonephritis
|
J:92084
|
salivary gland inflammation
|
J:92084
|
Faslpr/Faslpr Ifnar1tm1Agt/Ifnar1tm1Agt Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr)
|
glomerulonephritis
|
J:92084
|
salivary gland inflammation
|
J:92084
|
Faslpr/Faslpr Ifngtm1Ts/Ifng+
(MRL.Cg-Ifngtm1Ts Faslpr)
|
glomerulonephritis
|
J:123834
|
Faslpr/Faslpr Ifngtm1Ts/Ifngtm1Ts
(MRL.Cg-Ifngtm1Ts Faslpr)
|
kidney inflammation
|
J:123834
|
lung inflammation
|
J:123834
|
Faslpr/Faslpr Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Faslpr)
|
glomerulonephritis
|
J:92084
|
Faslpr/Faslpr Il4tm1Cgn/Il4tm1Cgn
(MRL.Cg-Il4tm1Cgn Faslpr)
|
glomerulonephritis
|
J:132514
|
lacrimal gland inflammation
|
J:132514
|
Faslpr/Faslpr Il27ratm1Mak/Il27ratm1Mak
(MRL.Cg-Il27ratm1Mak Faslpr)
|
glomerulonephritis
|
J:122148
|
Faslpr/Faslpr Irf1tm1Mak/Irf1+
(MRL.Cg-Irf1tm1Mak Faslpr)
|
glomerulonephritis
|
J:114771
|
Faslpr/Faslpr Irf1tm1Mak/Irf1tm1Mak
(MRL.Cg-Irf1tm1Mak Faslpr)
|
glomerulonephritis
|
J:114771
|
Faslpr/Faslpr Selptm1Bay/Selptm1Bay
(MRL.Cg-Selptm1Bay Faslpr)
|
dermatitis
|
J:127199
|
glomerulonephritis
|
J:127199
|
Faslpr/Faslpr Selplgtm1Fur/Selplgtm1Fur
(MRL.Cg-Selplgtm1Fur Faslpr)
|
dermatitis
|
J:127199
|
glomerulonephritis
|
J:127199
|
Faslpr/Faslpr Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp)
|
kidney inflammation
|
J:73396
|
Faslpr/Faslpr Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * MRL)
|
kidney inflammation
|
J:45448
|
Faslpr/Faslpr Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
|
kidney inflammation
|
J:122222
|
liver inflammation
|
J:122222
|
lung inflammation
|
J:122222
|
salivary gland inflammation
|
J:122222
|
Faslpr/Faslpr Tg(INS-Il10)#Sar/0
(NOD.Cg-Faslpr Tg(INS-Il10)#Sar)
|
insulitis
|
J:64051
|
Faslpr/Faslpr Tlr9tm1Aki/Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr)
|
glomerulonephritis
|
J:135036
|
Faslpr/Faslpr Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
glomerulonephritis
|
J:113557
|
kidney inflammation
|
J:113557
|
Faslpr/Faslpr Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6)
|
liver inflammation
|
J:92470
|
Faslpr/Faslpr Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
|
lacrimal gland inflammation
|
J:126929
|
Fastm1Cgn/Fastm1Cgn Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
|
alveolitis
|
J:114948
|
increased inflammatory response
|
J:114948
|
kidney inflammation
|
J:114948
|
liver inflammation
|
J:114948
|
lung inflammation
|
J:114948
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J)
|
interstitial pneumonia
|
J:7306
|
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
|
brain inflammation
|
J:120427
|
CNS inflammation
|
J:120427
|
eye inflammation
|
J:136745
|
liver inflammation
|
J:135830
|
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6)
|
dermatitis
|
J:153501
|
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
|
dermatitis
|
J:153501
|
glomerulonephritis
|
J:153501
|
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6)
|
glomerulonephritis
|
J:87990
|
Fasltm1.1Lest/Fasltm1.1Lest
(B6.129-Fasltm1.1Lest)
|
glomerulonephritis
|
J:87990
|
Fat1Gt(KST249)Byg/Fat1Gt(KST249)Byg Tg(Myl1-lacZ)1Ibdml/0
(involves: 129P2/OlaHsd)
|
myositis
|
J:199157
|
Fat1tm1.2Fhel/Fat1tm1.2Fhel Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J * SJL)
|
myositis
|
J:199157
|
Fbn1tm1Lper/Fbn1+
(involves: 129/Sv * CD-1)
|
lung inflammation
|
J:167276
|
Fbn1tm2Rmz/Fbn1tm2Rmz
(involves: 129S1/Sv * 129X1/SvJ)
|
aortitis
|
J:54081
|
lung inflammation
|
J:91815
|
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
|
alveolitis
|
J:15018,
J:30961,
J:6566
|
increased susceptibility to type IV hypersensitivity reaction
|
J:7185
|
lung inflammation
|
J:30961,
J:6566
|
Fbxl4tm1.2Lrsn/Fbxl4tm1.2Lrsn
(involves: C57BL/6N)
|
liver inflammation
|
J:303084
|
Fbxl5tm2.1Kei/Fbxl5tm2.1Kei Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
liver inflammation
|
J:176655
|
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl * C3H/HeN)
|
increased susceptibility to otitis media
|
J:85263
|
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl * C3H/HeN * C57BL/6J)
|
increased susceptibility to otitis media
|
J:114851
|
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl)
|
increased susceptibility to otitis media
|
J:250208
|
Fbxo11Jf/Fbxo11Mutt
(involves: BALB/c * C3H/HeN)
|
increased susceptibility to otitis media
|
J:114851
|
Fcer1atm1Knt/Fcer1atm1Knt
(involves: 129 * BALB/c)
|
increased susceptibility to type I hypersensitivity reaction
|
J:78659
|
Fcer1atm1Knt/Fcer1atm1Knt Fcer2atm1Max/Fcer2atm1Max Fcgr1tm1Jsv/Fcgr1tm1Jsv Fcgr2btm1Ttk/Fcgr2btm1Ttk Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.Cg-Fcgr2btm1Ttk Fcgr3tm1Jsv Fcer1atm1Knt Fcgr1tm1Jsv Fcer2atm1Max)
|
increased susceptibility to type I hypersensitivity reaction
|
J:144620
|
Fcer2atm1Max/Fcer2atm1Max
(involves: C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:57738
|
Fcer2atm1Max/Fcer2atm1Max Ighg1tm1.1Pyu/Ighg1+
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
|
increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Fcer2atm1Max/Fcer2atm1Max Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
|
increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Fcgr1tm1Jsv/Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c)
|
decreased susceptibility to induced arthritis
|
J:83995
|
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv Sle16C57BL/6/Sle16C57BL/6
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to induced arthritis
|
J:179175
|
kidney inflammation
|
J:179175
|
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6)
|
increased susceptibility to induced arthritis
|
J:190890
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(involves: 129S4/SvJae)
|
increased susceptibility to type I hypersensitivity reaction
|
J:31133
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk)
|
glomerulonephritis
|
J:64152
|
increased inflammatory response
|
J:64152
|
kidney inflammation
|
J:64152
|
liver inflammation
|
J:64152
|
lung inflammation
|
J:64152
|
pancreas inflammation
|
J:64152
|
salivary gland inflammation
|
J:64152
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(Not Specified)
|
increased susceptibility to induced arthritis
|
J:106191
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Il17atm1Yiw/Il17a+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
glomerulonephritis
|
J:191090
|
kidney inflammation
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas * 129S4/SvJae * BALB/c)
|
urinary bladder inflammation
|
J:207275
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Sle21129P2/Ola/Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk)
|
increased susceptibility to induced arthritis
|
J:179175
|
kidney inflammation
|
J:179175
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Traf3ip2tm1Sbn/Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
kidney inflammation
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Traf3ip2tm2Sbn/Traf3ip2tm2Sbn Cd79atm1(cre)Reth/Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
glomerulonephritis
|
J:191090
|
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J)
|
decreased susceptibility to induced arthritis
|
J:106191
|
Fcgr4tm1.1Rav/Fcgr4tm1.1Rav
(involves: C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:167375
|
Fcgr4tm1Rav/Fcgr4tm1Rav Tg(Ctsk-cre)1Rda/0
(involves: C57BL/6)
|
autoimmune arthritis
|
J:197378
|
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch)
|
chronic liver inflammation
|
J:244082
|
Fem1atm1Seno/Fem1atm1Seno
(C57BL/6-Fem1atm1Seno)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:228893
|
increased susceptibility to induced colitis
|
J:228893
|
Fen1tm3.1Bhsh/Fen1+
(Not Specified)
|
glomerulonephritis
|
J:231218
|
interstitial pneumonia
|
J:231218
|
lung inflammation
|
J:231218
|
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
|
glomerulonephritis
|
J:231218
|
interstitial pneumonia
|
J:231218
|
lung inflammation
|
J:231218
|
Fermt1tm1Ref/Fermt1tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
ileum inflammation
|
J:142913
|
large intestinal inflammation
|
J:142913
|
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ)
|
conjunctivitis
|
J:64748
|
Festm2Pag/Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased susceptibility to endotoxin shock
|
J:98590
|
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6)
|
increased susceptibility to induced arthritis
|
J:153951
|
increased susceptibility to induced colitis
|
J:153951
|
lung inflammation
|
J:153951
|
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
|
large intestinal inflammation
|
J:157383
|
Fgfr1Hspy/Fgfr1+
(C3HeB/FeJ-Hspy)
|
increased susceptibility to otitis media
|
J:95895
|
Fgfr1tm1Upir/Fgfr1tm1Upir Fgfr2tm1Dor/Fgfr2tm1Dor Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
|
dermatitis
|
J:221184
|
skin inflammation
|
J:158802,
J:221184
|
Fgfr2tm1Dsn/Fgfr2tm1Dsn Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
adipose tissue inflammation
|
J:119723
|
skin inflammation
|
J:119723
|
Fgfr2tm1Ewj/Fgfr2+ Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
bronchiolectasis
|
J:101174
|
Fgl1tm1b(EUCOMM)Hmgu/Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N)
|
dermatitis
|
J:269578
|
Fgl2tm1Pam/Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam)
|
glomerulonephritis
|
J:130895
|
FgrMhdaali18/Fgr+
(C3HeB/FeJ-FgrMhdaali18)
|
dermatitis
|
J:112868
|
increased inflammatory response
|
J:112868
|
FgrMhdaali18/FgrMhdaali18
(C3HeB/FeJ-FgrMhdaali18)
|
autoimmune arthritis
|
J:112868
|
dermatitis
|
J:112868
|
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6)
|
increased susceptibility to induced colitis
|
J:285283
|
liver inflammation
|
J:302658
|
Fignfi/Fignfi
(mixed)
|
conjunctivitis
|
J:13035
|
eye inflammation
|
J:13035
|
Fkbp11Gt(OST298786)Lex/Fkbp11Gt(OST298786)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased inflammatory response
|
J:103485
|
Fkrptm1Scbr/Fkrptm1Scbr Sox1tm1(cre)Take/Sox1+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
myositis
|
J:207119
|
Fkrptm1Scbr/Fkrptm1Scbr Sox1tm1(cre)Take/Sox1+ Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
myositis
|
J:207119
|
Flgft/Flgft
(involves: C57BL/6)
|
skin inflammation
|
J:151110
|
Flgft/Flgft
(Not Specified)
|
dermatitis
|
J:198332
|
Flgft/Flgft
(STOCK a/a Tmem79ma Flgft/J)
|
dermatitis
|
J:204304
|
Flgft/Flgft Tmem79ma/Tmem79ma
(involves: CBA/CaGr)
|
blepharitis
|
J:202453
|
skin inflammation
|
J:202453
|
Flgtm1Amag/Flgtm1Amag
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac)
|
dermatitis
|
J:198332
|
increased inflammatory response
|
J:229771
|
increased susceptibility to type IV hypersensitivity reaction
|
J:198332
|
Flicrem1Doi/Flicrem1Doi
(NOD/ShiLtDoi-Flicrem1Doi)
|
insulitis
|
J:241346
|
Flvcr2tm1.2Tda/Flvcr2tm1.2Tda
(involves: C57BL/6J)
|
brain inflammation
|
J:287134
|
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
osteoarthritis
|
J:79115
|
Fmodtm1Aol/Fmodtm1Aol Lumtm1Chak/Lumtm1Chak
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
osteoarthritis
|
J:79115
|
Fndc4tm1.1Mabo/Fndc4tm1.1Mabo
(involves: C57BL/6 * BALB/c)
|
increased susceptibility to induced colitis
|
J:236896
|
Fostm3.1Wag/Fostm3.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased susceptibility to endotoxin shock
|
J:175064
|
Fostm4.1Wag/Fostm4.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased susceptibility to endotoxin shock
|
J:175064
|
Fostm5.1Wag/Fostm5.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased susceptibility to endotoxin shock
|
J:175064
|
Fostm6.1Wag/Fostm6.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased susceptibility to endotoxin shock
|
J:175064
|
Fostm7Wag/Fostm7Wag Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:175064
|
Foxa2tm1.1Khk/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
respiratory system inflammation
|
J:284174
|
Foxf1em1Vvk/Foxf1+
(involves: C57BL/6 * DBA/2)
|
lung inflammation
|
J:296328
|
Foxm1tm1Rhc/Foxm1tm1Rhc Tg(Tek-cre)1Ywa/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
lung inflammation
|
J:167773
|
Foxn1nu/Foxn1+
(involves: BALB/c)
|
blepharitis
|
J:12543
|
increased incidence of corneal inflammation
|
J:12543
|
Foxn1nu/Foxn1nu
(involves: BALB/c)
|
blepharitis
|
J:12543
|
Foxo1tm1Flv/Foxo1tm1Flv Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased susceptibility to induced colitis
|
J:147057
|
Foxo3Gt(XAO26)Byg/Foxo3Gt(XAO26)Byg
(involves: 129P2/OlaHsd)
|
increased inflammatory response
|
J:93593
|
kidney inflammation
|
J:93593
|
lung inflammation
|
J:93593
|
salivary gland inflammation
|
J:93593
|
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
dermatitis
|
J:118179
|
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
|
blepharitis
|
J:11262
|
dermatitis
|
J:11262
|
increased inflammatory response
|
J:11262
|
liver inflammation
|
J:11262
|
Foxp3sf/Y
(involves: 101/H * C3H/HeH * STOCK MR)
|
conjunctivitis
|
J:10398
|
Foxp3sf/?
(Not Specified)
|
liver inflammation
|
J:138808
|
lung inflammation
|
J:138808
|
Foxp3sf/Y
(B6.Cg-Foxp3sf/J)
|
lung inflammation
|
J:125129
|
salivary gland inflammation
|
J:125129
|
skin inflammation
|
J:125129
|
Foxp3tm1(CD2/CD52)Shori/Foxp3tm1(CD2/CD52)Shori
(involves: C57BL/6)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:171378
|
Foxp3tm1(cre)Saka/Y
(involves: BALB/c)
|
stomach inflammation
|
J:140085
|
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
skin inflammation
|
J:82560
|
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dermatitis
|
J:117743
|
liver inflammation
|
J:117743
|
lung inflammation
|
J:117743
|
lymph node inflammation
|
J:117743
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dermatitis
|
J:117743
|
liver inflammation
|
J:117743
|
lung inflammation
|
J:117743
|
lymph node inflammation
|
J:117743
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
blepharitis
|
J:167922
|
conjunctivitis
|
J:167922
|
dermatitis
|
J:167922
|
Foxp3tm1Ayr/Y Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
dermatitis
|
J:97029
|
Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch)
|
dermatitis
|
J:117165
|
respiratory system inflammation
|
J:117165
|
Foxp3tm1Tch/Y
(B6.129X1-Foxp3tm1Tch)
|
dermatitis
|
J:117165
|
respiratory system inflammation
|
J:117165
|
Foxp3tm2.1(EGFP/cre)Shori/Y Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6)
|
pancreas inflammation
|
J:234397
|
Foxp3tm2Flv/Y
(involves: C57BL/6)
|
blepharitis
|
J:118631
|
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
conjunctivitis
|
J:117743
|
dermatitis
|
J:117743
|
liver inflammation
|
J:117743
|
lung inflammation
|
J:117743
|
lymph node inflammation
|
J:117743
|
Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch)
|
colitis
|
J:120636
|
Foxp3tm4(YFP/icre)Ayr/Y Zfp91tm1Smoc/Zfp91tm1Smoc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to induced colitis
|
J:306129
|
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr Ikzf4tm1Djr/Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ)
|
glomerulonephritis
|
J:294549
|
small intestinal inflammation
|
J:294549
|
Foxq1sa/Foxq1sa Lystbg/Lystbg
(involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl)
|
interstitial pneumonia
|
J:15166,
J:5311
|
Foxq1sa/Foxq1sa Lystbg/Lystbg
(involves: 101/Rl * C3H/Rl * C57BL10/Rl)
|
interstitial pneumonia
|
J:5311
|
lung inflammation
|
J:5311
|
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(involves: 129X1/SvJ)
|
colitis
|
J:197568
|
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6)
|
increased acute inflammation
|
J:159658
|
increased susceptibility to induced arthritis
|
J:159658
|
Frmd8em2Smoc/Frmd8em2Smoc Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:338904
|
increased susceptibility to induced colitis
|
J:338904
|
FrylGt(Ayu21-T312)Imeg/FrylGt(Ayu21-T312)Imeg
(B6J.Cg-FrylGt(Ayu21-T312)Imeg)
|
kidney inflammation
|
J:260667
|
Fth1tm1.1Lck/Fth1tm1.1Lck Tg(Mx1-cre)1Cgn/0
(B6.Cg-Fth1tm1.1Lck Tg(Mx1-cre)1Cgn)
|
liver inflammation
|
J:166515
|
Ftotm1.2Pzg/Ftotm1.2Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
dermatitis
|
J:166984
|
Ftotm1.3Pzg/Ftotm1.3Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
dermatitis
|
J:166984
|
Fxntm1Mkn/Fxntm1Mkn Tg(FXN)YG8Pook/0
(involves: 129/Sv * C57BL/6 * CBA)
|
brain inflammation
|
J:216422
|
Fxntm1Mkn/Fxntm1Pand
(involves: 129/Sv * C57BL/6)
|
brain inflammation
|
J:216422
|
Fyntm1Rmp/Fyntm1Rmp
(B6.129S2-Fyntm1Rmp)
|
increased susceptibility to type I hypersensitivity reaction
|
J:114287
|
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya)
|
pancreas inflammation
|
J:88785
|
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
glomerulonephritis
|
J:76041
|
increased inflammatory response
|
J:76041
|
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv)
|
glomerulonephritis
|
J:118837
|
Gadd45btm1Flv/Gadd45btm1Flv Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
glomerulonephritis
|
J:118837
|
Galctwi/Galctwi
(involves: CE/J)
|
CNS inflammation
|
J:78223
|
GaltGt(E285B04)Wrst/GaltGt(E285B04)Wrst
(involves: 129P2/OlaHsd * C57BL/6J)
|
brain inflammation
|
J:234753
|
liver inflammation
|
J:234753
|
Gasa1BALB/cCrSlc/Gasa1BALB/cCrSlc
(involves: BALB/cCrSlc * C57BL/6)
|
stomach inflammation
|
J:54699
|
Gasa1BALB/cCrSlc/Gasa1C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
|
stomach inflammation
|
J:54699
|
Gasa2BALB/cCrSlc/Gasa2BALB/cCrSlc
(involves: BALB/cCrSlc * C57BL/6)
|
stomach inflammation
|
J:54699
|
Gasa2BALB/cCrSlc/Gasa2BALB/cCrSlc Gasa4BALB/cCrSlc/Gasa4C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
|
stomach inflammation
|
J:75277
|
Gasa2BALB/cCrSlc/Gasa2C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
|
stomach inflammation
|
J:54699
|
Gasa3BALB/cCrSlc/Gasa3C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
|
stomach inflammation
|
J:75277
|
Gasa4BALB/cCrSlc/Gasa4C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
|
stomach inflammation
|
J:75277
|
Gasttm1Lcs/Gasttm1Lcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
stomach inflammation
|
J:97527
|
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(Not Specified)
|
kidney inflammation
|
J:227997
|
Gata5tm1Eno/Gata5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
urethritis
|
J:63036
|
vaginal inflammation
|
J:63036
|
Gatmem1Btlr/Gatmem1Btlr
(C57BL/6J-Gatmem1Btlr)
|
increased susceptibility to induced colitis
|
J:252049
|
Gatmem1Btlr/Gatmm1Btlr
(C57BL/6J-Gatmem1Btlr/Gatmm1Btlr)
|
increased susceptibility to induced colitis
|
J:252049
|
Gatmm1Btlr/Gatm+
(C57BL/6J-Gatmm1Btlr)
|
increased susceptibility to induced colitis
|
J:252049
|
Gatmm1Btlr/Gatmm1Btlr
(C57BL/6J-Gatmm1Btlr)
|
increased susceptibility to induced colitis
|
J:252049
|
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
liver inflammation
|
J:76409
|
lung inflammation
|
J:76409
|
lymph node inflammation
|
J:76409
|
skin inflammation
|
J:76409
|
Gcnt3tm1.1Jxm/Gcnt3tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to induced colitis
|
J:149909
|
Gdnftm1Lmgd/Gdnf+
(B6.129-Gdnftm1Lmgd)
|
tubulointerstitial nephritis
|
J:103081
|
Gfaptm1Pkny/Gfaptm1Pkny Ppt1tm1Hof/Ppt1tm1Hof Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
brain inflammation
|
J:177265
|
Gfertm1.1Crg/Gfertm1.1Crg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
liver inflammation
|
J:227242
|
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:75143
|
Gfustm1Jbl/Gfustm1Jbl
(involves: 129S2/SvPas * C57BL/6J)
|
large intestinal inflammation
|
J:82239
|
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
|
colitis
|
J:160090
|
intestinal inflammation
|
J:160090
|
Git2tm1Hsb/Git2tm1Hsb
(involves: C57BL/6 * CBA)
|
lung inflammation
|
J:112663
|
Gja1M1Jrt/Gja1+
(involves: C3H/HeJ * C57BL/6J)
|
heart inflammation
|
J:101733
|
Gjb1tm1Kwi/Y Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
optic nerve inflammation
|
J:219594
|
spinal cord inflammation
|
J:219594
|
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
optic nerve inflammation
|
J:219594
|
spinal cord inflammation
|
J:219594
|
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
stomach inflammation
|
J:234656
|
Glis2tm1Amj/Glis2tm1Amj
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:134208
|
GlmpGt(P084H04)Wrst/GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
liver inflammation
|
J:208774
|
Glmptm1Lex/Glmptm1Lex
(B6;129S5-Glmptm1Lex/Mmucd)
|
liver inflammation
|
J:171883
|
Gna12tm1Citb/Gna12tm1Citb Gna13tm2.1Soff/Gna13tm2.1Soff Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:149560
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd * C57BL/6J)
|
colitis
|
J:24434
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
colitis
|
J:24434
|
increased inflammatory response
|
J:30507
|
large intestinal inflammation
|
J:30507
|
peritoneal inflammation
|
J:30507
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd * C57BL/6)
|
colitis
|
J:91100
|
Gnai2tm2.1Lbi/Gnai2tm2.1Lbi Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA)
|
increased susceptibility to induced colitis
|
J:194587
|
Gnb1lGt(OST35527)Lex/Gnb1l+
(B6;129S5-Gnb1lGt(OST35527)Lex/Orl)
|
glomerulonephritis
|
J:82809
|
Gnetm1.1Masn/Gnetm1.1Masn
(involves: 129P2/OlaHsd * C57BL/6)
|
kidney inflammation
|
J:184315
|
Gnptabnym/Gnptabnym
(involves: BALB/cAnNHsd * C3H/HeNHsd)
|
brain inflammation
|
J:218156
|
Golm1Gt(KST273)Byg/Golm1Gt(KST273)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
kidney inflammation
|
J:151282
|
liver inflammation
|
J:151282
|
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(B6.129-Gpa33tm1Jkhh)
|
increased susceptibility to induced colitis
|
J:224768
|
increased susceptibility to type IV hypersensitivity reaction
|
J:224768
|
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(involves: 129 * C57BL/6)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:231808
|
increased susceptibility to induced colitis
|
J:231808
|
Gpc3tm1Fil/Y
(B6.Cg-Gpc3tm1Fil)
|
lung inflammation
|
J:73877
|
rhinitis
|
J:73877
|
Gpc3tm1Fil/Gpc3tm1Fil
(B6.Cg-Gpc3tm1Fil)
|
lung inflammation
|
J:73877
|
Gpdc1C3H/HeN/Gpdc1C3H/HeN
(involves: C3H/HeN-Gnai2tm1Uru * C57BL/6J-Gna2tm1Uru)
|
colitis
|
J:95140
|
Gpdc2C3H/HeN/Gpdc2C3H/HeN
(involves: C3H/HeN-Gnai2tm1Uru * C57BL/6J-Gna2tm1Uru)
|
colitis
|
J:95140
|
Gpdc3C3H/HeN/?
(involves: C3H/HeN-Gnai2tm1Uru * C57BL/6J-Gna2tm1Uru)
|
colitis
|
J:95140
|
Gpr15tm1.1Litt/Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt)
|
increased susceptibility to induced colitis
|
J:199126
|
Gpr34tm1.1Shbg/Gpr34tm1.1Shbg
(B6.Cg-Gpr34tm1.1Shbg)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:168120
|
Gpr35em1Niess/Gpr35em1Niess
(C57BL/6N-Gpr35em1Niess)
|
increased susceptibility to induced colitis
|
J:300275
|
Gpr35em2Niess/Gpr35em2Niess Cx3cr1tm2.1(cre/ERT2)Litt/Cx3cr1+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to induced colitis
|
J:300275
|
Gpr89tm1.1Ymae/Gpr89tm1.1Ymae Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6)
|
dermatitis
|
J:189574
|
Gpr108tm1.1Brs/Gpr108tm1.1Brs
(involves: 129S6/SvEvTac)
|
increased susceptibility to endotoxin shock
|
J:266821
|
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c)
|
increased inflammatory response
|
J:69473
|
kidney inflammation
|
J:69473
|
liver inflammation
|
J:69473
|
lung inflammation
|
J:69473
|
Gprc5atm1Rlo/Gprc5atm1Rlo
(involves: 129 * C57BL/6)
|
lung inflammation
|
J:127821
|
Gpsm3Gt(IST12408A1)Tigm/Gpsm3Gt(IST12408A1)Tigm
(involves: C57BL/6N)
|
decreased susceptibility to induced arthritis
|
J:193270
|
Gpx1tm1Kola/Gpx1tm1Kola
(involves: 129S2/SvPas * BALB/c * CF-1)
|
increased inflammatory response
|
J:79183
|
Gpx1tm1Ysh/Gpx1+ Gpx2tm2Coh/Gpx2tm2Coh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
intestinal inflammation
|
J:71506
|
Gpx1tm1Ysh/Gpx1tm1Ysh Gpx2tm2Coh/Gpx2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
intestinal inflammation
|
J:71506
|
Gpx1tm1Ysh/Gpx1tm1Ysh Gpx2tm2Coh/Gpx2tm2Coh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
colitis
|
J:71506
|
intestinal inflammation
|
J:71506
|
small intestinal inflammation
|
J:71506
|
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:193993
|
Gpx8tm1Lex/Gpx8tm1Lex
(B6;129S5-Gpx8tm1Lex/Mmucd)
|
dermatitis
|
J:171883
|
Grem2em1Stpg/Grem2em1Stpg
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J)
|
ovary inflammation
|
J:318711
|
Grem2tm1Akh/Grem2tm1Akh
(involves: 129/Sv * C57BL/6)
|
increased inflammatory response
|
J:250034
|
GrhprGt(OST383093)Lex/GrhprGt(OST383093)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
urinary bladder inflammation
|
J:181969
|
Grk6tm1.1Mca/Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca)
|
glomerulonephritis
|
J:225063
|
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6J)
|
kidney inflammation
|
J:268827
|
Gsdma3Ae/Gsdma3+
(involves: C57BL/6J * CAST/Ei)
|
skin inflammation
|
J:180149
|
Gsdma3M2Btlr/Gsdma3M2Btlr
(involves: C57BL/6J)
|
dermatitis
|
J:209203
|
Gstk1tm1Pgb/Gstk1tm1Pgb
(BALB/c-Gstk1tm1Pgb)
|
glomerulonephritis
|
J:177201
|
urethritis
|
J:177201
|
urinary bladder inflammation
|
J:177201
|
Gstz1tm1Pgb/Gstz1tm1Pgb
(BALB/c-Gstz1tm1Pgb/AnuApb)
|
liver inflammation
|
J:91519
|
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+ Malt1tm1c(EUCOMM)Hmgu/Malt1tm1c(EUCOMM)Hmgu Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
skin inflammation
|
J:292094
|
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+ Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
skin inflammation
|
J:292094
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+ Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
CNS inflammation
|
J:234435
|
lymph node inflammation
|
J:234435
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA)
|
increased susceptibility to induced pancreatitis
|
J:289183
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
dermatitis
|
J:157757
|
Gt(ROSA)26Sortm1(HA)Libl/Gt(ROSA)26Sortm1(HA)Libl Mogtm1(cre)Gkl/? Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: 129/Sv * BALB/c * C57BL/6)
|
brain inflammation
|
J:137838
|
optic nerve inflammation
|
J:137838
|
spinal cord inflammation
|
J:137838
|
Gt(ROSA)26Sortm1(MAML1)Wsp/Gt(ROSA)26Sor+ Tg(KRT14-rtTA)F42Efu/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6 * FVB)
|
conjunctivitis
|
J:194073
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
glomerulonephritis
|
J:260047
|
increased inflammatory response
|
J:260047
|
joint inflammation
|
J:260047
|
small intestinal inflammation
|
J:260047
|
Gt(ROSA)26Sortm1(Ptpn22*)Draw/Gt(ROSA)26Sor+ Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:201448
|
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
lung inflammation
|
J:205858
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+ Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6)
|
increased acute inflammation
|
J:256652
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sortm1.1(DUX4*)Plj
(B6(Cg)-Gt(ROSA)26Sortm1.1(DUX4*)Plj)
|
preputial gland inflammation
|
J:256652
|
Gt(ROSA)26Sortm1.1(Loxl2)Acan/Gt(ROSA)26Sortm1.1(Loxl2)Acan
(Not Specified)
|
epididymis inflammation
|
J:220689
|
increased inflammatory response
|
J:220689
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
increased inflammatory response
|
J:202090
|
intestinal inflammation
|
J:202090
|
kidney inflammation
|
J:202090
|
liver inflammation
|
J:202090
|
meningitis
|
J:202090
|
stomach inflammation
|
J:202090
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
increased inflammatory response
|
J:202090
|
intestinal inflammation
|
J:202090
|
kidney inflammation
|
J:202090
|
liver inflammation
|
J:202090
|
meningitis
|
J:202090
|
stomach inflammation
|
J:202090
|
Gt(ROSA)26Sortm2(CAG-Nr5a1)Fjd/Gt(ROSA)26Sor+ Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ)
|
uterus inflammation
|
J:269597
|
Gt(ROSA)26Sortm2(cre/ERT2)Brn/0 Tg(Sftpc-Grem1)105Mmyl/0
(involves: 129P2/OlaHsd * C57BL/6N)
|
lung inflammation
|
J:82809
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+ Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased inflammatory response
|
J:207306
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+ Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR)
|
increased inflammatory response
|
J:207306
|
Gt(ROSA)26Sortm3.1(CAG-Il17a)Awai/Gt(ROSA)26Sor+
(involves: BALB/c * C57BL/6)
|
skin inflammation
|
J:144710
|
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sortm4(HIF2A*)Kael Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:307422
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ Ripk3tm1Arte/Ripk3tm1Arte
(involves: C57BL/6NTac)
|
intestinal inflammation
|
J:209137
|
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N)
|
peritoneal inflammation
|
J:121321
|
Gy/Y
(involves: 101/H * C3H/HeH)
|
blepharitis
|
J:8335
|
H2-Ab1b-tm1Doi/H2-Ab1+
(involves: 129S2/SvPas * C57BL/6 * NOD/Lt)
|
insulitis
|
J:93557
|
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129S2/SvPas * C57BL/6 * NOD/Lt)
|
insulitis
|
J:93557
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Ighmtm1Cgn/Ighmtm1Cgn Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-Ighmtm1Cgn H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
|
heart inflammation
|
J:113267
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Rag1tm1Mom/Rag1tm1Mom Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
|
heart inflammation
|
J:113267
|
myocarditis
|
J:113267
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Rag1tm1Mom/Rag1tm1Mom Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)
|
myocarditis
|
J:88055
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
|
heart inflammation
|
J:87013,
J:86540
|
lung inflammation
|
J:86540
|
myositis
|
J:86540
|
salivary gland inflammation
|
J:86540
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell)
|
thyroid gland inflammation
|
J:113509
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL)
|
salivary gland inflammation
|
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv)
|
salivary gland inflammation
|
J:59245
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl)
|
heart inflammation
|
J:88055
|
insulitis
|
J:88055
|
myocarditis
|
J:88055
|
salivary gland inflammation
|
J:88055
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)
|
heart inflammation
|
J:88055
|
insulitis
|
J:88055
|
myocarditis
|
J:88055
|
salivary gland inflammation
|
J:88055
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL)
|
salivary gland inflammation
|
J:68641
|
H2-D1b-em5Dvs/H2-D1b-em5Dvs H2-K1d-em1Dvs/H2-K1d-em1Dvs Tg(HLA-A/H2-D/B2M)1Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-A/H2-D/B2M)1Dvs/Dvs)
|
insulitis
|
J:257229
|
H2-D1b-em5Dvs/H2-D1b-em5Dvs H2-K1d-em1Dvs/H2-K1d-em1Dvs Tg(HLA-B39/H2-D/B2m)2Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-B39/H2-D/B2M)2Dvs/Dvs)
|
insulitis
|
J:257229
|
H2-D1bm14/H2-D1bm14
(C57BL/6)
|
spinal cord inflammation
|
J:97717
|
H2-T18b/H2-T18b H2-T3tm1Luc/H2-T3tm1Luc Tcratm1Mom/Tcratm1Mom
(B6.Cg-Tcratm1Mom H2-T3tm1Luc)
|
colitis
|
J:142515
|
H2b/H2b
(NOD.B10SnJ-H2b)
|
periinsulitis
|
J:14178
|
H2b/H2g7 Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
mitral valve inflammation
|
J:275827
|
rheumatoid arthritis
|
J:36815,
J:275827
|
H2dlAb1-Ea/H2dlAb1-Ea Rag1tm1Mom/Rag1tm1Mom Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:189816
|
H2dlAb1-Ea/H2dlAb1-Ea Rag1tm1Mom/Rag1tm1Mom Tg(HLA-DRA,HLA-DRB5*0101)loKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:189816
|
H2dlAb1-Ea/H2dlAb1-Ea Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
brain inflammation
|
J:189816
|
CNS inflammation
|
J:189816
|
increased inflammatory response
|
J:189816
|
H2dlAb1-Ea/H2dlAb1-Ea Tg(HLA-DRA,HLA-DRB5*0101)loKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
brain inflammation
|
J:189816
|
H2g7/H2g7 Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
insulitis
|
J:111874
|
H2g7/H2g7 Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
insulitis
|
J:111874
|
H2h2/H2h2
(NOD.Cg-H2h2)
|
insulitis
|
J:14178
|
periinsulitis
|
J:14178
|
H2h4/H2h4
(NOD.Cg-H2h4)
|
insulitis
|
J:14178
|
periinsulitis
|
J:14178
|
thyroid gland inflammation
|
J:54563
|
H2i5/H2i5
(NOD.Cg-H2i5)
|
periinsulitis
|
J:14178
|
H2i7/H2g7
((NOD x NOD.Cg-H2i7)F1)
|
insulitis
|
J:14178
|
H2i7/H2i7
(NOD.Cg-H2i7)
|
periinsulitis
|
J:14178
|
H2k/H2k
(NOD.Cg-H2k)
|
periinsulitis
|
J:14178
|
H2q/? Ncf1m1J/Ncf1m1J
(B6.Cg-Ncf1m1J H2q)
|
increased susceptibility to induced arthritis
|
J:92437
|
increased susceptibility to type IV hypersensitivity reaction
|
J:92437
|
rheumatoid arthritis
|
J:92437
|
Habp2tm1Lex/Habp2tm1Lex
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6)
|
liver inflammation
|
J:207454
|
Hapstr1tm1.1Menm/Hapstr1tm1.1Menm Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
large intestinal inflammation
|
J:348964
|
Havcr1tm1Vlcg/Havcr1tm1Vlcg
(C.129-Havcr1tm1Vlcg)
|
respiratory system inflammation
|
J:187793
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow Slc12a4Rbc10/Slc12a4+
(involves: 129 * BALB/c * C57BL/6J)
|
liver inflammation
|
J:227339
|
Hc0/Hc0 Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J)
|
decreased susceptibility to induced arthritis
|
J:134111
|
Hc1/? Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J)
|
increased susceptibility to induced arthritis
|
J:134111
|
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6)
|
lung inflammation
|
J:111432
|
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
CNS inflammation
|
J:90687
|
Hfgi1C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
stomach inflammation
|
J:123483
|
Hfgi2C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
stomach inflammation
|
J:123483
|
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6)
|
dermatitis
|
J:81448
|
Hif1atm3Rsjo/Hif1atm3Rsjo Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Hprt1tm1(Pck1-cre)Vhh/Y
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
kidney inflammation
|
J:130751
|
Hif1atm3Rsjo/Hif1atm3Rsjo Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6)
|
kidney inflammation
|
J:106705
|
Hif1atm3Rsjo/Hif1atm3Rsjo Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to induced arthritis
|
J:107682
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Fabp1-cre)1Jig/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB/N)
|
increased susceptibility to induced colitis
|
J:93476
|
Hivep2tm1Sis/Hivep2tm1Sis
(either: (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj) or (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj))
|
CNS inflammation
|
J:263351
|
Hmgb1tm1.1Dltg/Hmgb1tm1.1Dltg Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to induced pancreatitis
|
J:225260
|
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to endotoxin shock
|
J:205499
|
Hmox1tm1.2Gkl/Hmox1tm1.2Gkl
(involves: 129 * BALB/cJ * C57BL/6)
|
increased inflammatory response
|
J:148498
|
liver inflammation
|
J:148498
|
Hmox1tm1Poss/Hmox1tm1Poss
(involves: 129S2/SvPas * C57BL/6)
|
glomerulonephritis
|
J:79254
|
liver inflammation
|
J:79254
|
lung inflammation
|
J:79254
|
Hnf1btm1Mya/Hnf1btm3Mya Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
liver inflammation
|
J:75935
|
Hnf1btm2Ics/Hnf1b+
(involves: 129 * C57BL/6N)
|
chronic pancreas inflammation
|
J:306082
|
Hnrnpdtm1Rjsc/Hnrnpdtm1Rjsc
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:116112
|
Hoxa5tm1Rob/Hoxa5tm1Rob
(involves: 129S/SvEv * C57BL/6 * MF1)
|
lung inflammation
|
J:113378
|
Hptm1Skl/Hptm1Skl Hpxtm1Altr/Hpxtm1Altr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)
|
liver inflammation
|
J:80539
|
Hpgdstm1Urad/Hpgdstm1Urad
(B6.129-Hpgdstm1Urad)
|
increased acute inflammation
|
J:107651
|
increased inflammatory response
|
J:107651
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
kidney inflammation
|
J:106705
|
Hps1ep/Hps1ep
(B6.C3Fe-Hps1ep/J)
|
alveolitis
|
J:110157
|
Hrhr/Hrhr Tg(CD2-Stat6*V625A*T626A)78Mhk/0
(involves: C3H * SKH1)
|
blepharitis
|
J:230018
|
eye inflammation
|
J:230018
|
Meibomian gland inflammation
|
J:230018
|
uveitis
|
J:230018
|
Hrrh/Hrrh
(Not Specified)
|
eye inflammation
|
J:16021
|
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))
|
glomerulonephritis
|
J:21316
|
lymph node inflammation
|
J:21316
|
Hsd17b13tm1Lex/Hsd17b13tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
liver inflammation
|
J:273927
|
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
(involves: 129 * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:302787
|
Hspb1tm1.1Jdn/Hspb1tm1.1Jdn
(B6.129S2(Cg)-Hspb1tm1.1Jdn)
|
increased inflammatory response
|
J:209117
|
Hspg2tm1Rdgr/Hspg2tm1Rdgr
(involves: 129S1/Sv * 129X1/SvJ)
|
osteoarthritis
|
J:121855
|
Htr3atm1Ckn/Htr3atm1Ckn
(involves: 129S1/Sv * C57BL/6J * DBA/2)
|
kidney inflammation
|
J:90942
|
prostate gland inflammation
|
J:90942
|
pyelonephritis
|
J:90942
|
seminal vesiculitis
|
J:90942
|
tubulointerstitial nephritis
|
J:90942
|
Hyal1tm1Stn/Hyal1tm1Stn
(involves: 129X1/SvJ * C57BL/6J)
|
osteoarthritis
|
J:136860
|
Hydinhyrh/Hydinhyrh
(involves: C57BL/6J * C57BL/10J * RIII)
|
rhinitis
|
J:137815
|
Ibdq1C57BL/6J/Ibdq1SAMP1/YitFcs
(involves: C57BL/6J * SAMP1/YitFc)
|
ileum inflammation
|
J:84661
|
Ibdq1SAMP1/YitFcs/Ibdq1SAMP1/YitFcs
(involves: C57BL/6J * SAMP1/YitFc)
|
ileum inflammation
|
J:84661
|
Ibdq2SAMP1/YitFcs/Ibdq2SAMP1/YitFcs
(involves: AKR/J * SAMP1/YitFcs)
|
small intestinal inflammation
|
J:105411
|
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
large intestinal inflammation
|
J:111227
|
Icam1tm1Jcgr/Icam1tm1Jcgr Tg(INS-Il10)#Sar/0
(NOD.Cg-Icam1tm1Jcgr Tg(INS-Il10)#Sar)
|
periinsulitis
|
J:66103
|
Icostm1Flv/Icos+
(NOD.129S1-Icostm1Flv)
|
insulitis
|
J:131529
|
Icostm1Flv/Icostm1Flv
(NOD.129S1-Icostm1Flv)
|
insulitis
|
J:131529
|
Id1tm1Zhu/Id1+ Id3tm1Zhu/Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor)
|
increased susceptibility to otitis media
|
J:311050
|
Id1tm1Zhu/Id1tm1Zhu Id3tm1Zhu/Id3+
(involves: 129S1/Sv * 129S4/SvJaeSor)
|
increased susceptibility to otitis media
|
J:311050
|
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S4/SvJaeSor)
|
lacrimal gland inflammation
|
J:93916
|
salivary gland inflammation
|
J:93916
|
Id3tm2.1Zhu/Id3tm2.1Zhu Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
parotid gland inflammation
|
J:172701
|
submandibular gland inflammation
|
J:172701
|
Idc/Idc+
(involves: 101 * C3H)
|
blepharitis
|
J:6686
|
Idd1NOD/Uf/Idd1NOD/Uf
(involves: C57BL/6 * NOD/Uf)
|
periinsulitis
|
J:33172
|
Idd3C57BL/10SnJ/Idd3C57BL/10SnJ Idd5.2C57BL/10SnJ/Idd5.2C57BL/10SnJ
(involves: C57BL/10SnJ * NOD/MrkTac)
|
insulitis
|
J:143549
|
Idd3C57BL/10SnJ/Idd3C57BL/10SnJ Idd5C57BL/10SnJ/Idd5C57BL/10SnJ
(involves: C57BL/10 * NOD/MrkTac)
|
pancreas inflammation
|
J:88667
|
Idd3NOD/?
(involves: C57BL/10 * NOD)
|
pancreas inflammation
|
J:17906
|
Idd4C57BL/6J/?
(involves: C57BL/6J * NOD)
|
pancreas inflammation
|
J:73763
|
Idd4NOD/Jsd/?
(involves: NOD/Jsd * NOR/LtJ)
|
pancreas inflammation
|
J:99002
|
Idd4NOD/Jsd/Idd4NOD/Jsd Idd9NOD/Jsd/Idd9NOD/Jsd
(involves: NOD/Jsd * NOR/LtJ)
|
pancreas inflammation
|
J:99002
|
Idd4NOR/LtJ/?
(involves: NOD/Jsd * NOR/LtJ)
|
pancreas inflammation
|
J:99002
|
Idd5NOD/Uf/Idd5NOD/Uf
(involves: C57BL/6 * NOD/Uf)
|
periinsulitis
|
J:33172
|
Idd9NOD/Jsd/?
(involves: NOD/Jsd * NOR/LtJ)
|
pancreas inflammation
|
J:99002
|
Idd9NOR/LtJ/?
(involves: NOD/Jsd * NOR/LtJ)
|
pancreas inflammation
|
J:99002
|
Idd16.1ALR/LtJ/Idd16.1ALR/LtJ
(involves: ALR/LtJ * NOD/LtJ)
|
pancreas inflammation
|
J:98187
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * BALB/c)
|
epididymis inflammation
|
J:170565
|
Ido2em1Lamn/Ido2em1Lamn Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
autoimmune arthritis
|
J:342726
|
Ido2em2Lamn/Ido2em2Lamn Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
autoimmune arthritis
|
J:342726
|
Iduatm1Efn/Iduatm1Efn
(involves: C57BL/6)
|
increased susceptibility to otitis media
|
J:123676
|
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
chronic liver inflammation
|
J:209917
|
glomerulonephritis
|
J:209917
|
increased inflammatory response
|
J:209917
|
skin inflammation
|
J:209917
|
Ifih1Rgsc422/Ifih1+ Ifnar1tm1Agt/Ifnar1+
(involves: 129S2/SvPas * C57BL/6JJcl * DBA/2JJcl)
|
glomerulonephritis
|
J:209917
|
Ifih1Rgsc422/Ifih1+ Mavstm1Aki/Mavs+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
glomerulonephritis
|
J:209917
|
Ifih1Rgsc422/Ifih1Rgsc422
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
glomerulonephritis
|
J:209917
|
Ifit1tm1(KOMP)Vlcg/Ifit1tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
brain inflammation
|
J:205203
|
Ifnar1tm1Agt/Ifnar1tm1Agt Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu Tg(KRT14-cre)1Cgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N * DBA/2)
|
dermatitis
|
J:312394
|
Ifnar1tm1Agt/Ifnar1tm1Agt Tg(CD46)373Zbz/Tg(CD46)373Zbz
(involves: 129S2/SvPas * C3H/He * C57BL/6)
|
brain inflammation
|
J:160878
|
lung inflammation
|
J:160878
|
meningitis
|
J:160878
|
Ifnar2tm1Pjh/Ifnar2tm1Pjh Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv)
|
increased susceptibility to endotoxin shock
|
J:168781
|
Ifnb1tm1Tl/Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl)
|
CNS inflammation
|
J:83021
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
glomerulonephritis
|
J:118730
|
increased susceptibility to type IV hypersensitivity reaction
|
J:118730
|
stomach inflammation
|
J:120556
|
Ifngtm1Ts/Ifngtm1Ts Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:191055
|
Ifngtm1Ts/Ifngtm1Ts Tg(SFTPC-Il18)AThos/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N * DBA/2)
|
lung inflammation
|
J:147547
|
Ifngtm1Ts/Ifngtm1Ts Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129-Ifngtm1Ts Tgfb1tm1Doe)
|
liver inflammation
|
J:69346
|
Ifngtm1Ts/Ifngtm1Ts Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Ifngtm1Ts/Ifngtm1Ts Tnfrsf1atm1Blt/Tnfrsf1atm1Blt Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
lung inflammation
|
J:119206
|
Ifngtm1Yiw/Ifngtm1Yiw
(B6.129X1-Ifngtm1Yiw)
|
liver inflammation
|
J:50405
|
peritoneal inflammation
|
J:50405
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
aortitis
|
J:115139
|
arteritis
|
J:115139
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * DBA/1OlaHsd)
|
increased susceptibility to induced arthritis
|
J:40634
|
Ifnktm1.1(KOMP)Vlcg/Ifnktm1.1(KOMP)Vlcg
(C57BL/6NTac-Ifnktm1.1(KOMP)Vlcg)
|
decreased susceptibility to chemically induced skin inflammation
|
J:322130
|
Igfbp1tm1Taub/Igfbp1tm1Taub
(involves: 129X1/SvJ * C57BL/6)
|
liver inflammation
|
J:81123
|
Igh-Jtm1(CB20)Riho/Igh-J+
(involves: C57BL/10 * DBA/1)
|
increased susceptibility to induced arthritis
|
J:179456
|
Igh-Jtm1(CB20)Riho/Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1)
|
increased susceptibility to induced arthritis
|
J:179456
|
Igh-Jtm1Aigl/Igh-J+ Mogtm1Dpd/Mogtm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
CNS inflammation
|
J:151335
|
Igh-Jtm1Aigl/Igh-J+ Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
CNS inflammation
|
J:151335
|
Igh-Jtm1Dhu/Igh-J+ Il2tm1Hor/Il2tm1Hor
(involves: 129/Sv * C57BL/6)
|
colitis
|
J:29999
|
Igh-Jtm1Dhu/Igh-Jtm1Dhu Il2tm1Hor/Il2tm1Hor
(involves: 129/Sv * C57BL/6)
|
colitis
|
J:29999
|
Ightm1.1(Igh564)Tik/Ightm1.1(Igh564)Tik Igktm1(Igk564)Tik/Igktm1(Igk564)Tik
(B6.129S4-Igktm1(Igk564)Tik Ightm1(Igh564)Tik)
|
glomerulonephritis
|
J:113555
|
Ighg1tm1.1Pyu/Ighg1+
(B6.C(Cg)-Ighg1tm1.1Pyu)
|
increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(B6.C(Cg)-Ighg1tm1.1Pyu)
|
increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Ighmtm1Cgn/Ighm+ Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
insulitis
|
J:91865
|
Ighmtm1Cgn/Ighm+ Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V281)3Jwt)
|
insulitis
|
J:91865
|
Ighmtm1Cgn/Ighmtm1Cgn
(NODCaj.129S2-Ighmtm1Cgn)
|
insulitis
|
J:93190
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
increased susceptibility to induced arthritis
|
J:157619
|
Ighmtm1Cgn/Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
insulitis
|
J:91865
|
Ighmtm1Cgn/Ighmtm1Cgn Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V281)3Jwt)
|
insulitis
|
J:91865
|
Ighmtm1Cgn/Ighmtm1Cgn Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ)
|
insulitis
|
J:80859
|
Ighmtm1Cgn/Ighmtm1Cgn Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Ighmtm1Cgn/Ighmtm1Cgn Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased inflammatory response
|
J:181257
|
kidney inflammation
|
J:181257
|
myocarditis
|
J:181257
|
tubular nephritis
|
J:181257
|
Ighmtm1Msn/Ighmtm1Msn
(involves: 129S/SvEv * C57BL/6)
|
kidney inflammation
|
J:111817
|
Igktm1Dhu/Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)
|
autoimmune arthritis
|
J:209872
|
Ignpq3BALB/cAJcl/Ignpq3HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc)
|
glomerulonephritis
|
J:116904
|
Ignpq3HIGA/Nsc/Ignpq3HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc)
|
glomerulonephritis
|
J:116904
|
Ikbipem1Bcgen/Ikbipem1Bcgen Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to induced colitis
|
J:282971
|
lung inflammation
|
J:282971
|
Ikbkbtm1Cgn/Ikbkbtm1Cgn Il20ratm1Rsab/Il20ratm1Rsab Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2)
|
skin inflammation
|
J:208995
|
Ikbkbtm1Cgn/Ikbkbtm1Cgn Il22tm1Jcrd/Il22tm1Jcrd Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2)
|
skin inflammation
|
J:208995
|
Ikbkbtm1Cgn/Ikbkbtm1Cgn Il22ra1tm1Rsab/Il22ra1tm1Rsab Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2)
|
skin inflammation
|
J:208995
|
Ikbkbtm1Cgn/Ikbkbtm1Cgn Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2)
|
skin inflammation
|
J:208995
|
Ikbkbtm1Cgn/Ikbkbtm1Cgn Tnfrsf1atm2Gkl/Tnfrsf1atm2Gkl Tg(KRT14-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
skin inflammation
|
J:208995
|
Ikbketm1Tman/Ikbketm1Tman
(B6.Cg-Ikbketm1Tman)
|
lung inflammation
|
J:119791
|
Ikbkgtm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
liver inflammation
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
liver inflammation
|
J:151485
|
Ikbkgtm1.1Dwat/Y Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
liver inflammation
|
J:202106
|
Ikbkgtm1.1Mpa/Y Tg(Vil1-cre)997Gum/0
(B6.Cg-Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum)
|
colitis
|
J:175865
|
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to endotoxin shock
|
J:137861
|
liver inflammation
|
J:118336
|
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum/0
(B6.Cg-Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum)
|
colitis
|
J:175865
|
Ikbkgtm1Mka/Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
erythroderma
|
J:63054
|
Ikbkgtm1Mpa/Ikbkg+
(involves: C57BL/6)
|
skin inflammation
|
J:63055
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
lung inflammation
|
J:20671
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c)
|
lung inflammation
|
J:20671
|
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
glomerulonephritis
|
J:81805
|
Il1atm1Yiw/Il1atm1Yiw Il1btm1Yiw/Il1btm1Yiw Tg(KRT14-CASP1)1Miz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dermatitis
|
J:78602
|
Il1r1em1Qizh/Il1r1em1Qizh
(C57BL/6-Il1r1em1Qizh)
|
increased susceptibility to induced arthritis
|
J:338375
|
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129 * C57BL/6)
|
osteomyelitis
|
J:58851
|
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
|
increased susceptibility to induced arthritis
|
J:125570
|
Il1r1tm1Imx/Il1r1tm1Imx Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
interstitial pneumonia
|
J:126652
|
lung inflammation
|
J:126652
|
osteomyelitis
|
J:58851
|
Il1r1tm1Imx/Il1r1tm1Imx Vsig4tm1Gne/Vsig4tm1Gne
(B6.Cg-Il1r1tm1Imx Vsig4tm1Gne)
|
increased susceptibility to induced colitis
|
J:281762
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv)
|
decreased susceptibility to induced arthritis
|
J:120707
|
Il1r1tm1Roml/Il1r1tm1Roml Nlrp3tm1Hhf/Nlrp3+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
skin inflammation
|
J:150054
|
Il1r2tm1.2Mchc/Il1r2tm1.2Mchc
(involves: BALB/cJ * C57BL/6J * C57BL/6NTac)
|
increased inflammatory response
|
J:347877
|
Il1r2tm1Yiw/Il1r2tm1Yiw
(B6.129P2-Il1r2tm1Yiw)
|
increased susceptibility to induced arthritis
|
J:274653
|
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(C.129P2-Il1rl1tm1Anjm)
|
increased susceptibility to induced pancreatitis
|
J:184801
|
Il1rntm1.1Cga/Il1rntm1.1Cga Lyz2tm1(cre)Ifo/Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo)
|
increased susceptibility to induced arthritis
|
J:162760
|
Il1rntm1Dih/Il1rn+
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:36387
|
Il1rntm1Dih/Il1rntm1Dih
(involves: 129S/SvEv * C57BL/6J)
|
increased acute inflammation
|
J:61600,
J:88605
|
increased susceptibility to endotoxin shock
|
J:36387
|
Il1rntm1Nick/Il1rn+
(involves: 129P2/OlaHsd * MF1)
|
aortitis
|
J:59410
|
Il1rntm1Nick/Il1rntm1Nick
(involves: 129P2/OlaHsd * MF1)
|
aortitis
|
J:59410
|
Il1rntm1Nick/Il1rntm1Nick
(involves: 129P2/OlaHsd * MF1 * BALB/cAnNHsd)
|
aortitis
|
J:89034
|
skin inflammation
|
J:89034
|
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd)
|
aortitis
|
J:89034
|
rheumatoid arthritis
|
J:89034
|
skin inflammation
|
J:89034
|
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd * C57BL/6)
|
aortitis
|
J:89034
|
rheumatoid arthritis
|
J:89034
|
Il1rntm1Yiw/Il1rntm1Yiw
(C.129-Il1rntm1Yiw)
|
rheumatoid arthritis
|
J:143719
|
Il1rntm1Yiw/Il1rntm1Yiw Il17atm1Yiw/Il17a+
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)
|
decreased susceptibility to induced arthritis
|
J:83408
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
colitis
|
J:37220,
J:29999,
J:15223
|
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
heart inflammation
|
J:29799
|
increased inflammatory response
|
J:29799
|
liver inflammation
|
J:29799
|
lung inflammation
|
J:29799
|
pancreas inflammation
|
J:29799
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
|
lacrimal gland inflammation
|
J:125129
|
large intestinal inflammation
|
J:125129
|
salivary gland inflammation
|
J:125129
|
Il2tm1Hor/Il2tm1Hor Rag2tm1Fwa/Rag2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
colitis
|
J:29999
|
Il2ratm1Dw/Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6)
|
colitis
|
J:64279
|
Il2ratm1Dw/Il2ratm1Dw
(B6.129S4-Il2ratm1Dw/J)
|
lacrimal gland inflammation
|
J:125129
|
large intestinal inflammation
|
J:125129
|
lung inflammation
|
J:125129
|
salivary gland inflammation
|
J:125129
|
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
liver inflammation
|
J:113547
|
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
cecum inflammation
|
J:24117
|
Il2rgtm1Wjl/Il2rgtm1Wjl Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S4/SvJae)
|
lung inflammation
|
J:140483
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
ileum inflammation
|
J:60609
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
ileum inflammation
|
J:60609
|
Il4tm1Cgn/Il4tm1Cgn
(NOD.Cg-H2b Il4tm1Cgn)
|
lacrimal gland inflammation
|
J:105803
|
salivary gland inflammation
|
J:105803
|
Il4tm1Cgn/Il4tm1Cgn
(either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD))
|
insulitis
|
J:85924
|
Il4tm1Cgn/Il4tm1Cgn
(MRL.129P2-Il4tm1Cgn)
|
lacrimal gland inflammation
|
J:132514
|
Il4tm1Cgn/Il4tm1Cgn Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
esophageal inflammation
|
J:205692
|
increased inflammatory response
|
J:205692
|
lung inflammation
|
J:205692
|
Il4tm1Cgn/Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
insulitis
|
J:85924
|
Il4tm1Nnt/Il4tm1Nnt
(C57BL/6-Il4tm1Nnt/J)
|
CNS inflammation
|
J:125605
|
stomach inflammation
|
J:120556
|
Il4tm2Nnt/Il4tm2Nnt
(BALB/c-Il4tm2Nnt)
|
ileum inflammation
|
J:60609
|
Il4tm2Nnt/Il4tm2Nnt Tgfb1tm1Doe/Tgfb1tm1Doe
(C.Cg-Tgfb1tm1Doe Il4tm2Nnt)
|
liver inflammation
|
J:69346
|
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/cJ)
|
liver inflammation
|
J:114751
|
Il4ratm1Fbb/Il4ratm2Fbb Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/c)
|
liver inflammation
|
J:114751
|
Il4ratm1Tch/Il4ratm1Tch
(involves: 129X1/SvJ * BALB/c)
|
respiratory system inflammation
|
J:86215
|
Il4ratm2Tch/Il4ratm2Tch
(C.129X1-Il4ratm2Tch)
|
increased susceptibility to type I hypersensitivity reaction
|
J:152376
|
respiratory system inflammation
|
J:152376
|
Il4ratm2Tch/Il4ratm2Tch Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/?
(B6.Cg-Il4ratm2Tch Tg(Scgb1a1-rtTA,tetO-IL13)1Eli)
|
respiratory system inflammation
|
J:152376
|
Il4ratm3.1Tch/Il4ratm3.1Tch
(C.129X1-Il4ratm3.1Tch)
|
increased susceptibility to type I hypersensitivity reaction
|
J:160806
|
Il5ratm1Ktk/Il5ratm1Ktk Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:91089
|
Il6tm1Kopf/Il6+ Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw)
|
esophageal inflammation
|
J:180282
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to induced colitis
|
J:79073
|
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
decreased susceptibility to induced arthritis
|
J:208213
|
Il6tm1Kopf/Il6tm1Kopf Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6)
|
skin inflammation
|
J:155575
|
Il6tm1Kopf/Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw)
|
esophageal inflammation
|
J:180282
|
Il6tm1Mur/Il6tm1Mur
(involves: 129/Sv * C57BL/6)
|
brain inflammation
|
J:40579
|
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6)
|
liver inflammation
|
J:202764
|
Il6sttm1Ard/Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6)
|
cecum inflammation
|
J:79555
|
conjunctivitis
|
J:79555
|
increased inflammatory response
|
J:79555
|
increased susceptibility to induced colitis
|
J:79073
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:142883
|
stomach inflammation
|
J:87206
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv)
|
increased susceptibility to endotoxin shock
|
J:168781
|
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6)
|
rheumatoid arthritis
|
J:133059
|
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd * C57BL/6)
|
intestinal inflammation
|
J:94537
|
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd)
|
increased susceptibility to endotoxin shock
|
J:151551
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
cecum inflammation
|
J:35020
|
colitis
|
J:68476
|
increased susceptibility to type IV hypersensitivity reaction
|
J:51636
|
intestinal inflammation
|
J:35020,
J:107077,
J:15222
|
large intestinal inflammation
|
J:35020
|
small intestinal inflammation
|
J:35020
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd)
|
increased susceptibility to endotoxin shock
|
J:117122,
J:118833
|
intestinal inflammation
|
J:113376
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
cecum inflammation
|
J:157787
|
increased susceptibility to induced colitis
|
J:157787
|
large intestinal inflammation
|
J:149347
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/1)
|
colitis
|
J:84100
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * 129S/SvEv)
|
colitis
|
J:59872
|
Il10tm1Cgn/Il10tm1Cgn Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
colitis
|
J:136179
|
Il10tm1Cgn/Il10tm1Cgn Nfil3tm1Look/Nfil3tm1Look
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
colitis
|
J:209365
|
Il10tm1Cgn/Il10tm1Cgn Nfil3tm1Pbro/Nfil3tm1Pbro
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
colitis
|
J:209365
|
Il10tm1Cgn/Il10tm1Cgn Tg(MUC1)79.24Gend/0
(B6.Cg-Il10tm1Cgn Tg(MUC1)79.24Gend)
|
large intestinal inflammation
|
J:149347
|
Il10tm1Cgn/Il10tm1Cgn Tg(Vil1-cre)997Gum/? Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac * SJL)
|
colitis
|
J:229155
|
Il10tm1Cgn/Il10tm1Cgn Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac)
|
colitis
|
J:229155
|
Il10tm1Cgn/Il10tm1Cgn Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
colitis
|
J:107077
|
intestinal inflammation
|
J:107077
|
Il10tm1Mhry/Il10tm1Mhry
(involves: 129P2/OlaHsd * C57BL/6)
|
intestinal inflammation
|
J:117628
|
Il10tm1Roer/Il10tm1Roer Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
colitis
|
J:134513
|
lung inflammation
|
J:134513
|
Il10tm1Roer/Il10tm1Roer Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2)
|
intestinal inflammation
|
J:94537
|
liver inflammation
|
J:94537
|
peritoneal inflammation
|
J:94537
|
Il10tm2Roer/Il10tm2Roer Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:117122
|
Il10tm2Roer/Il10tm2Roer Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to endotoxin shock
|
J:117122
|
Il10ram1Jskg/Il10ram1Jskg
(B6.Cg-Il10ram1Jskg)
|
colitis
|
J:146644
|
Il10ratm1.2Jack/Il10ratm1.2Jack
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)
|
cecum inflammation
|
J:157787
|
increased susceptibility to induced colitis
|
J:157787
|
Il10rbtm1Agt/Il10rbtm1Agt
(involves: 129S2/SvPas * C57BL/6)
|
colitis
|
J:134156
|
large intestinal inflammation
|
J:45917
|
Il10rbtm1Agt/Il10rbtm1Agt Tg(Cd4-TGFBR2)16Flv/?
(involves: 129S2/SvPas * C3H * C57BL/6)
|
colitis
|
J:134156
|
liver inflammation
|
J:134156
|
lung inflammation
|
J:134156
|
proctitis
|
J:134156
|
Il11ra1tm1Wehi/Il11ra1tm1Wehi Il6tm1Kopf/Il6tm1Kopf
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to induced colitis
|
J:79073
|
Il12atm1Jm/Il12atm1Jm Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv * 129S6/SvEvTac)
|
lung inflammation
|
J:140483
|
Il12btm1Jm/Il12btm1Jm Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv)
|
lung inflammation
|
J:140483
|
Il12btm1Jm/Il12btm1Jm Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J)
|
glomerulonephritis
|
J:106805
|
liver inflammation
|
J:106805
|
parotid gland inflammation
|
J:106805
|
salivary gland inflammation
|
J:106805
|
submandibular gland inflammation
|
J:106805
|
Il13tm2Anjm/Il13tm2Anjm
(C.129P2(B6)-Il13tm2Anjm)
|
increased susceptibility to type I hypersensitivity reaction
|
J:123772
|
Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6)
|
increased susceptibility to induced colitis
|
J:136279
|
Il17atm1Yiw/Il17atm1Yiw Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)
|
decreased susceptibility to induced arthritis
|
J:83408
|
Il17atm1Yiw/Il17atm1Yiw Il17ftm1Yiw/Il17ftm1Yiw Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129 * BALB/c)
|
rheumatoid arthritis
|
J:143719
|
Il17atm1Yiw/Il17atm1Yiw Il17ftm2Yiw/Il17ftm2Yiw
(involves: 129P2/OlaHsd * BALB/c)
|
nasal inflammation
|
J:143719
|
Il17bem1Cya/Il17bem1Cya
(C57BL/6-Il17bem1Cya)
|
increased susceptibility to induced colitis
|
J:339366
|
Il17bGt(371C12)Cmhd/Il17bGt(371C12)Cmhd
(B6.129-Il17bGt(371C12)Cmhd)
|
increased susceptibility to induced colitis
|
J:229778
|
Il17ftm1Yiw/Il17ftm1Yiw Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129 * BALB/c)
|
rheumatoid arthritis
|
J:143719
|
Il17ratm1.2Kurs/Il17ratm1.2Kurs
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)
|
skin inflammation
|
J:196483
|
Il17retm1Lex/Il17retm1Lex
(B6.129S5-Il17retm1Lex)
|
increased susceptibility to induced colitis
|
J:178967
|
Il18tm1Aki/Il18tm1Aki
(C.129P2-Il18tm1Aki)
|
stomach inflammation
|
J:120594
|
Il18tm1Aki/Il18tm1Aki
(B6.129P2-Il18tm1Aki)
|
increased susceptibility to induced colitis
|
J:173245
|
Il18tm1Aki/Il18tm1Aki Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129P2/OlaHsd * C57BL/6)
|
myocarditis
|
J:191055
|
Il19tm2Vlcg/Il19tm2Vlcg
(B6.Cg-Il19tm2Vlcg)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:229575
|
increased susceptibility to induced colitis
|
J:229575
|
Il20rbtm1Uwe/Il20rbtm1Uwe
(C.129P2-Il20rbtm1Uwe)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:143497
|
Il22tm1.1Lex/Il22tm1.1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
ear inflammation
|
J:118261
|
Il22tm1.1Lex/Il22tm1.1Lex
(involves: 129S5/SvEvBrd)
|
colitis
|
J:161073
|
lung inflammation
|
J:179011
|
Il22tm1Flv/Il22+
(B6.Cg-Il22tm1Flv)
|
increased susceptibility to endotoxin shock
|
J:126103
|
Il22tm1Flv/Il22tm1Flv
(B6.Cg-Il22tm1Flv)
|
increased susceptibility to endotoxin shock
|
J:126103
|
liver inflammation
|
J:126103
|
Il22tm1Flv/Il22tm1Flv
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to induced colitis
|
J:189217
|
Il22ra2tm2Vlcg/Il22ra2tm2Vlcg
(B6.Cg-Il22ra2tm2Vlcg)
|
colitis
|
J:189217
|
Il23atm1Gdy/Il23a+
(B6.Cg-Il23atm1Gdy)
|
increased susceptibility to induced colitis
|
J:139557
|
Il23atm1Gdy/Il23atm1Gdy
(B6.Cg-Il23atm1Gdy)
|
increased susceptibility to induced colitis
|
J:139557
|
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac)
|
increased susceptibility to type I hypersensitivity reaction
|
J:158594
|
lung inflammation
|
J:158594
|
Il25tm1Dart/Il25tm1Dart
(C57BL/6-Il25tm1Dart)
|
intestinal inflammation
|
J:123808
|
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:147706
|
Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:151552
|
Il33tm1Snak/Il33tm1Snak
(involves: C57BL/6 * CBA)
|
increased susceptibility to induced colitis
|
J:165513
|
lung inflammation
|
J:165513
|
Il36rntm1Hblu/Il36rn+ Tg(KRT14-Il1f6)1Hblu/?
(involves: 129 * C57BL/6 * DBA/2)
|
skin inflammation
|
J:126327
|
Il36rntm1Hblu/Il36rntm1Hblu
(C.129(B6)-Il36rntm1Hblu)
|
increased susceptibility to chemically induced skin inflammation
|
J:260118
|
Il36rntm1Hblu/Il36rntm1Hblu Tg(KRT14-Il1f6)1Hblu/?
(involves: 129 * C57BL/6 * DBA/2)
|
skin inflammation
|
J:126327
|
Il36rntm1Kopf/Il36rntm1Kopf
(B6.129S5-Il36rntm1Kopf)
|
dermatitis
|
J:193548
|
Ilktm1Star/Ilktm1Star Tg(KRT14-cre)1Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
skin inflammation
|
J:172934
|
Ilktm1Star/Ilktm1Star Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
tubulointerstitial nephritis
|
J:129286,
J:129244
|
In(2a;Itch)18H/In(2a;Itch)18H
(involves: 101/H * C3H/HeH)
|
increased inflammatory response
|
J:45910
|
interstitial pneumonia
|
J:24934
|
lung inflammation
|
J:24934
|
Inavatm1.1Itl/Inavatm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased susceptibility to induced colitis
|
J:257317
|
Inhatm1Bay/Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
chronic liver inflammation
|
J:20450
|
Inhbbtm1Jae/Inhbbtm1Jae
(either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
increased incidence of corneal inflammation
|
J:16995
|
Inpp5dm1Anu/Inpp5dm1Anu
(C57BL/6JAnu-Inpp5dm1Anu)
|
lung inflammation
|
J:104190
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
ileum inflammation
|
J:173301
|
intestinal inflammation
|
J:173301
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)1Ell)
|
salivary gland inflammation
|
J:98583
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)3Ell)
|
salivary gland inflammation
|
J:98583
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Mnt/Ins2tm1Mnt Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
pancreas inflammation
|
J:152798
|
Ins2tm1Jja/Ins2tm1Jja
(NOD.129S2-Ins2tm1Jja)
|
insulitis
|
J:85309
|
Insrm1Btlr/Insrm1Btlr
(C57BL/6J-Insrm1Btlr)
|
increased susceptibility to induced colitis
|
J:267534
|
Insrtm1Khn/Insrtm1Khn Leprtm1.1Chua/Leprtm1.1Chua Tg(Pomc1-cre)16Lowl/0
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
liver inflammation
|
J:192274
|
ovary inflammation
|
J:192274
|
white adipose tissue inflammation
|
J:192274
|
Irak1tm1Jth/Y Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL)
|
myocarditis
|
J:84829
|
Irak1tm1Jth/Irak1tm1Jth Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL)
|
myocarditis
|
J:84829
|
Irak3tm1Flv/Irak3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:78189
|
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
|
insulitis
|
J:229884
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:43086
|
Irf2tm1Mak/Irf2tm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
dermatitis
|
J:66034
|
Irf3tm1Ttg/Irf3tm1Ttg Sting1em1Jmin/Sting1em1Jmin
(involves: 129S/SvEv * C57BL/6N)
|
lung inflammation
|
J:251372
|
Isg20em1Cya/Isg20em1Cya Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6N * ICR)
|
kidney inflammation
|
J:343183
|
Isl1Drsh/Isl1+
(C3HeB/FeJ-Isl1Drsh)
|
increased susceptibility to otitis media
|
J:202214
|
Itchtm1.1Alta/Itchtm1.1Alta Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dermatitis
|
J:204685
|
increased inflammatory response
|
J:204685
|
lung inflammation
|
J:204685
|
Itchtm1.1Alta/Itchtm1.1Alta Gt(ROSA)26Sortm1Hjf/Gt(ROSA)26Sor+ Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased inflammatory response
|
J:204685
|
Itga3tm1Son/Itga3tm1Son Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * FVB/N)
|
skin inflammation
|
J:145988
|
Itga3tm1Son/Itga3tm1Son Tg(KRT5-cre)5132Jlj/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
skin inflammation
|
J:145988
|
Itga5tm1Hyn/Itga5+ Nischedsn/Nisch+
(C3H.Cg-Nischedsn Itga5tm1Hyn)
|
increased susceptibility to otitis media
|
J:244907
|
Itga5tm1Hyn/Itga5+ Nischedsn/Nischedsn
(C3H.Cg-Nischedsn Itga5tm1Hyn)
|
increased susceptibility to otitis media
|
J:244907
|
Itgavtm2Hyn/Itgavtm2.1Hyn Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB)
|
colitis
|
J:125508
|
Itgavtm2Hyn/Itgavtm2.1Hyn Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL)
|
colitis
|
J:125508
|
increased inflammatory response
|
J:125508
|
large intestinal inflammation
|
J:125508
|
Itgb1tm1Ref/Itgb1tm1Ref Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)
|
skin inflammation
|
J:65038
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * PL/J)
|
dermatitis
|
J:109598,
J:32126
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J * PL/J)
|
dermatitis
|
J:84126
|
Itgb2tm1Bay/Itgb2tm1Bay Psrs1PL/J/Psrs1PL/J
(B6.Cg-(D10Mit126-D10Mit38) Itgb2tm1Bay)
|
rheumatoid arthritis
|
J:134251
|
Itgb2tm1Bay/Itgb2tm1Bay Psrs1PL/J/Psrs1PL/J
(B6.Cg-(D10Mit75-D10Mit271) Itgb2tm1Bay)
|
rheumatoid arthritis
|
J:134251
|
Itgb2tm1Bay/Itgb2tm2Bay
(PL.129S7-Itgb2tm1Bay Itgb2tm2Bay)
|
dermatitis
|
J:84126
|
Itgb2tm1Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J * PL/J)
|
dermatitis
|
J:84126
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
conjunctivitis
|
J:48542
|
dermatitis
|
J:48542
|
increased inflammatory response
|
J:48542
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
dermatitis
|
J:52262
|
myositis
|
J:119666
|
Itgb4tm2Son/Itgb4tm2Son Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
ear inflammation
|
J:96543
|
Itgb6tm1Des/Itgb6tm1Des
(involves: 129S4/SvJae * C57BL/6J)
|
respiratory system inflammation
|
J:33139
|
Itgb6tm1Des/Itgb6tm1Des
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
respiratory system inflammation
|
J:51592
|
Itgb6tm1Des/Itgb6tm1Des Mmp12tm1Sds/Mmp12tm1Sds
(involves: 129/Sv * 129T2/SvEms)
|
lung inflammation
|
J:89578
|
Itgb6tm1Des/Itgb6tm1Des Tg(SFTPC-ITGB6)1Des/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
respiratory system inflammation
|
J:51592
|
Itgb7tm1Cgn/Itgb7tm1Cgn
(C57BL/6-Itgb7tm1Cgn/J)
|
colitis
|
J:127413
|
Itgb7tm1Cgn/Itgb7tm1Cgn Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6)
|
autoimmune arthritis
|
J:136667
|
Itgb7tm1Mshi/Itgb7tm1Mshi
(involves: C57BL/6)
|
colitis
|
J:127413
|
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
|
ear inflammation
|
J:199153
|
skin inflammation
|
J:199153
|
Jak3wil/Jak3wil
(C57BL/6JSfdAnu-Jak3wil/Anu)
|
large intestinal inflammation
|
J:104190
|
Jam3tm1Rha/Jam3tm1Rha
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:121841
|
Juntm1Rsjo/Juntm1Rsjo Tg(KRT14-cre)8Brn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased incidence of corneal inflammation
|
J:84743
|
Juntm4Wag/Juntm4Wag Junbtm3Wag/Junbtm3Wag Tg(Krt1-5-cre/ERT)1Ipc/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
autoimmune arthritis
|
J:116380
|
increased inflammatory response
|
J:116380
|
skin inflammation
|
J:116380
|
Juntm4Wag/Juntm4Wag Tg(Sftpc-cre)1Blh/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
lung inflammation
|
J:179883
|
Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
|
dermatitis
|
J:155575
|
glomerulonephritis
|
J:155575
|
increased inflammatory response
|
J:155575
|
tubulointerstitial nephritis
|
J:155575
|
Jundtm1Mya/Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
increased susceptibility to endotoxin shock
|
J:65879
|
liver inflammation
|
J:65879
|
Juptm1.1Glr/Juptm1.1Glr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
heart inflammation
|
J:170618
|
Kcna1mceph/Kcna1mceph
(BALB/cByJ-Kcna1mceph/J)
|
ear inflammation
|
J:119491
|
eye inflammation
|
J:119491
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * BALB/cByJ * C3HeB/FeJ)
|
ear inflammation
|
J:119491
|
eye inflammation
|
J:119491
|
Kcne2tm1a(EUCOMM)Wtsi/Kcne2tm1a(EUCOMM)Wtsi
(C57BL/6N-Kcne2tm1a(EUCOMM)Wtsi)
|
stomach inflammation
|
J:230226
|
Kcne3tm1Gwab/Kcne3tm1Gwab
(involves: C57BL/6)
|
increased inflammatory response
|
J:210381
|
Kcnj8mydy/Kcnj8mydy
(involves: C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:126658
|
Kcnj8sos/Kcnj8sos
(C57BL/6J-Kcnj8sos)
|
increased susceptibility to endotoxin shock
|
J:149353
|
Kif1cOrch3-BALB/cByJ/Kif1cOrch3-BALB/cByJ
(involves: BALB/cByJ * DBA/2)
|
testis inflammation
|
J:35331
|
Kif27Gt(OST441915)Lex/Kif27Gt(OST441915)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased susceptibility to otitis media
|
J:185566
|
maxillary sinus inflammation
|
J:185566
|
KitW-sh/KitW-sh Lyntm1Ard/Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH)
|
glomerulonephritis
|
J:161523
|
KitW/KitW-v
((WB/ReJ x C57BL/6J-KitW-v/J)F1-KitW/KitW-v/J)
|
kidney inflammation
|
J:113500
|
KitW/KitW-v
((WB KitW x B6.Cg-KitW-v)F1)
|
decreased susceptibility to induced arthritis
|
J:178942
|
KitlSl/KitlSl-d
(involves: C57BL/6 * WC)
|
dermatitis
|
J:5758
|
stomach inflammation
|
J:2777
|
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J)
|
lung inflammation
|
J:229255
|
Klf4tm1Khk/Klf4tm1Khk Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S6/SvEvTac * FVB/N)
|
blepharitis
|
J:117671
|
Klf5M1Btlr/Klf5M1Btlr
(C57BL/6J-Klf5M1Btlr)
|
increased susceptibility to induced colitis
|
J:265229
|
Klf5tm1Jaw/Klf5tm1Jaw Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB)
|
lacrimal gland inflammation
|
J:175263
|
Klf15tm1Jain/Klf15tm1Jain
(involves: 129X1/SvJ)
|
blood vessel inflammation
|
J:203920
|
Klk6tm1Gsot/Klk6+
(involves: C57BL/6)
|
decreased susceptibility to chemically induced skin inflammation
|
J:270051
|
Klk6tm1Gsot/Klk6tm1Gsot
(involves: C57BL/6)
|
decreased susceptibility to chemically induced skin inflammation
|
J:270051
|
Klrc1tm1Mmka/Klrc1tm1Mmka
(B6.129-Klrc1tm1Mmka)
|
liver inflammation
|
J:222503
|
lung inflammation
|
J:222503
|
Kmt2etm1Apa/Kmt2etm1Apa
(129S6/SvEvTac-Kmt2etm1Apa)
|
blepharitis
|
J:145445
|
Kprptm1Msug/Kprp+
(involves: C57BL/6)
|
increased susceptibility to chemically induced skin inflammation
|
J:286659
|
Krastm4Tyj/Kras+ Krt19tm1(cre/ERT)Ggu/Krt19+ Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac)
|
lung inflammation
|
J:254370
|
Krastm4Tyj/Kras+ Ptentm1Hwu/Ptentm1Hwu Scgb1a1tm1.1(cre)Fjd/Scgb1a1+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
lung inflammation
|
J:131721
|
Krastm4Tyj/Kras+ Tg(Scgb1a1-cre)1Kkw/?
(involves: 129 * C57BL/6 * FVB/N)
|
increased inflammatory response
|
J:107260
|
Krastm4Tyj/Kras+ Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae)
|
lung inflammation
|
J:191425
|
Krastm4Tyj/Krastm4Tyj Trim33tm1Los/Trim33tm1Los Tg(Pdx1-cre)89.1Dam/0
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * DBA/2)
|
pancreas inflammation
|
J:151781
|
Krt2tm1a(KOMP)Wtsi/Krt2tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
skin inflammation
|
J:214772
|
Krt18tm1Tmm/Krt18+
(involves: 129P2/OlaHsd)
|
liver inflammation
|
J:309021
|
Krt18tm1Tmm/Krt18tm1Tmm
(involves: 129P2/OlaHsd)
|
liver inflammation
|
J:309021
|
Krt76tm1a(KOMP)Wtsi/Krt76tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
skin inflammation
|
J:232539
|
Ksr1tm1Shaw/Ksr1tm1Shaw
(Not Specified)
|
decreased susceptibility to induced arthritis
|
J:140520
|
Lacc1em3Arkr/Lacc1em3Arkr
(C57BL/6NTac-Lacc1em3Arkr)
|
increased susceptibility to endotoxin shock
|
J:244365
|
Lacc1em4Arkr/Lacc1em4Arkr
(C57BL/6NTac-Lacc1em4Arkr)
|
increased susceptibility to endotoxin shock
|
J:244365
|
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
increased susceptibility to endotoxin shock
|
J:244365
|
Lama2tm1Eeng/Lama2tm1Eeng
(involves: 129S1/Sv)
|
myositis
|
J:170192
|
Lama3tm1.1Grsb/Lama3tm1.1Grsb
(involves: C57BL/6)
|
lung inflammation
|
J:235712
|
Lama3tm1Arte/Lama3tm1Arte Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6 * CD-1)
|
skin inflammation
|
J:240054
|
Lama5tm2Jhm/Lama5tm1Jhm Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
tubulointerstitial nephritis
|
J:185850
|
Lamb2tm1Jrs/Lamb2tm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
glomerulonephritis
|
J:23783
|
Lamc2jeb/Lamc2jeb
(129X1/SvJ-Lamc2jeb)
|
ear inflammation
|
J:158873
|
Lancl1tm1.1Pfw/Lancl1tm1.1Pfw
(involves: 129 * C57BL/6)
|
brain inflammation
|
J:214805
|
Lao1tm1Oka/Lao1tm1Oka
(involves: 129S2/SvPas * C57BL/6J)
|
mastitis
|
J:260668
|
Large1myd/Large1myd
(MYD/Le-Os +/+ Largemyd/J)
|
myositis
|
J:5670
|
Large1myd/Large1myd
(B6C3Fe a/a-Large1myd/J)
|
myositis
|
J:27793
|
Lat2tm1Wz/Lat2tm1Wz
(Not Specified)
|
increased susceptibility to endotoxin shock
|
J:181866
|
Lat2tm3.1Wz/Lat2tm3.1Wz
(B6.Cg-Lat2tm3.1Wz)
|
increased susceptibility to endotoxin shock
|
J:181866
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
glomerulonephritis
|
J:125722
|
increased inflammatory response
|
J:262891
|
kidney inflammation
|
J:262891
|
liver inflammation
|
J:125722
|
lung inflammation
|
J:125722
|
pancreas inflammation
|
J:262891
|
phlebitis
|
J:262891
|
salivary gland inflammation
|
J:262891
|
Lbw2NZB/BlScr/Lbw2NZB/BlScr
(involves: NZB * NZW)
|
glomerulonephritis
|
J:45708
|
Lbw2NZB/BlScr/Lbw2NZW/LacScr
(involves: NZB * NZW)
|
glomerulonephritis
|
J:20991
|
Lctlp1FVB/NJ/Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:122919
|
Lctlp2FVB/NJ/Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:122919
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
liver inflammation
|
J:175559
|
Ldlrtm1Her/Ldlrtm1Her Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
skin inflammation
|
J:61147
|
Lect2tm1Ymg/Lect2tm1Ymg
(involves: 129P2/OlaHsd * C57BL/6J)
|
liver inflammation
|
J:90961
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
lung inflammation
|
J:115772
|
Lepob/Lepob
(B6.Cg-Lepob/OlaHsd)
|
increased susceptibility to endotoxin shock
|
J:124815
|
liver inflammation
|
J:124815
|
Lepob/Lepob
(B6.Cg-Lepob/JRj)
|
liver inflammation
|
J:277927
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J)
|
pancreas inflammation
|
J:118305
|
periinsulitis
|
J:118305
|
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl)
|
white adipose tissue inflammation
|
J:171755
|
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
lung inflammation
|
J:115772
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/OlaHsd)
|
increased susceptibility to endotoxin shock
|
J:124815
|
liver inflammation
|
J:124815
|
Leprdb/Leprdb
(B6.BKS(D)-Leprdb/JOrlRj)
|
liver inflammation
|
J:277927
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb)
|
kidney inflammation
|
J:346348
|
Lgals2tm1.1Cfg/Lgals2tm1.1Cfg
(involves: C57BL/6)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:217719
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(B6.129S2-Lgals3tm1Ftl)
|
brain inflammation
|
J:109126
|
lung inflammation
|
J:109126
|
small intestinal inflammation
|
J:109126
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * C57BL/6)
|
peritoneal inflammation
|
J:60741
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1)
|
liver inflammation
|
J:221030
|
Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * SJL)
|
lung inflammation
|
J:131407
|
Lgals3bptm1Megt/Lgals3bptm1Megt
(involves: 129P2/OlaHsd * C57BL/Ka)
|
increased susceptibility to endotoxin shock
|
J:94936
|
Lgals9tm1Glp/Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp)
|
increased susceptibility to induced arthritis
|
J:132889
|
lgr/lgr
(Not Specified)
|
eye inflammation
|
J:13879
|
Lgr4Gt(LST020)Byg/Lgr4Gt(LST020)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of corneal inflammation
|
J:134299
|
Lhcgrtm1Hht/Lhcgrtm1Hht
(involves: 129S7/SvEvBrd * C57BL/6J)
|
epididymis inflammation
|
J:105533
|
prostate gland inflammation
|
J:105533
|
reproductive system inflammation
|
J:105533
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6)
|
increased acute inflammation
|
J:119777
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * BALB/c)
|
increased susceptibility to endotoxin shock
|
J:136940
|
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
intestinal inflammation
|
J:157574
|
liver inflammation
|
J:157574
|
Lilrb4atm1Eol/Lilrb4atm1Eol
(B6.129P2-Lilrb4atm1Eol)
|
increased inflammatory response
|
J:129969
|
Lilrb4atm1Hrk/Lilrb4atm1Hrk
(involves: 129/Sv * BALB/c)
|
increased susceptibility to type I hypersensitivity reaction
|
J:70491
|
Limk2Gt(OST80053)Lex/Limk2Gt(OST80053)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased incidence of corneal inflammation
|
J:192231
|
Limk2whe/Limk2whe
(B6.Cg-Lepob Limk2whe/GrsrJ)
|
increased incidence of corneal inflammation
|
J:127016
|
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
liver inflammation
|
J:270182
|
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1)
|
lung inflammation
|
J:101217
|
LmnaDhe/Lmna+
(B6(D2)-LmnaDhe/TyGrsrJ)
|
increased susceptibility to otitis media
|
J:188496
|
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
keratoconjunctivitis sicca
|
J:261974
|
Lncucc1em1Bwu/Lncucc1em1Bwu
(C57BL/6-Lncucc1em1Bwu)
|
increased susceptibility to induced colitis
|
J:340220
|
Loricrintm1Der/Loricrintm1Der
(FVB.129S7-Loricrintm1Der)
|
erythroderma
|
J:65187
|
Lpar2tm1Dgen/Lpar2tm1Dgen
(B6.Cg-Lpar2tm1Dgen)
|
increased susceptibility to type I hypersensitivity reaction
|
J:184061
|
lung inflammation
|
J:184061
|
Lpn1NZB/Lpn1NZB
(involves: NZB * NZW)
|
kidney inflammation
|
J:6026
|
Lpn1NZB/Lpn1NZW
(involves: NZB * NZW)
|
kidney inflammation
|
J:6026
|
Lpn2NZB/Lpn2NZW
(involves: NZB * NZW)
|
kidney inflammation
|
J:6026
|
Lpn2NZW/Lpn2NZW
(involves: NZB * NZW)
|
kidney inflammation
|
J:6026
|
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL)
|
aortitis
|
J:307289
|
arteritis
|
J:307289
|
blood vessel inflammation
|
J:307289
|
cardiovalvulitis
|
J:307289
|
gallbladder inflammation
|
J:307289
|
glomerulonephritis
|
J:307289
|
increased inflammatory response
|
J:307289
|
intestinal inflammation
|
J:307289
|
liver inflammation
|
J:307289
|
lung inflammation
|
J:307289
|
mastitis
|
J:307289
|
myocarditis
|
J:307289
|
myositis
|
J:307289
|
pancreas inflammation
|
J:307289
|
stomach inflammation
|
J:307289
|
Lprm3MRL/MpJ/Lprm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
glomerulonephritis
|
J:44625
|
Lrbaem1Btlr/Lrbaem1Btlr
(C57BL/6J-Lrbaem1Btlr)
|
increased susceptibility to induced colitis
|
J:274652
|
Lrbaem2Btlr/Lrbaem2Btlr
(C57BL/6J-Lrbaem2Btlr)
|
increased susceptibility to induced colitis
|
J:274652
|
Lrbaem3Btlr/Lrbaem3Btlr
(C57BL/6J-Lrbaem3Btlr)
|
increased susceptibility to induced colitis
|
J:274652
|
Lrbam1Btlr/Lrbam1Btlr
(C57BL/6J-Lrbam1Btlr)
|
increased susceptibility to induced colitis
|
J:274652
|
Lrbam2Btlr/Lrbam2Btlr
(C57BL/6J-Lrbam2Btlr)
|
increased susceptibility to induced colitis
|
J:274652
|
Lrdm1MRL/MpJ/?
(involves: CAST/Ei * MRL/MpJ-Faslpr/J)
|
kidney inflammation
|
J:3304
|
Lrdm2MRL/MpJ/?
(involves: CAST/Ei * MRL/MpJ-Faslpr/J)
|
kidney inflammation
|
J:3304
|
Lrig2tm1.1Hhed/Lrig2tm1.1Hhed
(involves: 129 * C57BL/6 * FVB/N)
|
increased inflammatory response
|
J:205929
|
Lrp1tm2Her/Lrp1tm2Her Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL)
|
brain inflammation
|
J:167724
|
Lrp6tm1Arma/Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma)
|
liver inflammation
|
J:225450
|
Lrp12em1Gpt/Lrp12em1Gpt Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JGpt * DBA/2)
|
increased susceptibility to induced colitis
|
J:338432
|
Lrrc25em1Cya/Lrrc25em1Cya
(C57BL/6J-Lrrc25em1Cya/Cya)
|
heart inflammation
|
J:270157
|
Lrrk2tm2.1Shn/Lrrk2tm2.1Shn
(involves: 129 * C57BL/6)
|
kidney inflammation
|
J:160542
|
Lse/Lse+
(B6C3Fe a/a-Lse/J)
|
keratoconjunctivitis sicca
|
J:338204
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
decreased susceptibility to induced arthritis
|
J:115034
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
decreased susceptibility to induced arthritis
|
J:115034
|
Ltahlb382/Ltahlb382
(C57BL/6J-Ltahlb382/J)
|
liver inflammation
|
J:134498
|
lung inflammation
|
J:134498
|
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor)
|
decreased susceptibility to induced arthritis
|
J:131779
|
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased susceptibility to induced arthritis
|
J:163271
|
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(B6.Cg-Ltb4r1tm1Tksh)
|
lung inflammation
|
J:118995
|
Ltb4r2tm1Bodd/Ltb4r2tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:163271
|
Ltbtm1Kpf/Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf)
|
colitis
|
J:158663
|
Ltbp3tm1Bdvc/Ltbp3tm1Bdvc
(involves: 129S6/SvEvTac)
|
osteoarthritis
|
J:76213,
J:79920
|
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(B6.129S2-Ltbp4Gt(U3Cre)1Vmel)
|
colitis
|
J:78819
|
proctitis
|
J:78819
|
Ltc4stm1Blam/Ltc4stm1Blam
(involves: 129S7/SvEvBrd * C57BL/6)
|
respiratory system inflammation
|
J:88647
|
Lxw2NZW/LacScr/Lxw2NZW/LacScr
(involves: BXSB/Scr * NZW/LacScr)
|
glomerulonephritis
|
J:86924
|
Lynmld4/Lynmld4
(involves: C57BL/6)
|
glomerulonephritis
|
J:144799
|
peritoneal inflammation
|
J:144799
|
Lyntm1.1Calo/Lyntm1.1Calo Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
glomerulonephritis
|
J:200745
|
increased inflammatory response
|
J:200745
|
liver inflammation
|
J:200745
|
lung inflammation
|
J:200745
|
skin inflammation
|
J:200745
|
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd)
|
glomerulonephritis
|
J:161523
|
Lyntm1Ard/Lyntm1Ard
(B6.129P2-Lyntm1Ard)
|
glomerulonephritis
|
J:144799
|
peritoneal inflammation
|
J:144799
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
glomerulonephritis
|
J:146161,
J:200745
|
liver inflammation
|
J:146161
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
glomerulonephritis
|
J:71174
|
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:29751
|
Lynweeb/Lynweeb
(C57BL/6-Lynweeb)
|
glomerulonephritis
|
J:146161
|
liver inflammation
|
J:146161
|
Lypd8tm2Ktak/Lypd8tm2Ktak
(B6.Cg-Lypd8tm2Ktak)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:232706
|
increased susceptibility to induced colitis
|
J:232706
|
Lystbg/Lystbg
(B6.C3Rl-Lystbg)
|
alveolitis
|
J:110157
|
Lyz2tm1(cre)Ifo/Lyz2+ Pikfyvetm1b(EUCOMM)Hmgu/Pikfyvetm1b(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:244776
|
Lyz2tm1(cre)Ifo/Lyz2+ St18tm1c(KOMP)Wtsi/St18tm1c(KOMP)Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased inflammatory response
|
J:298828
|
Lyz2tm1.1Graf/Lyz2tm1.1Graf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased inflammatory response
|
J:82642
|
Macroh2a1tm1Peh/Macroh2a1tm1Peh Macroh2a2tm1.1Peh/Macroh2a2tm1.1Peh
(129S6.Cg-Macroh2a2tm1.1Peh Macroh2a1tm1Peh)
|
blepharitis
|
J:220524
|
MafOfl/MafOfl
(either: 102/ElH or C3H/HeH)
|
tubular nephritis
|
J:82475
|
Magi2tm1Key/Magi2tm1Key
(involves: 129S4/SvJae)
|
tubulointerstitial nephritis
|
J:213553
|
Malat1tm1.2Dlsp/Malat1tm1.2Dlsp
(B6J.Cg-Malat1tm1.2Dlsp)
|
brain inflammation
|
J:239375
|
Man2a1tm1Jxm/Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
glomerulonephritis
|
J:74579
|
liver inflammation
|
J:74579
|
lung inflammation
|
J:74579
|
Man2a1tm1Jxm/Man2a1tm1Jxm Rag1tm1Mom/Rag1tm1Mom
(B6.129-Rag1tm1Mom Man2a1tm1Jxm)
|
kidney inflammation
|
J:124348
|
Map3k1tm1Glj/Map3k1tm1Glj
(involves: 129S/SvEv)
|
heart inflammation
|
J:78068
|
Map3k7tm1.1Gkl/Map3k7tm1.1Gkl Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:211916
|
increased susceptibility to endotoxin shock
|
J:211916
|
Map3k7tm1Aki/Map3k7tm1Aki Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
liver inflammation
|
J:160521
|
Map3k7tm1Aki/Map3k7tm1Aki Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
colitis
|
J:112837
|
Map3k7tm1Aki/Map3k7tm1Aki Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd * C57BL/6)
|
colitis
|
J:238318
|
Map3k8tm1Pnt/Map3k8tm1Pnt Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Map3k14aly/Map3k14aly
(involves: C57BL/6J)
|
bile duct inflammation
|
J:48224
|
increased inflammatory response
|
J:38580,
J:48224
|
kidney inflammation
|
J:38580
|
lacrimal gland inflammation
|
J:38580
|
liver inflammation
|
J:48224
|
lung inflammation
|
J:48224
|
pancreas inflammation
|
J:48224
|
Mapk9tm1Flv/Mapk9tm1Flv Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Mapk11tm1Jda/Mapk11tm1Jda Mapk14tm1Jda/Mapk14tm1Jda
(involves: 129 * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:165966
|
Mapk11tm1Jsca/Mapk11tm1Jsca Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
autoimmune arthritis
|
J:107771
|
ileum inflammation
|
J:107771
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Marchf2em1Cnu/Marchf2em1Cnu
(C57BL/6-Marchf2em1Cnu)
|
increased susceptibility to endotoxin shock
|
J:297482
|
Marcotm1Ktry/Marcotm1Ktry
(B6.129S6-Marcotm1Ktry)
|
increased inflammatory response
|
J:115081
|
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
glomerulonephritis
|
J:68830
|
kidney inflammation
|
J:68830
|
lung inflammation
|
J:68830
|
salivary gland inflammation
|
J:68830
|
Mat1atm1Jmm/Mat1atm1Jmm
(involves: 129/Sv * C57BL/6)
|
liver inflammation
|
J:69408
|
Matn3tm1Brd/Matn3tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
osteoarthritis
|
J:112002
|
Mavstm1Aki/Mavstm1Aki
(involves: 129S/SvEv * C57BL/6)
|
brain inflammation
|
J:162888
|
CNS inflammation
|
J:162888
|
Mavstm1Itl/Mavstm1Itl Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:181257
|
myocarditis
|
J:181257
|
myositis
|
J:181257
|
skin inflammation
|
J:181257
|
stomach inflammation
|
J:181257
|
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
insulitis
|
J:323838
|
salivary gland inflammation
|
J:323838
|
Mbd3tm2Bh/Mbd3tm2Bh Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased susceptibility to induced colitis
|
J:167984
|
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt)
|
increased susceptibility to induced colitis
|
J:146454
|
Mc3rtm1Butl/Mc3rtm1Butl
(B6.Cg-Mc3rtm1Butl)
|
increased inflammatory response
|
J:178147
|
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J)
|
liver inflammation
|
J:177386
|
white adipose tissue inflammation
|
J:177386
|
Mc4rtm1Matsu/Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu)
|
liver inflammation
|
J:285412
|
Mdktm1Tmu/Mdktm1Tmu
(129S2-Mdktm1Tmu)
|
tubular nephritis
|
J:93637
|
MecomJbo/Mecom+
(C3N.C-MecomJbo)
|
increased susceptibility to otitis media
|
J:113445
|
respiratory system inflammation
|
J:113445
|
MecomJbo/Mecom+
(involves: BALB/c)
|
increased susceptibility to otitis media
|
J:250208
|
Mecp2tm1.1Bird/Y SqleSum3-Jus/Sqle+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
dermatitis
|
J:198551
|
Mecp2tm1.1Bird/Y Sum2M1Jus/Sum2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
dermatitis
|
J:198551
|
eye inflammation
|
J:198551
|
Mecp2tm1.1Bird/Y Sum4M1Jus/Sum4+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
dermatitis
|
J:198551
|
eye inflammation
|
J:198551
|
Mecp2tm1.1Bird/Y Sum5M1Jus/Sum5+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
eye inflammation
|
J:198551
|
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi Tg(Adipoq-icre/ERT2)1Soff/0
(involves: C57BL/6J * C57BL/6N)
|
white adipose tissue inflammation
|
J:298822
|
Mefvtm1Chae/Mefvtm1Chae
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
increased inflammatory response
|
J:82763
|
increased susceptibility to endotoxin shock
|
J:82763
|
Mefvtm3.1(MEFV)Chae/Mefvtm3.1(MEFV)Chae
(B6.129S6-Mefvtm3.1(MEFV)Chae)
|
autoimmune arthritis
|
J:172117
|
dermatitis
|
J:172117
|
increased inflammatory response
|
J:172117
|
Mefvtm4.1(MEFV)Chae/Mefvtm4.1(MEFV)Chae
(B6.129S6-Mefvtm4.1(MEFV)Chae)
|
autoimmune arthritis
|
J:172117
|
dermatitis
|
J:172117
|
increased inflammatory response
|
J:172117
|
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
(B6.129S6-Mefvtm5.1(MEFV)Chae)
|
autoimmune arthritis
|
J:172117
|
dermatitis
|
J:172117
|
increased inflammatory response
|
J:172117
|
joint inflammation
|
J:172117
|
liver inflammation
|
J:172117
|
skin inflammation
|
J:172117
|
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae Nlrp3tm1Tsc/Nlrp3tm1Tsc
(involves: 129S6/SvEvTac * C57BL/6)
|
increased inflammatory response
|
J:172117
|
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae Rag1tm1Mom/Rag1tm1Mom
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased inflammatory response
|
J:172117
|
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))
|
pancreas inflammation
|
J:67128
|
Mep1atm1Bond/Mep1atm1Bond
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to induced colitis
|
J:145685
|
urinary bladder inflammation
|
J:145037
|
Mertktm1Gkm/Mertktm1Gkm
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased susceptibility to endotoxin shock
|
J:53423
|
Mertktm1Gkm/Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm)
|
insulitis
|
J:147153
|
Mettm1Gvw/Met+
(involves: 129 * C57BL/6J)
|
glomerulonephritis
|
J:94722
|
Mettm2Gvw/Met+
(involves: 129 * C57BL/6J)
|
glomerulonephritis
|
J:94722
|
Mettm4Gvw/Met+
(involves: 129 * C57BL/6J)
|
glomerulonephritis
|
J:94722
|
Metrnltm1d(KOMP)Wtsi/Metrnltm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
increased susceptibility to endotoxin shock
|
J:268270
|
kidney inflammation
|
J:268270
|
liver inflammation
|
J:268270
|
uterus inflammation
|
J:268270
|
Mfge8Gt(KST227)Byg/Mfge8Gt(KST227)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
mastitis
|
J:107106
|
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi)
|
increased susceptibility to type I hypersensitivity reaction
|
J:250123
|
Mfsd8tm1a(EUCOMM)Hmgu/Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
CNS inflammation
|
J:211608
|
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
glomerulonephritis
|
J:80661
|
Mgat5btm1Nta/Mgat5btm1Nta
(Not Specified)
|
brain inflammation
|
J:199165
|
Milr1tm1Shib/Milr1tm1Shib
(involves: C57BL/6N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:161854
|
Mir10bem1Rosay/Mir10bem1Rosay
(C57BL/6J-Mir10bem1Rosay)
|
large intestinal inflammation
|
J:342486
|
Mir21atm1.1Mer/Mir21atm1.1Mer
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:179235
|
Mir21atm1.1Mer/Mir21atm1.1Mer
(B6.129S1-Mir21atm1.1Mer)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:179235
|
Mir34atm1.1Pisc/Mir34atm1.1Pisc Mirc21tm1.1Pisc/Mirc21tm1.1Pisc Mirc34tm1.1Pisc/Mirc34tm1.1Pisc
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
nasal inflammation
|
J:256929
|
Mir100em1Nju/Mir100em1Nju Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
liver inflammation
|
J:281439
|
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6)
|
liver inflammation
|
J:190066
|
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ)
|
liver inflammation
|
J:190067
|
Mir122tm1.2Kgh/Mir122tm1.2Kgh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
liver inflammation
|
J:190067
|
Mir139em1Jwli/Mir139em1Jwli
(C57BL/6J-Mir139em1Jwli)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:280467,
J:248779
|
increased susceptibility to induced colitis
|
J:248779
|
Mir140tm1.1Asah/Mir140tm1.1Asah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased susceptibility to induced arthritis
|
J:160358
|
osteoarthritis
|
J:160358
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to endotoxin shock
|
J:173671
|
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
increased acute inflammation
|
J:173671
|
increased susceptibility to endotoxin shock
|
J:173671
|
Mir149em1Ydw/Mir149em1Ydw
(C57BL/6J-Mir149em1Ydw)
|
increased susceptibility to endotoxin shock
|
J:294318
|
Mir155tm1Brd/Mir155tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
intestinal inflammation
|
J:121095
|
lung inflammation
|
J:121095
|
Mir216aem1Uf/Mir216aem1Uf
(C57BL/6-Mir216aem1Uf)
|
increased susceptibility to induced pancreatitis
|
J:278847
|
Mir216aem2Uf/Mir216aem2Uf
(C57BL/6-Mir216aem2Uf)
|
increased susceptibility to induced pancreatitis
|
J:278847
|
Mir216bem1Uf/Mir216bem1Uf
(C57BL/6-Mir216bem1Uf)
|
increased susceptibility to induced pancreatitis
|
J:278847
|
Mir217em1Uf/Mir217em1Uf
(C57BL/6-Mir217em1Uf)
|
increased susceptibility to induced pancreatitis
|
J:278847
|
Mir217em2Uf/Mir217em2Uf
(C57BL/6-Mir217em2Uf)
|
increased susceptibility to induced pancreatitis
|
J:278847
|
Mir223tm1Fcam/Mir223tm1Fcam
(involves: 129S4/SvJae * C57BL/6)
|
increased acute inflammation
|
J:140009
|
lung inflammation
|
J:140009
|
Mirc32tm1.1Jtm/Mirc32tm1.1Jtm Tg(Myh11-cre,-EGFP)2Mik/?
(B6.Cg-Mirc32tm1.1Jtm Tg(Myh11-cre,-EGFP)2Mik)
|
increased susceptibility to induced colitis
|
J:214382
|
Mirc32tm1.1Jtm/Mirc32tm1.1Jtm Twist2tm1(cre)Dor/Twist2+
(B6.129(Cg)-Twist2tm1.1(cre)Dor Mirc32tm1.1Jtm)
|
increased susceptibility to induced colitis
|
J:214382
|
Mirc32tm1.2Jtm/Mirc32tm1.2Jtm
(B6.129(Cg)-Mirc32tm1.2Jtm)
|
increased susceptibility to induced colitis
|
J:214382
|
Mispem1Nsas/Mispem1Nsas
(FVB/NJcl-Mispem1Nsas)
|
increased susceptibility to induced colitis
|
J:333842
|
MitfTg(Tff3-Tmem207)2Tamo/Mitf+
(involves: C57BL/6)
|
kidney inflammation
|
J:244533
|
Mlkltm1.1Wsa/Mlkltm1.1Wsa Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
dermatitis
|
J:312394
|
Mmdtm1Beij/Mmdtm1Beij
(Not Specified)
|
decreased susceptibility to induced arthritis
|
J:304637
|
Mmetm1Cge/Mmetm1Cge
(B6.129S4-Mmetm1Cge)
|
dermatitis
|
J:66854
|
increased susceptibility to type I hypersensitivity reaction
|
J:66854
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
brain inflammation
|
J:94099
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd)
|
autoimmune arthritis
|
J:121780
|
Mmp2tm1Ito/Mmp2tm1Ito Timp3tm1Osya/Timp3tm1Osya
(involves: 129P2/OlaHsd * C57BL/6)
|
aortitis
|
J:193744
|
Mmp3tm1Mrl/Mmp3tm1Mrl
(either: (129S7/SvEvBrd X B10.RIII)N2 or ((involves: 129S7/SvEvBrd * C57BL/6) X B10.RIII)N2)
|
autoimmune arthritis
|
J:46038
|
joint inflammation
|
J:46038
|
osteoarthritis
|
J:46038
|
Mmp7tm1Lmm/Mmp7tm1Lmm
(B6.129-Mmp7tm1Lmm)
|
increased susceptibility to induced colitis
|
J:149388
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
myocarditis
|
J:148442
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129/Sv * 129S6/SvEvTac)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:55723
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6)
|
lung inflammation
|
J:88065
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(C3N.129S6-Mmp9tm1Tvu)
|
decreased susceptibility to induced arthritis
|
J:150311
|
joint inflammation
|
J:150311
|
Mmp10tm1Jkmg/Mmp10tm1Jkmg
(B6.129X1-Mmp10tm1Jkmg)
|
lung inflammation
|
J:153651
|
Mmp14tm1Hbh/Mmp14tm1Hbh
(involves: 129P2/OlaHsd * Black Swiss)
|
autoimmune arthritis
|
J:57969
|
Mmuttm1Cpv/Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
tubulointerstitial nephritis
|
J:147313
|
Mmuttm1Cpv/Mmuttm1Cpv Tg(Alb-Mut)#Cpv/0
(involves: C57BL/6)
|
tubulointerstitial nephritis
|
J:200689
|
Mocosem2(IMPC)Ics/Mocosem2(IMPC)Ics
(involves: C57BL/6N)
|
kidney inflammation
|
J:336718
|
tubulointerstitial nephritis
|
J:336718
|
Mogtm1Dpd/Mogtm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6)
|
CNS inflammation
|
J:151335
|
Mol2DBA/2N/Mol2DBA/2N
(involves: BALB/cAnFcr * DBA/2N)
|
increased inflammatory response
|
J:58921
|
mpc253H/mpc253H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
colitis
|
J:234901
|
Mpdk2C57BL/6J/Mpdk2CAST/Ei
(involves: C57BL/6J * CAST/Ei)
|
bile duct inflammation
|
J:99468
|
Mpdk2CAST/Ei/Mpdk2CAST/Ei
(involves: C57BL/6J * CAST/Ei)
|
bile duct inflammation
|
J:99468
|
Mpdk7C57BL/6J/Mpdk7CAST/Ei
(involves: C57BL/6J * CAST/Ei)
|
bile duct inflammation
|
J:99468
|
Mpdk7CAST/Ei/Mpdk7CAST/Ei
(involves: C57BL/6J * CAST/Ei)
|
bile duct inflammation
|
J:99468
|
Mpdk8C57BL/6J/Mpdk8CAST/Ei
(involves: C57BL/6J * CAST/Ei)
|
bile duct inflammation
|
J:99468
|
Mpdk8CAST/Ei/Mpdk8CAST/Ei
(involves: C57BL/6J * CAST/Ei)
|
bile duct inflammation
|
J:99468
|
Mpzl3rc/Mpzl3rc
(C57BL/6J-Mpzl3rc/J)
|
dermatitis
|
J:93038
|
liver inflammation
|
J:93038
|
Mpzl3tm1(KOMP)Mbp/Mpzl3tm1(KOMP)Mbp
(C57BL/6-Tyrc-Brd Mpzl3tm1(KOMP)Mbp)
|
seborrheic dermatitis
|
J:210832
|
skin inflammation
|
J:210832
|
Msmpem1Jzx/Msmpem1Jzx
(C57BL/6-Msmpem1Jzx)
|
liver inflammation
|
J:311042
|
Mst1tm1Jab/Mst1tm1Jab
(involves: 129P2/OlaHsd * Black Swiss)
|
increased susceptibility to induced colitis
|
J:46185
|
Mst1rtm1.1Sew/Mst1rtm1.1Sew
(involves: 129/Ola * CD-1 * NIH Black Swiss)
|
increased acute inflammation
|
J:75503
|
increased susceptibility to endotoxin shock
|
J:75503
|
Mst1rtm1Ber/Mst1rtm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased inflammatory response
|
J:76451
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
kidney inflammation
|
J:126620
|
lung inflammation
|
J:120196
|
mt-Co1m1Jiha
(involves: C57BL/6J * M. m. domesticus)
|
heart inflammation
|
J:132659
|
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
dermatitis
|
J:137101
|
glomerulonephritis
|
J:137101
|
liver inflammation
|
J:137101
|
panniculitis
|
J:137101
|
skin inflammation
|
J:137101
|
MtapGt(RRK081)Byg/Mtap+
(129P2/OlaHsd-MtapGt(RRK081)Byg)
|
arteritis
|
J:123675
|
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg)
|
increased inflammatory response
|
J:186118
|
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:212144
|
insulitis
|
J:212144
|
salivary gland inflammation
|
J:212144
|
Mtv7BALB/c/Mtv7BALB/c
(involves: B10.Q * BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:27701
|
Mtv7BALB/c/Mtv7DBA/2
(involves: B10.Q * BALB/c * DBA/2)
|
decreased susceptibility to induced arthritis
|
J:27701
|
Mtv7DBA/2/Mtv7DBA/2
(C.D2-Mtv7DBA/2)
|
decreased susceptibility to induced arthritis
|
J:27701
|
Muc2eey/Muc2eey
(C57BL/6-Muc2eey)
|
ileum inflammation
|
J:194148
|
increased susceptibility to induced colitis
|
J:194148
|
Muc2M1Btlr/Muc2+
(C57BL/6J-Muc2M1Btlr)
|
increased susceptibility to induced colitis
|
J:150326
|
Muc2M1Btlr/Muc2M1Btlr
(C57BL/6J-Muc2M1Btlr)
|
increased susceptibility to induced colitis
|
J:150326
|
Muc2m2Btlr/?
(C57BL/6J-Muc2m2Btlr)
|
increased susceptibility to induced colitis
|
J:159359
|
Muc2m3Btlr/Muc2m3Btlr
(C57BL/6J-Muc2m3Btlr)
|
increased susceptibility to induced colitis
|
J:254906
|
Muc2tm1Avel/Muc2tm1Avel
(involves: 129P2/OlaHsd * C57BL/6)
|
colitis
|
J:216831
|
large intestinal inflammation
|
J:216831
|
Muc2wnn/Muc2+
(C57BL/6-Muc2wnn)
|
increased susceptibility to induced colitis
|
J:194148
|
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn)
|
colitis
|
J:194148
|
ileum inflammation
|
J:194148
|
increased susceptibility to induced colitis
|
J:194148
|
Muc5btm1.2Evns/Muc5btm1.2Evns
(B6.129S1-Muc5btm1.2Evns)
|
increased susceptibility to otitis media
|
J:207159
|
respiratory system inflammation
|
J:207159
|
Muc13tm1.1Mamg/Muc13tm1.1Mamg
(involves: 129 * C57BL/6)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:313870
|
increased susceptibility to induced colitis
|
J:313870
|
large intestinal inflammation
|
J:313870
|
small intestinal inflammation
|
J:313870
|
Mug1tm1Vln/Mug1tm1Vln
(B.129P2-Mug1tm1Vln)
|
liver inflammation
|
J:57485
|
Mug1tm2Vln/Mug1tm2Vln Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln Mug1tm2Vln)
|
liver inflammation
|
J:57485
|
Mus81tm1Esse/Mus81+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased inflammatory response
|
J:222498
|
Mus81tm1Esse/Mus81tm1Esse
(involves: 129P2/OlaHsd * C57BL/6J)
|
lung inflammation
|
J:222498
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
bronchiolitis
|
J:162707
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
increased susceptibility to induced colitis
|
J:167340
|
Myd88tm1Aki/Myd88tm1Aki
(C.129P2-Myd88tm1Aki)
|
decreased susceptibility to induced arthritis
|
J:178054
|
Myd88tm1Aki/Myd88tm1Aki Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased susceptibility to induced colitis
|
J:163410
|
Myh4arl/Myh4arl
(involves: C3H/HeH * C57BL/6J)
|
myositis
|
J:181892
|
Myh6tm1Jse/Myh6+ Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6)
|
liver inflammation
|
J:153302
|
lung inflammation
|
J:153302
|
Myh9tm1.1(MYH9*)Mjk/Myh9+
(B6.Cg-Myh9tm1.1(MYH9*)Mjk)
|
increased incidence of corneal inflammation
|
J:175367
|
Myh10tm7Rsad/Myh10tm7Rsad Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
heart inflammation
|
J:170148
|
Myl3tm1a(EUCOMM)Hmgu/Myl3tm1a(EUCOMM)Hmgu Tg(Col2a1-cre)1Xya/0
(involves: C57BL/6J * C57BL/6N)
|
osteoarthritis
|
J:343166
|
Myl3tm1a(EUCOMM)Hmgu/Myl3tm1a(EUCOMM)Hmgu Tg(Col2a1-cre/ERT)KA3Smac/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
increased susceptibility to induced arthritis
|
J:343166
|
Mylktm1Mzhu/Mylktm1Mzhu Taglntm1(cre/ERT2)Feil/?
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
small intestinal inflammation
|
J:141907
|
Myo1dem1Btlr/Myo1dem1Btlr
(C57BL/6J-Myo1dem1Btlr)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:267525
|
increased susceptibility to induced colitis
|
J:267525
|
Myo1dm1Btlr/Myo1dm1Btlr
(C57BL/6J-Myo1dm1Btlr)
|
increased susceptibility to induced colitis
|
J:267525
|
Myo1dm1Btlr/Myo1dm2Btlr
(C57BL/6J-Myo1dm1Btlr/Myo1dm2Btlr)
|
increased susceptibility to induced colitis
|
J:267525
|
Myo1dm2Btlr/Myo1dm2Btlr
(C57BL/6J-Myo1dm2Btlr)
|
increased susceptibility to induced colitis
|
J:267525
|
Myo1dm3Btlr/Myo1dm3Btlr
(C57BL/6J-Myo1dm3Btlr)
|
increased susceptibility to induced colitis
|
J:267525
|
Myo1dm4Btlr/Myo1dm4Btlr
(C57BL/6J-Myo1dm4Btlr)
|
increased susceptibility to induced colitis
|
J:267525
|
N4bp1tm1.2Vmd/N4bp1tm1.2Vmd
(involves: C57BL/6)
|
lung inflammation
|
J:297419
|
Naglutm1Efn/Naglutm1Efn
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to otitis media
|
J:129390
|
Nba4NZB/Nba4NZB
(involves: NZB * SWR)
|
glomerulonephritis
|
J:96060
|
Nba5NZB/Nba5NZB
(C57BL/6-Nba5 Yaa)
|
glomerulonephritis
|
J:95829
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Nba8NZB/Nba8NZB
(involves: NZB * SWR)
|
glomerulonephritis
|
J:73097
|
Nba10NZB/?
(involves: C57BL/6 * NZB * SB/Le)
|
glomerulonephritis
|
J:95829
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Nba10NZB/Nba10NZB Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB)
|
glomerulonephritis
|
J:134128
|
Nba10NZB/Nba10NZB Tlr7tm1Aki/Y X/Yaa
(B6.Cg-Nba10NZB Tlr7tm1Aki Yaa)
|
glomerulonephritis
|
J:137656
|
Nba10NZB/Nba10NZB X/Yaa
(C57BL/6-Nba2 Yaa)
|
glomerulonephritis
|
J:95829,
J:137656
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Nba11NZB/Nba11NZB
(involves: NZB * SWR)
|
glomerulonephritis
|
J:96263
|
Nba11NZB/Nba11SWR
(involves: NZB * SWR)
|
glomerulonephritis
|
J:96263
|
Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi
(C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased inflammatory response
|
J:220801
|
Nbwa2NZB/?
(involves: BALB/c * NZB * NZW)
|
glomerulonephritis
|
J:88464
|
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J)
|
increased acute inflammation
|
J:28267
|
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
lung inflammation
|
J:260777
|
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6)
|
heart inflammation
|
J:141377
|
liver inflammation
|
J:141377
|
lung inflammation
|
J:141377
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:120086
|
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
|
chronic liver inflammation
|
J:207622
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
dermatitis
|
J:116617
|
increased inflammatory response
|
J:116617
|
lung inflammation
|
J:116617
|
Ndfip1tm1.1Pmo/Ndfip1tm1.1Pmo Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
esophageal inflammation
|
J:205692
|
skin inflammation
|
J:205692
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+ Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N)
|
esophageal inflammation
|
J:267519
|
small intestinal inflammation
|
J:267519
|
Ndst2tm1Rls/Ndst2tm1Rls
(B6.Cg-Ndst2tm1Rls)
|
decreased susceptibility to induced arthritis
|
J:142880
|
Nedd4ltm1.1Hkb/Nedd4ltm1.1Hkb Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
lung inflammation
|
J:169296
|
Nedd4ltm1Shkr/Nedd4ltm1Shkr
(involves: C57BL/6 * C57BL/6J)
|
lung inflammation
|
J:205657
|
Nedd4ltm1Shkr/Nedd4ltm1Shkr
(involves: 129 * C57BL/6 * C57BL/6J)
|
lung inflammation
|
J:205657
|
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6)
|
joint inflammation
|
J:106077
|
Neil2tm1.1Tkhz/Neil2tm1.1Tkhz
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
lung inflammation
|
J:225791
|
Nek8m1Btlr/Nek8m1Btlr
(C57BL/6J-Nek8m1Btlr)
|
increased susceptibility to induced colitis
|
J:267544
|
Nf1tm1.1Kest/Nf1tm1c(KOMP)Wtsi Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)
|
dermatitis
|
J:234172
|
Nf1tm1c(KOMP)Wtsi/Nf1tm1c(KOMP)Wtsi Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * FVB/N)
|
dermatitis
|
J:234172
|
Nf2tm1Gth/Nf2tm2Gth Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased susceptibility to otitis media
|
J:63264
|
Nf2tm2Gth/Nf2tm2Gth Tg(Mpz-cre)1Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased susceptibility to otitis media
|
J:63264
|
Nf2tm2Gth/Nf2tm2Gth Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased susceptibility to otitis media
|
J:63264
|
Nfat5tm1Rao/Nfat5tm1Rao
(B6.129-Nfat5tm1Rao)
|
tubulointerstitial nephritis
|
J:88636
|
Nfatc1tm3Glm/Nfatc1tm3Glm Sh3bp2tm1Bjro/Sh3bp2tm1Bjro Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
liver inflammation
|
J:144598
|
lung inflammation
|
J:144598
|
lymph node inflammation
|
J:144598
|
stomach inflammation
|
J:144598
|
Nfatc2tm1Glm/Nfatc2tm1Glm Nfatc3tm1Glm/Nfatc3tm1Glm
(involves: 129S2/SvPas)
|
blepharitis
|
J:51339
|
increased inflammatory response
|
J:51339
|
interstitial pneumonia
|
J:51339
|
Nfe2l1tm1Jefc/Nfe2l1tm1Ywk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J)
|
liver inflammation
|
J:97188
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR)
|
glomerulonephritis
|
J:104016
|
lung inflammation
|
J:118068
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to induced colitis
|
J:116676
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * CD-1)
|
increased acute inflammation
|
J:122813
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6)
|
liver inflammation
|
J:136120
|
Nfil3tm1.1Kubo/Nfil3tm1.1Kubo
(B6.Cg-Nfil3tm1.1Kubo)
|
increased susceptibility to induced colitis
|
J:172134
|
Nfil3tm1Pbro/Nfil3tm1Pbro
(B6.129S6-Nfil3tm1Pbro)
|
colitis
|
J:209365
|
Nfkb1M3Btlr/Nfkb1M3Btlr
(C57BL/6J-Nfkb1M3Btlr)
|
increased susceptibility to induced colitis
|
J:254821
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
cecum inflammation
|
J:67107
|
large intestinal inflammation
|
J:67107
|
peritoneal inflammation
|
J:67107
|
Nfkb1tm1Bal/Nfkb1tm1Bal Relatm1Bal/Rela+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
cecum inflammation
|
J:67107
|
large intestinal inflammation
|
J:67107
|
peritoneal inflammation
|
J:67107
|
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv)
|
liver inflammation
|
J:46912
|
lung inflammation
|
J:46912
|
Nfkb2Lym1/Nfkb2+
(BALB/c-Nfkb2Lym1)
|
liver inflammation
|
J:154812
|
lung inflammation
|
J:154812
|
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
|
liver inflammation
|
J:154812
|
lung inflammation
|
J:154812
|
Nfkbiatm1Stw/Nfkbiatm1Stw
(involves: 129S1/Sv)
|
dermatitis
|
J:32527
|
Nfkbibtm1Bal/Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal)
|
decreased susceptibility to induced arthritis
|
J:163302
|
Nfkbidtm1Ktak/Nfkbidtm1Ktak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:113334
|
increased susceptibility to induced colitis
|
J:113334
|
Nfkbiztm1.1Muta/Nfkbiztm1.1Muta Tg(CAG-cre)13Miya/?
(involves: C57BL/6)
|
dermatitis
|
J:194832
|
Nfkbiztm1.1Muta/Nfkbiztm1.1Muta Tg(KRT5-cre)1Tak/?
(involves: C3H * C57BL/6)
|
dermatitis
|
J:194832
|
Nfkbiztm1Aki/Nfkbiz+ Stat6tm1Aki/Stat6tm1Aki
(C.129P2-Stat6tm1Aki Nfkbiztm1Aki)
|
skin inflammation
|
J:141704
|
Nfkbiztm1Aki/Nfkbiztm1Aki
(involves: 129P2/OlaHsd)
|
blepharitis
|
J:96363
|
conjunctivitis
|
J:96363
|
corneal limbitis
|
J:96363
|
dermatitis
|
J:194832,
J:91297
|
eye inflammation
|
J:96363
|
interstitial pneumonia
|
J:194832
|
lacrimal gland inflammation
|
J:194832
|
periocular dermatitis
|
J:194832
|
Nfkbiztm1Aki/Nfkbiztm1Aki
(C.129P2-Nfkbiztm1Aki)
|
blepharitis
|
J:141704
|
conjunctivitis
|
J:141704
|
dermatitis
|
J:141704
|
eye inflammation
|
J:141704
|
perioral dermatitis
|
J:141704
|
skin inflammation
|
J:141704
|
Nfkbiztm1Aki/Nfkbiztm1Aki Stat6tm1Aki/Stat6tm1Aki
(C.129P2-Stat6tm1Aki Nfkbiztm1Aki)
|
blepharitis
|
J:141704
|
dermatitis
|
J:141704
|
eye inflammation
|
J:141704
|
skin inflammation
|
J:141704
|
Nfkbiztm1Aki/Nfkbiztm1Aki Tnftm1Sek/Tnftm1Sek
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
conjunctivitis
|
J:194832
|
dermatitis
|
J:194832
|
Nfkbiztm1Mamo/Nfkbiztm1Mamo
(involves: 129S7/SvEvBrd)
|
dermatitis
|
J:95040
|
Nid2Gt(GST011)Byg/Nid2Gt(GST011)Byg
(involves: 129P2/OlaHsd)
|
osteoarthritis
|
J:229684
|
Ninj2em1Cqxu/Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu)
|
white adipose tissue inflammation
|
J:332575
|
NipblGt(RRS564)Byg/Nipbl+
(involves: 129P2/OlaHsd * CD-1)
|
eye inflammation
|
J:154117
|
Nischedsn/Nischedsn
(C3H.B6-Nischedsn)
|
increased susceptibility to otitis media
|
J:244907
|
Nischedsn/NischV33A
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased susceptibility to otitis media
|
J:244907
|
NischV33A/NischV33A
(involves: BALB/c * C57BL/6J)
|
increased susceptibility to otitis media
|
J:244907
|
Nlrc3tm1Bhk/Nlrc3tm1Bhk
(B6.129S6-Nlrc3tm1Bhk)
|
increased susceptibility to endotoxin shock
|
J:187586
|
Nlrp1aNeut1/Nlrp1a+
(C.B6-Nlrp1aNeut1)
|
increased inflammatory response
|
J:191055
|
liver inflammation
|
J:191055
|
lung inflammation
|
J:191055
|
meningitis
|
J:191055
|
myocarditis
|
J:191055
|
pancreas inflammation
|
J:191055
|
Nlrp1aNeut1/Nlrp1aNeut1
(C.B6-Nlrp1aNeut1)
|
increased inflammatory response
|
J:191055
|
liver inflammation
|
J:191055
|
lung inflammation
|
J:191055
|
meningitis
|
J:191055
|
myocarditis
|
J:191055
|
pancreas inflammation
|
J:191055
|
Nlrp3tm1Bhk/Nlrp3tm1Bhk
(B6.129S6-Nlrp3tm1Bhk/J)
|
white adipose tissue inflammation
|
J:256504
|
Nlrp3tm1Flv/Nlrp3tm1Hhf Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
increased inflammatory response
|
J:150054
|
Nlrp3tm1Hhf/Nlrp3+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased inflammatory response
|
J:150054
|
Nlrp3tm1Hhf/Nlrp3+ Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129/Sv * C57BL/6 * CBA)
|
skin inflammation
|
J:150054
|
Nlrp3tm1Hhf/Nlrp3+ Tg(Zp3-cre)3Mrt/?
(involves: 129/Sv * FVB/N)
|
increased inflammatory response
|
J:150054
|
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6)
|
dermatitis
|
J:150053
|
increased susceptibility to type IV hypersensitivity reaction
|
J:150053
|
Nlrp3tm2Hhf/Nlrp3+ Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129/Sv * C57BL/6 * CBA)
|
skin inflammation
|
J:150054
|
Nlrp3tm3.1Hhf/Nlrp3+
(involves: 129)
|
increased inflammatory response
|
J:202147
|
joint inflammation
|
J:202147
|
meningitis
|
J:202147
|
osteomyelitis
|
J:202147
|
Nlrp6tm1Flv/Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv)
|
increased susceptibility to induced colitis
|
J:173245
|
Nlrp6tm1Macha/Nlrp6tm1Macha
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased susceptibility to induced colitis
|
J:173352
|
Nlrp12tm1Tdk/Nlrp12tm1Tdk
(B6.Cg-Nlrp12tm1Tdk)
|
increased inflammatory response
|
J:178951
|
increased susceptibility to induced colitis
|
J:178951
|
Nlrx1tm1Jpyt/Nlrx1tm1Jpyt
(involves: C57BL/6 * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:173995
|
Nme5tm1Lex/Nme5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
maxillary sinus inflammation
|
J:185566
|
nasal inflammation
|
J:185566
|
nmf370/nmf370
(C57BL/6J-nmf370/J)
|
ear inflammation
|
J:87349
|
nmf391/nmf391
(C57BL/6J-nmf391/J)
|
ear inflammation
|
J:87349
|
Nod2tm1Flv/Nod2tm1Flv
(C.129S1-Nod2tm1Flv)
|
decreased susceptibility to induced arthritis
|
J:178054
|
Nod2tm1Jhgt/Nod2tm1Jhgt
(B6.Cg-Nod2tm1Jhgt)
|
increased susceptibility to induced colitis
|
J:124575
|
Nod2tm1Mka/Nod2tm1Mka
(involves: C57BL/6)
|
increased susceptibility to induced colitis
|
J:96128
|
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6)
|
skin inflammation
|
J:64036
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd)
|
increased inflammatory response
|
J:51635
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6)
|
pancreas inflammation
|
J:65562
|
Nos3m1Btlr/Nos3m1Btlr
(C57BL/6J-Nos3m1Btlr)
|
increased susceptibility to induced colitis
|
J:225268
|
Nos3M2Btlr/Nos3M2Btlr
(C57BL/6J-Nos3M2Btlr)
|
increased susceptibility to induced colitis
|
J:272392
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J)
|
increased inflammatory response
|
J:103018
|
kidney inflammation
|
J:148626
|
Notch1tm1Con/Notch1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
aortic valve inflammation
|
J:187551
|
Notch1tm2Rko/Notch1tm3(cre)Rko
(involves: 129X1/SvJ * C57BL/6)
|
chronic liver inflammation
|
J:171829
|
NotumGt(OST172035)Lex/NotumGt(OST172035)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
periodontium inflammation
|
J:266040
|
Nox1tm1.1Anrt/Nox1tm1.1Anrt Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL)
|
colitis
|
J:194294
|
Npas3tm1Mesu/Npas3tm1Mesu
(B6.129S6-Npas3tm1Mesu)
|
bronchiectasis
|
J:150793
|
Npc1m1N/Npc1m1N
(BALB/cNctr-Npc1m1N/J)
|
nasal inflammation
|
J:209834
|
Nphp3pcy/Nphp3pcy
(KK-Nphp3pcy)
|
kidney inflammation
|
J:8302
|
Nphp3pcy/Nphp3pcy
(either: D2.KK-Nphp3pcy or (involves: DBA/2Fg * DBA/2J * KK))
|
kidney inflammation
|
J:11399
|
Nphp3pol/Nphp3pol
(C57BL/6JSfdAnu-Nphp3pol/Anu)
|
kidney inflammation
|
J:104190
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:234268
|
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased inflammatory response
|
J:158168
|
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj)
|
liver inflammation
|
J:200842
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
|
liver inflammation
|
J:118204
|
Nr3c1tm1.1Jaci/Nr3c1tm1.1Jaci Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
heart inflammation
|
J:201995
|
Nr3c1tm2Ljm/Nr3c1tm2Ljm Tg(Lck-cre)548Jxm/?
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
cecum inflammation
|
J:97484
|
increased susceptibility to endotoxin shock
|
J:97484
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:239509
|
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn Tg(Lck-cre)1Jtak/0
(Not Specified)
|
increased susceptibility to induced colitis
|
J:205658
|
Nr5a2tm1Auw/Nr5a2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to induced colitis
|
J:123697
|
Nr5a2tm1Sjns/Nr5a2tm1Sjns Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL)
|
increased susceptibility to induced colitis
|
J:123697
|
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of corneal inflammation
|
J:85753
|
keratoconjunctivitis sicca
|
J:85753
|
Nss1NOD/ShiLtJ/Nss1NOD/ShiLtJ
(involves: C57BL/10 * NOD)
|
salivary gland inflammation
|
J:73932
|
Ntan1tm1Avar/Ntan1tm1Avar
(involves: 129)
|
increased acute inflammation
|
J:62140
|
Nudt7em1Ejj/Nudt7em1Ejj
(involves: C57BL/6N)
|
increased susceptibility to induced arthritis
|
J:266261
|
osteoarthritis
|
J:266261
|
Nudt21tm1.1Ejwpj/Nudt21tm1.1Ejwpj Tg(Col1a1-cre/ERT2)1Crm/0
(involves: C57BL/6J * CBA/J)
|
increased acute inflammation
|
J:283035
|
Oca2p-8Btlr/Oca2p-8Btlr
(C57BL/6J-Oca2p-8Btlr)
|
increased susceptibility to induced colitis
|
J:264643
|
OclnGt(ROSA)39Tshi/OclnGt(ROSA)39Tshi
(involves: DBA/2)
|
stomach inflammation
|
J:110222
|
Oclntm1Sts/Oclntm1Sts
(involves: 129S4/SvJae * C57BL/6)
|
stomach inflammation
|
J:99467
|
Oclntm1Tshi/Oclntm1Tshi
(involves: C57BL/6 * DBA/2)
|
stomach inflammation
|
J:110222
|
Oclntm2Sts/Oclntm2Sts
(involves: 129S4/SvJae * C57BL/6)
|
stomach inflammation
|
J:99467
|
Odf2tm1.1Sats/Odf2tm1.2Sats Tg(CAG-cre)13Miya/0
(involves: C57BL/6 * C57BL/6J)
|
increased susceptibility to otitis media
|
J:181294
|
sinus inflammation
|
J:181294
|
Olfm4tm1Gpro/Olfm4tm1Gpro
(involves: 129X1/SvJ * Black Swiss)
|
stomach inflammation
|
J:161279
|
Onecut1tm1.1Mga/Onecut1tm1.1Mga Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
pancreas inflammation
|
J:155058
|
Orai1tm1Rao/Orai1tm1Rao
(involves: C57BL/6NTac * ICR)
|
blepharitis
|
J:139730
|
Orai2tm1.1Itl/Orai2tm1.1Itl Tg(Cma1-cre)#Roer/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:278536
|
Orch4BALB/cByJ/Orch4BALB/cByJ
(involves: BALB/cByJ * DBA/2)
|
testis inflammation
|
J:35331
|
Orch5BALB/cByJ/Orch5BALB/cByJ
(involves: BALB/cByJ * DBA/2)
|
testis inflammation
|
J:35331
|
Orm2em1Bcgen/Orm2em1Bcgen
(involves: C57BL/6J)
|
liver inflammation
|
J:333118
|
Orm2tm1(KOMP)Vlcg/Orm2tm1(KOMP)Vlcg
(C57BL/6N-Orm2tm1(KOMP)Vlcg/Mmucd)
|
kidney inflammation
|
J:292194
|
Os/Os+
(ROP/GnLeJ)
|
glomerulonephritis
|
J:28323
|
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan)
|
increased inflammatory response
|
J:214124
|
white adipose tissue inflammation
|
J:214124
|
Ostm1gl/Ostm1gl
(GL/Le Edardl-J +/+ Ostm1gl/J)
|
eye inflammation
|
J:13053
|
Otcspf-ash/Y
(B6EiC3Sn a/A-Otcspf-ash/J)
|
increased susceptibility to endotoxin shock
|
J:108979
|
Otud1em2Gpt/Otud1em2Gpt
(C57BL/6-Otud1em2Gpt)
|
increased susceptibility to endotoxin shock
|
J:287309
|
Otud5tm1Vmd/Otud5tm1Vmd Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
intestinal inflammation
|
J:219495
|
Otulinem1Gvl/Otulintm1c(EUCOMM)Hmgu Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA/2)
|
dermatitis
|
J:312394
|
Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
dermatitis
|
J:312394
|
P2rx2tm1Ckn/P2rx2tm1Ckn P2rx3tm1Ckn/P2rx3tm1Ckn
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:86890
|
P2ry6tm1Jabo/P2ry6tm1Jabo Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac)
|
lung inflammation
|
J:179177
|
P2ry6tm1Jabo/P2ry6tm1Jabo Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sortm9(cre/ESR1)Arte P2ry6tm1Jabo)
|
lung inflammation
|
J:179177
|
Panx3tm1c(KOMP)Wtsi/Panx3tm1c(KOMP)Wtsi Tg(Col2a1-cre)1Star/0
(involves: C3H * C57BL/6 * C57BL/6J * C57BL/6N)
|
decreased susceptibility to induced arthritis
|
J:233542
|
Panx3tm1d(KOMP)Wtsi/Panx3tm1d(KOMP)Wtsi
(involves: BALB/cJ * C3H * C57BL/6 * C57BL/6N)
|
decreased susceptibility to induced arthritis
|
J:233542
|
Papss2bm/Papss2bm
(involves: C57BL/6J * LDJ/Le)
|
autoimmune arthritis
|
J:166514
|
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:92244
|
Pax6Sey-4H/Pax6+
(involves: 101/H * C3H/HeCrj * C3H/HeH)
|
increased susceptibility to induced pancreatitis
|
J:124276
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+
(involves: C57BL/6)
|
myositis
|
J:180899
|
Pbxip1tm1Cya/Pbxip1tm1Cya Tg(Col2a1-cre/ERT)KA3Smac/0
(involves: FVB/N)
|
osteoarthritis
|
J:270267
|
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:184882
|
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
insulitis
|
J:153040
|
pancreas inflammation
|
J:153040
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(B6.129S2-Pdcd1tm1Hon)
|
autoimmune arthritis
|
J:78802
|
glomerulonephritis
|
J:78802
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas)
|
increased inflammatory response
|
J:222944
|
Pdcd1tm1Hon/Pdcd1tm1Hon Vsirtm1Lex/Vsirtm1Lex
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)
|
increased inflammatory response
|
J:222944
|
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac)
|
insulitis
|
J:123785
|
Pdcd10tm1Kwhi/Pdcd10tm1.1Kwhi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/?
(involves: C57BL/6 * CBA)
|
CNS inflammation
|
J:173947
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw Rag2tm1Fwa/Rag2tm1Fwa Tnfrsf4tm2(cre)Nik/Tnfrsf4+ Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
dermatitis
|
J:226194
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw Tnfrsf4tm2(cre)Nik/Tnfrsf4+ Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129X1/SvJ * C57BL/6)
|
dermatitis
|
J:226194
|
Pdss2kd/Pdss2kd
(CBA/H-Pdss2kd)
|
tubulointerstitial nephritis
|
J:197578
|
Pdss2kd/Pdss2kd
(B6.CBACaH(CAST)-Pdss2kd)
|
tubulointerstitial nephritis
|
J:101779
|
Pdss2tm1Dalg/Pdss2tm1Dalg Tg(NPHS2-cre)295Lbh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
tubulointerstitial nephritis
|
J:136670
|
Pdx1tm1Ted/Pdx1+
(involves: 129P2/OlaHsd)
|
pancreas inflammation
|
J:82969
|
Pecam1tm1Mak/Pecam1+
(D1.129P2-Pecam1tm1Mak)
|
increased susceptibility to induced arthritis
|
J:106275
|
Pecam1tm1Mak/Pecam1tm1Mak
(D1.129P2-Pecam1tm1Mak)
|
increased susceptibility to induced arthritis
|
J:106275
|
joint inflammation
|
J:106275
|
Pecam1tm1Mak/Pecam1tm1Mak
(B6.129P2-Pecam1tm1Mak)
|
liver inflammation
|
J:95226
|
Pecam1tm1Mak/Pecam1tm1Mak PitgpC57BL/6/PitgpC57BL/6
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
peritoneal inflammation
|
J:144817
|
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig)
|
lung inflammation
|
J:62435
|
Perptm2Att/Perptm2Att Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S4/SvJae)
|
skin inflammation
|
J:167545
|
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac)
|
liver inflammation
|
J:278655
|
phlebitis
|
J:278655
|
Pex7tm1Nbra/Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6)
|
liver inflammation
|
J:158845
|
Pfdn1Gt(GTR1.3)1Rul/Pfdn1Gt(GTR1.3)1Rul
(involves: 129)
|
sinus inflammation
|
J:137415
|
Pgdtm1.1Pse/Pgdtm1.1Pse Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
blepharitis
|
J:313817
|
ear inflammation
|
J:313817
|
increased susceptibility to type I hypersensitivity reaction
|
J:313817
|
Pgia3DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl)
|
increased inflammatory response
|
J:66460
|
Pgia5BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
|
increased inflammatory response
|
J:66460
|
Pgia8DBA/2/Pgia8DBA/2
(C.D2-(D15Mit12-D15Mit267))
|
decreased susceptibility to induced arthritis
|
J:137478
|
Pgia8DBA/2/Pgia8DBA/2
(involves: BALB/c * DBA/2)
|
decreased susceptibility to induced arthritis
|
J:137478
|
Pgia8DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl)
|
increased inflammatory response
|
J:66460
|
Pgia9BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
|
increased inflammatory response
|
J:66460
|
Pgia9DBA/2/Pgia9DBA/2
(C.D2-(D15Mit267-D15Mit41))
|
decreased susceptibility to induced arthritis
|
J:137478
|
Pgia9DBA/2/Pgia9DBA/2
(involves: BALB/c * DBA/2)
|
decreased susceptibility to induced arthritis
|
J:137478
|
Pgia10BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
|
increased inflammatory response
|
J:66460
|
Pgia12BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
|
increased inflammatory response
|
J:66460
|
Pgia13C3H/HeJCr/Pgia13C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:65424
|
Pgia14C3H/HeJCr/Pgia14C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:65424
|
Pgia15C3H/HeJCr/Pgia15C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:65424
|
Pgia26BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
|
increased inflammatory response
|
J:84150
|
Pgia39DBA/2Crl/Pgia39DBA/2Crl Pgia6DBA/2Crl/Pgia6DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl)
|
increased susceptibility to induced arthritis
|
J:84150
|
Pgia39DBA/2Crl/Pgia39DBA/2Crl Pgia26BALB/cCrl/Pgia26BALB/cCrl
(involves: BALB/cCrl * DBA/2Crl)
|
increased susceptibility to induced arthritis
|
J:84150
|
Pgis1DBA/2/Pgis1DBA/2
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis1DBA/2/Pgis1DBA/2 Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis1DBA/2/Pgis1DBA/2 Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(C.129S-Pglyrp1tm1Rdz)
|
increased susceptibility to induced arthritis
|
J:178054
|
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(involves: 129S5/SvEvBrd * BALB/c)
|
increased susceptibility to induced colitis
|
J:178053
|
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp1tm1Rdz Pglyrp2tm1Rdz)
|
decreased susceptibility to induced arthritis
|
J:178054
|
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp2tm1Rdz)
|
decreased susceptibility to induced arthritis
|
J:178054
|
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(involves: 129S/SvEv * BALB/c)
|
increased susceptibility to induced colitis
|
J:178053
|
Pglyrp3tm1Rdz/Pglyrp3tm1Rdz
(involves: 129S6/SvEvTac * BALB/c)
|
increased susceptibility to induced colitis
|
J:178053
|
Pglyrp4tm1Rdz/Pglyrp4tm1Rdz
(involves: 129S6/SvEvTac * BALB/c)
|
increased susceptibility to induced colitis
|
J:178053
|
Pgm3Gt(W037B08)Wrst/Pgm3mld1
(involves: 129S1/Sv * C57BL/6)
|
glomerulonephritis
|
J:125094
|
Pgrtm1Bwo/Pgrtm1Bwo
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
uterus inflammation
|
J:28980
|
Pgrtm2(cre)Lyd/Pgr+ Criptotm2.2Mms/Criptotm2.2Mms
(involves: 129/Sv * C57BL/6N * CD-1)
|
endometrium inflammation
|
J:324146
|
Pgrmc1em1Ejho/Pgrmc1em1Ejho
(involves: C57BL/6N)
|
liver inflammation
|
J:268130
|
PhexHyp-Duk/Y
(involves: BALB/cAnBomUrd)
|
ear inflammation
|
J:132678
|
increased susceptibility to otitis media
|
J:132678
|
PhexHyp/?
(involves: C57BL/6J)
|
enthesitis
|
J:192371
|
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N)
|
liver inflammation
|
J:142512
|
Pias1tm1Kes/Pias1tm1Kes
(involves: 129S/Sv * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:92167
|
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
glomerulonephritis
|
J:169710
|
Pik3cdtm1.1Bvan/Pik3cdtm1.1Bvan
(involves: 129P2/OlaHsd * BALB/c)
|
intestinal inflammation
|
J:78412
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(B6.129S4-Pik3cdtm1Tnr)
|
decreased susceptibility to induced arthritis
|
J:134324
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129-Pik3cdtm1Tnr Pik3cgtm1Pngr)
|
decreased susceptibility to induced arthritis
|
J:134324
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129P2-Pik3cgtm1Pngr)
|
decreased susceptibility to induced arthritis
|
J:134324
|
Pik3r4tm1.1Mpnd/Pik3r4tm1.1Mpnd Tg(ACTA1-cre)79Jme/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL)
|
myositis
|
J:198770
|
Pikfyvetm2.1Tssk/Pikfyvetm2.1Tssk Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
intestinal inflammation
|
J:193689
|
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb)
|
increased susceptibility to endotoxin shock
|
J:191085
|
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
chronic liver inflammation
|
J:234283
|
increased inflammatory response
|
J:234283
|
intestinal inflammation
|
J:234283
|
kidney inflammation
|
J:234283
|
lung inflammation
|
J:234283
|
salivary gland inflammation
|
J:234283
|
Pip5k1btm1Tssk/Pip5k1btm1Tssk
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:97991
|
Piptm1Myal/Piptm1Myal
(involves: 129S/SvEv * C57BL/6)
|
arteritis
|
J:202016
|
colitis
|
J:202016
|
Pja2tm1.2Afel/Pja2tm1.2Afel
(involves: 129S6/SvEvTac * C57BL/6J)
|
kidney inflammation
|
J:345592
|
Pkd1tm1Djmp/Pkd1tm1Djmp
(involves: 129P2/OlaHsd * C57BL/6)
|
kidney inflammation
|
J:94582
|
Pkd1tm1Jzh/Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))
|
bile duct inflammation
|
J:52573
|
kidney inflammation
|
J:52573
|
Pkhd1tm1.1Ggg/Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
bile duct inflammation
|
J:125113
|
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
|
glomerulonephritis
|
J:193187
|
Pkp3tm1.1Fvr/Pkp3tm1.1Fvr
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)
|
dermatitis
|
J:136451
|
Pla1aem1Appsc/Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc)
|
decreased susceptibility to chemically induced skin inflammation
|
J:333902
|
decreased susceptibility to induced arthritis
|
J:333902
|
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:201008
|
Pla2g3tm1Murm/Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6)
|
ear inflammation
|
J:197334
|
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to type I hypersensitivity reaction
|
J:39254
|
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(NOD.129P2(B6)-Pla2g4atm1Tksh)
|
insulitis
|
J:99775
|
Pla2g4eem1Murm/Pla2g4eem1Murm
(C57BL/6NSlc-Pla2g4eem1Murm)
|
increased susceptibility to chemically induced skin inflammation
|
J:333700
|
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg)
|
autoimmune arthritis
|
J:75303
|
chronic joint inflammation
|
J:75303
|
Plautm1.1Bug/Plautm1.1Bug
(involves: C57BL/6)
|
liver inflammation
|
J:164542
|
trachea inflammation
|
J:164542
|
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
decreased susceptibility to induced arthritis
|
J:75303
|
Plautm1Mlg/Plautm1Mlg
(B6.129S2-Plautm1Mlg)
|
increased inflammatory response
|
J:164542
|
liver inflammation
|
J:164542
|
trachea inflammation
|
J:164542
|
Plaurtm1Jld/Plaurtm1Jld
(B6.129P2-Plaurtm1Jld)
|
increased inflammatory response
|
J:164542
|
liver inflammation
|
J:164542
|
trachea inflammation
|
J:164542
|
Plaurtm1Jld/Plaurtm1Jld Tg(MSR1-Plau)1Ddi/0
(B6.Cg-Plaurtm1Jld Tg(MSR1-Plau)1Ddi)
|
heart inflammation
|
J:113474
|
Plcd1tm1.1Kfu/Plcd1tm1.1Kfu Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:205633
|
Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
|
dermatitis
|
J:157757
|
ear inflammation
|
J:157757
|
skin inflammation
|
J:157757
|
Plcg2Ali5/Plcg2+
(C3HeB/FeJ-Plcg2Ali5)
|
dermatitis
|
J:97930
|
osteoarthritis
|
J:97930
|
Plcg2Ali5/Plcg2+
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
glomerulonephritis
|
J:97930
|
Plcg2Ali5/Plcg2+ Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C3HeB/FeJ * C3HeB/FeJ-Plcg2Ali5)
|
dermatitis
|
J:97930
|
osteoarthritis
|
J:97930
|
Plcg2Ali5/Plcg2Ali5
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
glomerulonephritis
|
J:97930
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
decreased susceptibility to induced arthritis
|
J:157619
|
Pld3em1Nemz/Pld3em1Nemz Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.Cg-Pld3em1Nemz Pld4tm1.1Nemz)
|
liver inflammation
|
J:281205
|
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss)
|
proctitis
|
J:39419
|
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld)
|
conjunctivitis
|
J:46096
|
eye inflammation
|
J:46096
|
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss)
|
colitis
|
J:36591
|
Plgrkttm1Lmls/Plgrkt+
(B6.Cg-Plgrkttm1Lmls)
|
dermatitis
|
J:282437
|
Plgrkttm1Lmls/Plgrkttm1Lmls
(B6.Cg-Plgrkttm1Lmls)
|
dermatitis
|
J:282437
|
Plp1tm1Kan/Y Tspan2tm1Hbw/Tspan2tm1Hbw
(B6.Cg-Tspan2tm1Hbw Plp1tm1Kan)
|
brain inflammation
|
J:201143
|
Pls1tm1Fri/Pls1tm1Fri
(B6.129-Pls1tm1Fri)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:216723
|
increased susceptibility to induced colitis
|
J:216723
|
plt/plt
(either: B6.DDD-plt or C.DDD-plt)
|
increased inflammatory response
|
J:110910
|
lacrimal gland inflammation
|
J:110910
|
parotid gland inflammation
|
J:110910
|
salivary gland inflammation
|
J:110910
|
submandibular gland inflammation
|
J:110910
|
Pofut1tm2Pst/Pofut1tm1Pst Shhtm2(cre/ERT2)Cjt/Shh+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
lung inflammation
|
J:150051
|
Polbtm1.1Jbsw/Polb+
(involves: 129/Sv * C57BL/6)
|
dermatitis
|
J:206872
|
glomerulonephritis
|
J:206872
|
lymph node inflammation
|
J:206872
|
salivary gland inflammation
|
J:206872
|
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
dermatitis
|
J:206872
|
glomerulonephritis
|
J:206872
|
lymph node inflammation
|
J:206872
|
salivary gland inflammation
|
J:206872
|
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh)
|
liver inflammation
|
J:234615
|
Postntm1Sjc/Postntm1Sjc
(involves: C57BL/6)
|
periodontium inflammation
|
J:103753
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae)
|
heart inflammation
|
J:63801
|
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N)
|
skin inflammation
|
J:63040
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
glomerulonephritis
|
J:168799
|
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA * ICR)
|
increased susceptibility to induced arthritis
|
J:58222
|
Ppargtm2Rev/Ppargtm2Rev Tg(Krt1-15-cre/PGR*)22Cot/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
skin inflammation
|
J:150977
|
Ppargtm2Rev/Ppargtm2Rev Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
skin inflammation
|
J:123403
|
Ppargc1atm1Brsp/Ppargc1a+
(involves: 129S4/SvJae * C57BL/6)
|
increased inflammatory response
|
J:264271
|
Ppiatm1Lubn/Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn)
|
blepharitis
|
J:93591
|
heart inflammation
|
J:93591
|
increased inflammatory response
|
J:93591
|
increased susceptibility to type I hypersensitivity reaction
|
J:93591
|
liver inflammation
|
J:93591
|
pancreas inflammation
|
J:93591
|
Ppm1atm1.2Lavi/Ppm1atm1.2Lavi
(B.129(Cg)-Ppm1atm1.2Lavi)
|
increased acute inflammation
|
J:216372
|
Ppp1r8tm1.1Itl/Ppp1r8tm1Ave Tg(Alb1-cre)7Gsc/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
liver inflammation
|
J:238108
|
Ppp1r12atm1Mzhu/Ppp1r12atm1Mzhu Tg(Acta2-cre)#Xya/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
small intestinal inflammation
|
J:207752
|
Ppp1r13lwa3-J/Ppp1r13lwa3-J
(BALB/cJ-Ppp1r13lwa3-J/J)
|
heart inflammation
|
J:264272
|
Ppp6ctm1Shma/Ppp6ctm1Shma Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6 * CBA * CD-1)
|
increased susceptibility to chemically induced skin inflammation
|
J:231809
|
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6)
|
brain inflammation
|
J:95522
|
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
brain inflammation
|
J:177265
|
Prap1tm1Lex/Prap1tm1Lex
(B6.129S5-Prap1tm1Lex)
|
increased inflammatory response
|
J:304152
|
Prdm1tm1Clme/Prdm1tm1Clme Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
kidney inflammation
|
J:178876
|
Prdx3Gt(Betageo-puro)711Lex/Prdx3Gt(Betageo-puro)711Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
lung inflammation
|
J:118595
|
Prf1tm1Sdz/Prf1+
(NOD.B6-Prf1tm1Sdz)
|
insulitis
|
J:43468
|
periinsulitis
|
J:43468
|
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz)
|
insulitis
|
J:43468
|
periinsulitis
|
J:43468
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J)
|
brain inflammation
|
J:92260,
J:120427
|
CNS inflammation
|
J:120427
|
liver inflammation
|
J:92260
|
lymph node inflammation
|
J:92260
|
Prg2tm1Nal/Prg2tm1Nal
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
respiratory system inflammation
|
J:65655
|
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno)
|
white adipose tissue inflammation
|
J:235379
|
PrkcdM1Btlr/PrkcdM1Btlr
(C57BL/6J-PrkcdM1Btlr)
|
increased susceptibility to induced colitis
|
J:265145
|
Prkcdm2Btlr/Prkcdm2Btlr
(C57BL/6J-Prkcdm2Btlr)
|
increased susceptibility to induced colitis
|
J:265146
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:76135
|
increased acute inflammation
|
J:76135
|
Prkdchanky/Prkdchanky
(either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))
|
cecum inflammation
|
J:104190
|
colitis
|
J:104190
|
interstitial pneumonia
|
J:104190
|
liver inflammation
|
J:104190
|
Prkdcscid/Prkdcscid
(C.BKa-Prkdcscid)
|
salivary gland inflammation
|
J:21965
|
Prkdcscid/Prkdcscid
(B6.Cg-Prkdcscid/Sz)
|
stomach inflammation
|
J:120556
|
Prmt3tm1a(EUCOMM)Wtsi/Prmt3tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased incidence of corneal inflammation
|
J:213427
|
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
liver inflammation
|
J:50527
|
Procrtm1.1Pcl/Procrtm1.1Pcl
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:225914
|
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
increased inflammatory response
|
J:102652
|
Prph2em1Sal/Prph2+
(C57BL/6J-Prph2em1Sal)
|
eye inflammation
|
J:342243
|
Prph2em1Sal/Prph2em1Sal
(C57BL/6J-Prph2em1Sal)
|
eye inflammation
|
J:342243
|
Prss3btm1.1Satom/Prss3b+
(B6(FVB)-Prss3btm1.1Satom)
|
acute pancreas inflammation
|
J:267764
|
chronic pancreas inflammation
|
J:267764
|
Prxl2atm1(KOMP)Vlcg/Prxl2atm1(KOMP)Vlcg
(C57BL/6N-Prxl2atm1(KOMP)Vlcg)
|
white adipose tissue inflammation
|
J:234040
|
Psaptm2Ggb/Psaptm2Ggb
(involves: 129S/SvEv * C57BL/6J)
|
CNS inflammation
|
J:137650
|
kidney inflammation
|
J:137650
|
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J)
|
CNS inflammation
|
J:78223
|
Psen1tm1Bdes/Psen1+ Psen2tm1Bdes/Psen2tm1Bdes
(involves: 129P2/OlaHsd)
|
arteritis
|
J:91235
|
dermatitis
|
J:91235
|
glomerulonephritis
|
J:91235
|
increased incidence of corneal inflammation
|
J:91235
|
increased inflammatory response
|
J:91235
|
kidney inflammation
|
J:91235
|
skin inflammation
|
J:91235
|
Psip1Gt(betageo)1Hgs/Psip1Gt(betageo)1Hgs
(B6.129P2-Psip1Gt(betageo)1Hgs)
|
blepharitis
|
J:112975
|
Psip1Gt(betageo)1Hgs/Psip1Gt(betageo)1Hgs
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1))
|
blepharitis
|
J:112975
|
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
|
increased inflammatory response
|
J:261081
|
skin inflammation
|
J:261081
|
Pstpip2cmo/Pstpip2cmo
(C.Cg-Pstpip2cmo/J)
|
ear inflammation
|
J:104476
|
osteomyelitis
|
J:104476,
J:105410
|
Pstpip2Lupo/Pstpip2Lupo
(either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J))
|
skin inflammation
|
J:125785
|
Pstpip2Lupo/Pstpip2Lupo Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C3HeB/FeJ * C57BL/6J)
|
skin inflammation
|
J:125785
|
Pstpip2m1Bcs/Pstpip2m1Bcs
(involves: C57BL/6)
|
ear inflammation
|
J:196534
|
skin inflammation
|
J:196534
|
Ptafrtm1Tksh/Ptafrtm1Tksh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:88505
|
Ptentm1Hwu/Ptentm1Hwu Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
lung inflammation
|
J:148947
|
Ptentm1Hwu/Ptentm1Hwu Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)
|
prostate gland inflammation
|
J:93902
|
pyelonephritis
|
J:124208
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
liver inflammation
|
J:138099
|
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(B6.129-Ptgdr2tm1Tasa)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
brain inflammation
|
J:243958
|
respiratory system inflammation
|
J:61023
|
Ptger3tm1Sna/Ptger3tm1Sna
(B6.129P2-Ptger3tm1Sna/Sna)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptger4tm1.1Matb/Ptger4tm1.1Matb Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
heart inflammation
|
J:158439
|
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to induced arthritis
|
J:78964
|
rheumatoid arthritis
|
J:78964
|
Ptges2tm1Kymm/Ptges2tm1Kymm
(B6.Cg-Ptges2tm1Kymm)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgestm1Aki/Ptgestm1Aki
(B6.129P2-Ptgestm1Aki)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:75611
|
increased susceptibility to induced colitis
|
J:158426,
J:60668
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(B6.129P2-Ptgs1tm1Unc)
|
decreased susceptibility to induced arthritis
|
J:110716
|
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun
(involves: 129S6/SvEvTac)
|
kidney inflammation
|
J:148699
|
Ptgs2tm1.1Wls/Ptgs2tm1.1Wls
(B6.129-Ptgs2tm1.1Wls)
|
increased susceptibility to endotoxin shock
|
J:156331
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd)
|
pyelonephritis
|
J:29974
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd * C57BL/6)
|
peritoneal inflammation
|
J:118171
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
peritoneal inflammation
|
J:29510
|
tubulointerstitial nephritis
|
J:29510
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to induced colitis
|
J:158426,
J:60668
|
peritoneal inflammation
|
J:60668
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
decreased susceptibility to induced arthritis
|
J:110716
|
Ptgs2tm1Unc/Ptgs2tm2.1Hahe
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased susceptibility to induced colitis
|
J:158426
|
Ptgs2tm2.1(Ptgs1)Fun/Ptgs2tm2.1(Ptgs1)Fun
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
kidney inflammation
|
J:118171
|
peritoneal inflammation
|
J:118171
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c)
|
increased inflammatory response
|
J:90541
|
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd)
|
increased inflammatory response
|
J:94077
|
lung inflammation
|
J:142845
|
salivary gland inflammation
|
J:142845
|
Ptpn6me-B2/Ptpn6me-B2
(involves: BALB/c)
|
interstitial pneumonia
|
J:169850
|
skin inflammation
|
J:169850
|
Ptpn6me-v/Ptpn6me-v
(C57BL/6J-Ptpn6me-v)
|
interstitial pneumonia
|
J:7531
|
rheumatoid arthritis
|
J:20845
|
Ptpn6me/Ptpn6me
(either: (involves: C3H * C57BL/6J) or (involves: C57BL/6J * C57BL/6N))
|
lung inflammation
|
J:5999
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased acute inflammation
|
J:172422
|
liver inflammation
|
J:172422
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Stat3tm1Vpo/Stat3tm1Vpo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
liver inflammation
|
J:172422
|
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
glomerulonephritis
|
J:201448
|
increased inflammatory response
|
J:201448
|
Ptpn22tm2Achn/Ptpn22tm2Achn Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
|
glomerulonephritis
|
J:147129
|
liver inflammation
|
J:147129
|
lung inflammation
|
J:147129
|
Ptprcm1Smv/Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
CNS inflammation
|
J:214487
|
Ptprctm1Mak/Ptprctm1Mak Ptprjtm1.2Weis/Ptprjtm1.2Weis
(B6.Cg-Ptprctm1Mak Ptprjtm1.2Weis)
|
liver inflammation
|
J:131736
|
lung inflammation
|
J:131736
|
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
|
glomerulonephritis
|
J:66501
|
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis)
|
liver inflammation
|
J:147129
|
lung inflammation
|
J:147129
|
Ptprntm1Aln/Ptprntm1Aln
(NOD.129S4-Ptprntm1Aln)
|
insulitis
|
J:107161
|
Ptx3tm1Mant/Ptx3tm1Mant
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
lung inflammation
|
J:85080
|
Pxdnmhdakta048/Pxdnmhdakta048
(involves: C3HeB/FeJ * C57BL/6J)
|
eye inflammation
|
J:213336
|
Pycardtm1Flv/Pycardtm1Flv
(B6.129S5-Pycardtm1Flv)
|
increased susceptibility to induced colitis
|
J:173245
|
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi)
|
liver inflammation
|
J:284765
|
Pzptm1Vln/Pzptm1Vln
(involves: 129P2/OlaHsd * C57BL)
|
increased susceptibility to induced pancreatitis
|
J:28328
|
pancreas inflammation
|
J:28328
|
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln)
|
liver inflammation
|
J:57485
|
Rab11atm1.1Ngao/Rab11atm1.1Ngao Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
intestinal inflammation
|
J:215917
|
Rab26em1Guwa/Rab26em1Guwa
(Not Specified)
|
increased susceptibility to endotoxin shock
|
J:306921
|
Rab32tm1c(KOMP)Wtsi/Rab32tm1c(KOMP)Wtsi Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:267497
|
increased susceptibility to induced colitis
|
J:267497
|
Rab44em1Rbrc/Rab44em1Rbrc
(Not Specified)
|
increased susceptibility to type I hypersensitivity reaction
|
J:304506
|
Rad23btm1Gvh/Rad23btm1Gvh
(involves: 129P2/OlaHsd * C57BL/6)
|
blepharitis
|
J:74288
|
conjunctivitis
|
J:74288
|
Rag1tm1Bal/Rag1tm1Bal Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6)
|
liver inflammation
|
J:92470
|
Rag1tm1Mom/Rag1tm1Mom
(B6.129S7-Rag1tm1Mom)
|
dermatitis
|
J:111828
|
ear inflammation
|
J:111828
|
Rag1tm1Mom/Rag1tm1Mom Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J)
|
increased inflammatory response
|
J:117880
|
Rag1tm1Mom/Rag1tm1Mom Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6)
|
rheumatoid arthritis
|
J:54056
|
small intestinal inflammation
|
J:54056
|
Rag2tm1.1Cgn/Rag2tm1.1Cgn Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2)
|
CNS inflammation
|
J:134764
|
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
colitis
|
J:122108
|
erythroderma
|
J:122108
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
colitis
|
J:116136
|
lung inflammation
|
J:140483
|
Rag2tm1Fwa/Rag2tm1Fwa Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S/SvEv * 129S6/SvEvTac)
|
colitis
|
J:141481
|
large intestinal inflammation
|
J:141481
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
thyroid gland inflammation
|
J:78309
|
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified)
|
insulitis
|
J:201171
|
Raph1tm1.2Fbg/Raph1tm1.2Fbg
(involves: 129S4/SvJae * C57BL/6)
|
increased inflammatory response
|
J:238262
|
large intestinal inflammation
|
J:238262
|
Rasa1tm1Wid/Rasa1tm1Wid
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6N)
|
increased susceptibility to induced colitis
|
J:189241
|
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6)
|
glomerulonephritis
|
J:85189
|
Rasgrp4tm1(cre)Rls/Rasgrp4tm1(cre)Rls
(C57BL/6-Rasgrp4tm1(cre)Rls)
|
decreased susceptibility to induced arthritis
|
J:186519
|
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
|
glomerulonephritis
|
J:168749
|
Rbpjtm1Kyo/Rbpj+
(involves: 129S2/SvPas * CD-1)
|
aortic valve inflammation
|
J:187551
|
Rc3h1Gt(CC0753)Wtsi/Rc3h1Gt(CC0753)Wtsi
(B6.129P2-Rc3h1Gt(CC0753)Wtsi)
|
chronic liver inflammation
|
J:199407
|
ileum inflammation
|
J:199407
|
intestinal inflammation
|
J:199407
|
Rc3h1san/Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))
|
glomerulonephritis
|
J:98938
|
liver inflammation
|
J:98938
|
Rc3h1san/Rc3h1san
(involves: C57BL/6JSfdAnu)
|
cecum inflammation
|
J:199407
|
chronic liver inflammation
|
J:199407
|
colitis
|
J:199407
|
ileum inflammation
|
J:199407
|
small intestinal inflammation
|
J:199407
|
Rc3h1san/Rc3h1san Rc3h2tm1.2Cgv/Rc3h2tm1.2Cgv
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
increased inflammatory response
|
J:196137
|
kidney inflammation
|
J:196137
|
Rcan1tm1Fmc/Rcan1tm1Fmc
(involves: 129S4/SvJae)
|
increased susceptibility to endotoxin shock
|
J:152536
|
Rdns/Rdns+
(C57BL/6J-Rdns/GrsrJ)
|
increased susceptibility to otitis media
|
J:223062
|
Reltm1Brv/Reltm1Brv
(involves: 129S1/Sv)
|
dermatitis
|
J:46911
|
Relatm1Asba/Relatm1Asba Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6J * SJL)
|
increased susceptibility to induced colitis
|
J:131977
|
Relatm1Bal/Relatm1Bal Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S4/SvJae * C57BL/6)
|
heart inflammation
|
J:60742
|
liver inflammation
|
J:60742
|
lung inflammation
|
J:60742
|
Relatm1Mpa/Relatm1Mpa Tg(Alb1-cre)7Gsc/0
(involves: FVB/N)
|
increased susceptibility to endotoxin shock
|
J:137861
|
Relatm1Rsch/Relatm1Rsch Ptf1atm1(cre)Hnak/?
(involves: C57BL/6)
|
lung inflammation
|
J:122194
|
pancreas inflammation
|
J:122194
|
Relatm2.1Gho/Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6)
|
increased inflammatory response
|
J:163663
|
interstitial pneumonia
|
J:163663
|
liver inflammation
|
J:163663
|
lung inflammation
|
J:163663
|
myositis
|
J:163663
|
Relatm2.1Gho/Relatm2.1Gho Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased incidence of corneal inflammation
|
J:163663
|
liver inflammation
|
J:163663
|
Relbshep/Relbshep
(A;C-Relbshep/GrsrJ)
|
liver inflammation
|
J:171971
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri)
|
glomerulonephritis
|
J:76450
|
increased inflammatory response
|
J:23081,
J:76450
|
liver inflammation
|
J:76450
|
lung inflammation
|
J:76450
|
skin inflammation
|
J:76450
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(involves: C57BL/6)
|
increased inflammatory response
|
J:120659
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
epididymis inflammation
|
J:22675
|
intestinal inflammation
|
J:22675
|
liver inflammation
|
J:22675
|
lung inflammation
|
J:22675
|
myositis
|
J:22675
|
ovary inflammation
|
J:22675
|
salivary gland inflammation
|
J:22675
|
stomach inflammation
|
J:22675
|
Relbtm1Brv/Relbtm1Brv
(either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
dermatitis
|
J:63950
|
lung inflammation
|
J:63950
|
Ren1tm1Tkh/Ren1tm1Tkh
(C57BL/6-Ren1tm1Tkh)
|
kidney inflammation
|
J:110082
|
Retntm1Laz/Retntm1Laz Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6)
|
white adipose tissue inflammation
|
J:171262
|
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex)
|
liver inflammation
|
J:235058
|
white adipose tissue inflammation
|
J:235058
|
Retnlbtm1Mer/Retnlbtm1Mer
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to induced colitis
|
J:141524
|
Rgs3tm1Ndul/Rgs3tm1Ndul
(B6.129-Rgs3tm1Ndul)
|
increased susceptibility to type I hypersensitivity reaction
|
J:210195
|
lung inflammation
|
J:210195
|
Rgs13tm1Drue/Rgs13tm1Drue
(B6.129S-Rgs13tm1Drue)
|
increased susceptibility to type I hypersensitivity reaction
|
J:130209
|
Rgsc1547/Rgsc1547+
(involves: C3H * C57BL/6JJcl)
|
increased susceptibility to otitis media
|
J:133634
|
Rhbdd1tm1.1Mfm/Rhbdd1tm1.1Mfm
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:346394
|
Rhbdd3tm1Caox/Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox)
|
liver inflammation
|
J:197348
|
Rhbdf2cub/Rhbdf2cub
(B6.Cg-Rhbdf2cub)
|
white adipose tissue inflammation
|
J:82006
|
Rigitm1Zgwg/Rigitm1Zgwg
(involves: 129S1/Sv)
|
colitis
|
J:139868
|
increased susceptibility to induced colitis
|
J:139868
|
Ripk1tm1Led/Ripk1tm1Led
(involves: 129S6/SvEvTac)
|
lymph node inflammation
|
J:46522
|
Rnase4em1Zpxu/Rnase4em1Zpxu
(Not Specified)
|
increased susceptibility to induced colitis
|
J:354138
|
Rnase4em2Zpxu/Rnase4em2Zpxu Tg(Vil1-cre)DNju/0
(involves: C57BL/6 * C57BL/6J)
|
increased susceptibility to induced colitis
|
J:354138
|
Rnf20Gt(RRJ249)Byg/Rnf20+
(involves: 129P2/OlaHsd)
|
increased susceptibility to induced colitis
|
J:268221
|
Rnf43em2Mage/Rnf43em2Mage
(Not Specified)
|
stomach inflammation
|
J:285428
|
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6)
|
CNS inflammation
|
J:160681
|
lung inflammation
|
J:160681
|
Rnf139tm1(KOMP)Wtsi/Rnf139tm1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
liver inflammation
|
J:231404
|
Rnf186em1Ktak/Rnf186em1Ktak
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:258197
|
increased susceptibility to induced colitis
|
J:258197
|
Rnf186tm1Ktak/Rnf186tm1Ktak
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:258197
|
increased susceptibility to induced colitis
|
J:258197
|
Ro60tm1Woln/Ro60tm1Woln
(involves: 129S1/Sv * C57BL/6)
|
glomerulonephritis
|
J:84627
|
Rock1tm1Sna/Rock1tm1Sna
(B6N.129X1-Rock1tm1Sna)
|
blepharitis
|
J:98250
|
Rorasg/Rorasg
(involves: C57BL/6)
|
lung inflammation
|
J:135863
|
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
|
colitis
|
J:158663
|
Rpap3tm1c(KOMP)Wtsi/Rpap3tm1c(KOMP)Wtsi Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6N * DBA/2)
|
small intestinal inflammation
|
J:314346
|
Rpl22Gt(GST000137)Lex/Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd)
|
glomerulonephritis
|
J:123569
|
Rpl38Ts/Rpl38+
(TSJ/Le)
|
increased susceptibility to otitis media
|
J:168509
|
Rprd1btm1Tshu/Rprd1btm1Tshu Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:300857
|
Rps6ka4tm1Jsca/Rps6ka4tm1Jsca Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(B6.Cg-Rps6ka5tm1Jsca Rps6ka4tm1Jsca)
|
increased susceptibility to endotoxin shock
|
J:139576
|
skin inflammation
|
J:139576
|
Rptortm1Ahir/Rptortm1Ahir Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Rptortm1Ahir Tg(Itgax-cre)1-1Reiz)
|
increased susceptibility to induced colitis
|
J:188676
|
Rsph9em1Jwji/Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji)
|
sinus inflammation
|
J:294184
|
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
|
glomerulonephritis
|
J:235399
|
Runx1tm8Spe/Runx1tm8Spe
(involves: 129/Sv * C57BL/6)
|
lung inflammation
|
J:120100
|
Runx3tm1Itan/Runx3tm1Itan Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
lung inflammation
|
J:125953
|
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
colitis
|
J:93240
|
intestinal inflammation
|
J:93240
|
lung inflammation
|
J:88424
|
small intestinal inflammation
|
J:93240
|
stomach inflammation
|
J:93240
|
Runx3tm3.1Yg/Runx3tm3.1Yg
(Not Specified)
|
intestinal inflammation
|
J:224898
|
Rxratm1Krc/Rxratm1Krc Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
glomerulonephritis
|
J:168799
|
Rxratm2Ipc/Rxratm4Ipc Tg(KRT14-cre)1Ipc/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
skin inflammation
|
J:67149
|
Rxratm4Ipc/Rxratm4Ipc Rxrbtm1Pcn/Rxrbtm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S2/SvPas)
|
dermatitis
|
J:102470
|
ear inflammation
|
J:102470
|
Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs Trp53tm1Sia/Trp53tm1Sia
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
myositis
|
J:117828
|
Sall4tm1Brd/Sall4+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
ear inflammation
|
J:117866
|
increased susceptibility to otitis media
|
J:117866
|
Satb1tm2Kos/Satb1tm2Kos Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
kidney inflammation
|
J:252606
|
pancreas inflammation
|
J:252606
|
salivary gland inflammation
|
J:252606
|
Sbsnem1Ham/Sbsnem1Ham
(C57BL/6N-Sbsnem1Ham)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:296400
|
Scara5tm1Ktry/Scara5tm1Ktry
(B6N.129X1-Scara5tm1Ktry)
|
adipose tissue inflammation
|
J:195536
|
interstitial pneumonia
|
J:195536
|
liver inflammation
|
J:195536
|
lung inflammation
|
J:195536
|
skin inflammation
|
J:195536
|
urinary bladder inflammation
|
J:195536
|
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6)
|
glomerulonephritis
|
J:208237
|
skin inflammation
|
J:208237
|
Scd2swty/Scd2swty
(C57BL/6JSfdAnu-Scd2swty/Anu)
|
blepharitis
|
J:104190
|
Scgnem1Ezb/Scgnem1Ezb
(C57BL/6-Scgnem1Ezb)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:285572
|
Scgnem2Ezb/Scgnem2Ezb
(C57BL/6-Scgnem2Ezb)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:285572
|
Scn3btm1a(KOMP)Wtsi/Scn3btm1a(KOMP)Wtsi
(C57BL/6N-Scn3btm1a(KOMP)Wtsi/Wtsi)
|
myositis
|
J:232539
|
Scn9atm1Dgen/Scn9atm1Dgen
(either: (involves: 129P2/OlaHsd * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))
|
dermatitis
|
J:223425
|
Scp2tm1Kier/Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr)
|
liver inflammation
|
J:124895
|
Sctrtm1Bkcc/Sctrtm1Bkcc
(B6.129S7-Sctrtm1Bkcc)
|
kidney inflammation
|
J:121376
|
Sdc1tm1Cma/Sdc1tm1Cma
(either: C.Cg-Sdc1tm1Cma or B6.Cg-Sdc1tm1Cma)
|
increased inflammatory response
|
J:80682
|
seb/seb
(Him:OF1)
|
dermatitis
|
J:64455
|
lymph node inflammation
|
J:20987
|
skin inflammation
|
J:8983
|
Sec23bGt(AD0407)Wtsi/Sec23bGt(AD0407)Wtsi
(B6J.129P2-Sec23bGt(AD0407)Wtsi)
|
pancreas inflammation
|
J:186391
|
Secia1DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia2DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia3FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia4DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia5DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia6DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia7FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia8FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Sectm1aem1Gcfa/Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa)
|
heart inflammation
|
J:317204
|
increased susceptibility to endotoxin shock
|
J:317204
|
Seletm1Alb/Seletm1Alb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
eye inflammation
|
J:101979
|
Seletm2Alb/Seletm2Alb Selltm2Alb/Selltm2Alb Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
lung inflammation
|
J:70682
|
Seletm2Alb/Seletm2Alb Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
eye inflammation
|
J:101979
|
Selltm1.1Rpmc/Selltm1.1Rpmc
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
increased inflammatory response
|
J:249558
|
Selltm1Flv/Sell+
(involves: C57BL/6 * NOD)
|
pancreas inflammation
|
J:88947
|
Selltm1Flv/Selltm1Flv
(involves: C57BL/6 * NOD)
|
pancreas inflammation
|
J:88947
|
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
eye inflammation
|
J:101979
|
Selptm1Bay/Selptm1Bay
(D1.129S7(B6J)-Selptm1Bay)
|
increased susceptibility to induced arthritis
|
J:57086
|
Senp1tm1Wami/Senp1tm1Wami Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
|
myocarditis
|
J:228009
|
pancreas inflammation
|
J:228009
|
Serpina1em#Chmu/Serpina1em#Chmu
(involves: C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:259615
|
respiratory system inflammation
|
J:259615
|
Serpina3cem1Smoc/Serpina3cem1Smoc
(C57BL/6-Serpina3cem1Smoc)
|
white adipose tissue inflammation
|
J:343846
|
Serpina6tm1Tew/Serpina6tm1Tew
(involves: 129/SvEmcTer * C57BL/6N)
|
increased susceptibility to endotoxin shock
|
J:112974
|
Serpinb1atm1.1Cben/Serpinb1atm1.1Cben
(129S6/SvEvTac-Serpinb1atm1.1Cben)
|
lung inflammation
|
J:125918
|
Serpinc1tm1Dwr/Serpinc1tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ)
|
liver inflammation
|
J:115658
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
glomerulonephritis
|
J:85989
|
increased acute inflammation
|
J:133227
|
respiratory system inflammation
|
J:66093
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S2-Serpine1tm1Mlg/J)
|
heart inflammation
|
J:101486
|
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd * NIH Black Swiss)
|
lung inflammation
|
J:110382
|
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd)
|
lung inflammation
|
J:107841
|
Sftpctm1Swg/Sftpctm1Swg
(either: 129 or (involves: 129 * Black Swiss))
|
conjunctivitis
|
J:82925
|
Sftpdtm1Jhf/Sftpdtm1Jhf
(involves: 129P2/OlaHsd * Black Swiss)
|
lung inflammation
|
J:62282,
J:50436
|
Sgcatm1Kcam/Sgcatm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
heart inflammation
|
J:177563
|
Sgcatm1Kcam/Sgcatm1Kcam Sgcetm1Vinni/Sgcetm1Vinni
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
heart inflammation
|
J:177563
|
Sgcbtm1Oza/Sgcbtm1Oza
(involves: 129S4/SvJae * C57BL/6J)
|
myositis
|
J:57590
|
sgl/sgl
(involves: C3H * C57BL/6J)
|
conjunctivitis
|
J:56826
|
Sgp5NZB/?
(involves: C57BL/6 * NZB * SB/Le)
|
glomerulonephritis
|
J:95829
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor)
|
kidney inflammation
|
J:117491
|
Sh3bp2tm1.1Ics/Sh3bp2tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
increased inflammatory response
|
J:221901
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
blepharitis
|
J:117880
|
dermatitis
|
J:117880
|
increased inflammatory response
|
J:117880
|
joint inflammation
|
J:117880
|
liver inflammation
|
J:117880
|
lung inflammation
|
J:117880
|
myositis
|
J:117880
|
osteomyelitis
|
J:117880
|
spinal cord inflammation
|
J:117880
|
stomach inflammation
|
J:117880
|
Sh3pxd2bnee/Sh3pxd2bnee
(B10.Cg-H2h4 Sh3pxd2bnee/GrsrJ)
|
eye inflammation
|
J:262132
|
hypopyon
|
J:262132
|
increased susceptibility to otitis media
|
J:153369
|
Sharpincpdm-Dem/Sharpincpdm-Dem
(CBy.OcB3-Sharpincpdm-Dem)
|
dermatitis
|
J:121810
|
skin inflammation
|
J:121810
|
Sharpincpdm/Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm)
|
dermatitis
|
J:14539
|
esophageal inflammation
|
J:31745
|
folliculitis
|
J:31745
|
joint inflammation
|
J:14539
|
lung inflammation
|
J:31745
|
lymph node inflammation
|
J:31745
|
stomach inflammation
|
J:31745
|
Sharpincpdm/Sharpincpdm
(involves: C57BL/KaLawRij * FVB/NJ)
|
skin inflammation
|
J:121810
|
SialsMRL/MpJ/SialsMRL/MpJ
(involves: C3H/HeJ * MRL/MpJ)
|
salivary gland inflammation
|
J:66636
|
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J)
|
liver inflammation
|
J:236042
|
Sigirrtm1Lix/Sigirrtm1Lix
(involves: 129S6/SvEvTac * BALB/c)
|
increased inflammatory response
|
J:85151
|
increased susceptibility to endotoxin shock
|
J:85151
|
Sigirrtm1Mant/Sigirrtm1Mant
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased susceptibility to induced colitis
|
J:88907
|
Siglecftm1.2Avrk/Siglecftm1.2Avrk
(B6.129(FVB)-Siglecftm1.2Avrk)
|
lung inflammation
|
J:204811
|
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd)
|
increased inflammatory response
|
J:229999
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129)
|
interstitial pneumonia
|
J:81010
|
lung inflammation
|
J:81010
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
glomerulonephritis
|
J:160869
|
interstitial pneumonia
|
J:81010
|
lung inflammation
|
J:81010
|
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac)
|
liver inflammation
|
J:178653
|
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
colitis
|
J:112817
|
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv)
|
liver inflammation
|
J:205529
|
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL)
|
heart inflammation
|
J:43650
|
Slc2a6em1Kusu/Slc2a6em1Kusu
(involves: C57BL/6JCrlj)
|
increased susceptibility to endotoxin shock
|
J:270487
|
Slc2a9tm1.2Thor/Slc2a9tm1.2Thor
(involves: C57BL/6 * C57BL/6N)
|
kidney inflammation
|
J:153089
|
tubulointerstitial nephritis
|
J:153089
|
Slc3a1pbl/Slc3a1pbl
(C3HeB/FeJ-Slc3a1pbl)
|
tubulointerstitial nephritis
|
J:85461
|
Slc3a1pbl/Slc3a1pbl
(involves: C3HeB/FeJ * MRL/MpJ)
|
kidney inflammation
|
J:85461
|
Slc5a2m2Btlr/Slc5a2m2Btlr
(C57BL/6J-Slc5a2m2Btlr)
|
increased susceptibility to induced colitis
|
J:265117
|
Slc5a6tm1.1Said/Slc5a6tm1.1Said Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2)
|
cecum inflammation
|
J:307482
|
small intestinal inflammation
|
J:307482
|
Slc7a9tm1Nune/Slc7a9tm1Nune
(involves: 129P2/OlaHsd * C57BL/6J)
|
tubulointerstitial nephritis
|
J:85462
|
Slc9a2tm1Ges/Slc9a2tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
stomach inflammation
|
J:65754
|
Slc9a4tm1Ges/Slc9a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss)
|
stomach inflammation
|
J:98566
|
Slc9a8m1Btlr/Slc9a8m1Btlr
(C57BL/6J-Slc9a8m1Btlr)
|
increased susceptibility to induced colitis
|
J:267481
|
Slc12a1urehr3/Slc12a1urehr3
(involves: C3HeB/FeJ)
|
pyelitis
|
J:159994
|
pyelonephritis
|
J:159994
|
Slc12a2em1Dlp/Slc12a2em1Dlp
(involves: C57BL/6J * DBA/2J)
|
large intestinal inflammation
|
J:285398
|
Slc19a3tm1Said/Slc19a3tm1Said
(involves: C57BL/6)
|
chronic liver inflammation
|
J:170952
|
kidney inflammation
|
J:170952
|
Slc22a4tm1Atsu/Slc22a4tm1Atsu
(involves: C57BL/6J)
|
intestinal inflammation
|
J:207006
|
Slc24a3em#Ebje/Slc24a3em#Ebje
(C57BL/6J-Slc24a3em#Ebje)
|
increased susceptibility to induced colitis
|
J:308448
|
Slc25a17Gt(XB686)Byg/Slc25a17Gt(XB686)Byg
(involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster)
|
liver inflammation
|
J:291257
|
Slc26a1tm1Mark/Slc26a1tm1Mark
(involves: 129X1/SvJ * CD-1)
|
kidney inflammation
|
J:158567
|
Slc26a4m2Btlr/Slc26a4m2Btlr
(C57BL/6J-Slc26a4m2Btlr)
|
increased susceptibility to induced colitis
|
J:236690
|
Slc30a4lm/Slc30a4lm
(C57BL/6J-Slc30a4lm)
|
dermatitis
|
J:5911,
J:7690
|
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:211266
|
conjunctivitis
|
J:211266
|
dermatitis
|
J:211266
|
increased inflammatory response
|
J:211266
|
preputial gland inflammation
|
J:211266
|
prostate gland inflammation
|
J:211266
|
salivary gland inflammation
|
J:211266
|
stomach inflammation
|
J:211266
|
urinary bladder inflammation
|
J:211266
|
Slc37a2tm1Dgen/Slc37a2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:311521
|
Slc39a5tm1.1Gka/Slc39a5tm1.1Gka
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased susceptibility to induced pancreatitis
|
J:209760
|
Slc39a5tm1Gka/Slc39a5tm1Gka Tg(Cela1-cre/ERT)1Lgdn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to induced pancreatitis
|
J:209760
|
Slc43a2Gt(258C1)Cmhd/Slc43a2Gt(258C1)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
liver inflammation
|
J:237439
|
Slc44a4tm1.2Said/Slc44a4tm1.2Said
(involves: BALB/cJ * C57BL/6J * C57BL/6N)
|
increased susceptibility to induced colitis
|
J:351314
|
Sle1NZW/Sle1NZW Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW)
|
glomerulonephritis
|
J:134128
|
Sle1cNZB/Sle1cNZM2410/J
(involves: C57BL/6J * NZB * NZM2410/J)
|
glomerulonephritis
|
J:145133
|
Sle2NZM2410/Aeg/Sle2NZM2410/Aeg
(involves: C57BL/6J * NZM2410/Aeg)
|
glomerulonephritis
|
J:25006
|
Sle3NZM2410/Aeg/?
(involves: C57BL/6J * NZM2410/Aeg)
|
glomerulonephritis
|
J:52863
|
Sle7BXSB/J/Sle7BXSB/J
(involves: BXSB/J * C57BL/10Ola)
|
glomerulonephritis
|
J:60445
|
Sle8BXSB/J/Sle8BXSB/J
(involves: BXSB/J * C57BL/10Ola)
|
glomerulonephritis
|
J:60445
|
Sle12C57BL/6J/Sle12C57BL/6J
(involves: C57BL/6J * NZM2410/Aeg)
|
glomerulonephritis
|
J:52863
|
Sle12C57BL/6J/Sle12NZM2410/Aeg
(involves: C57BL/6J * NZM2410/Aeg)
|
glomerulonephritis
|
J:52863
|
Sle12NZM2410/Aeg/Sle12NZM2410/Aeg
(involves: C57BL/6J * NZM2410/Aeg)
|
glomerulonephritis
|
J:52863
|
Slpitm1Nkw/Slpitm1Nkw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:82214
|
Smad2tm3Rob/Smad2tm3Rob Smad3tm1Xfw/Smad3tm1Xfw
(involves: 129/Sv * 129S/SvEv * C57BL/6 * ICR)
|
osteoarthritis
|
J:95374
|
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
colitis
|
J:53510
|
increased inflammatory response
|
J:53510
|
pancreas inflammation
|
J:53510
|
small intestinal inflammation
|
J:53510
|
stomach inflammation
|
J:53510
|
Smad3tm1Cxd/Smad3tm1Cxd
(B6.129S6-Smad3tm1Cxd)
|
tubulointerstitial nephritis
|
J:102084
|
Smad3tm1Cxd/Smad3tm1Cxd
(involves: 129S6/SvEvTac)
|
osteoarthritis
|
J:68792
|
Smad3tm1Par/Smad3tm1Par
(129-Smad3tm1Par/J)
|
increased inflammatory response
|
J:106572
|
Smad4tm1.1Gsu/Smad4tm1.1Gsu Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(MtTGFA)Lmb/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
chronic pancreas inflammation
|
J:229184
|
Smad9tm3Jfm/Smad9tm3Jfm
(involves: 129S4/SvJaeSor)
|
lung inflammation
|
J:150213
|
Smcr8em1Btlr/Smcr8em1Btlr
(C57BL/6J-Smcr8em1Btlr)
|
increased susceptibility to induced colitis
|
J:268243
|
Smcr8em2Btlr/Smcr8em2Btlr
(C57BL/6J-Smcr8em2Btlr)
|
increased susceptibility to induced colitis
|
J:268243
|
Smcr8m1Btlr/Smcr8+
(C57BL/6J-Smcr8m1Btlr)
|
increased susceptibility to induced colitis
|
J:268243
|
Smcr8m1Btlr/Smcr8m1Btlr
(C57BL/6J-Smcr8m1Btlr)
|
increased susceptibility to induced colitis
|
J:268243
|
Smcr8m2Btlr/Smcr8m2Btlr
(C57BL/6J-Smcr8m2Btlr)
|
increased susceptibility to induced colitis
|
J:268243
|
Smcr8m3Btlr/Smcr8m3Btlr
(C57BL/6J-Smcr8m3Btlr)
|
increased susceptibility to induced colitis
|
J:268243
|
Smpdl3btm1a(EUCOMM)Wtsi/Smpdl3btm1a(EUCOMM)Wtsi
(C57BL/6-Smpdl3btm1a(EUCOMM)Wtsi)
|
increased susceptibility to endotoxin shock
|
J:224870
|
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6)
|
intestinal inflammation
|
J:104648
|
Snai2tm1Look/Snai2tm1Look
(involves: 129X1/SvJ * C57BL/6)
|
blepharitis
|
J:80652
|
Snai2tm2Grid/Snai2tm2Grid
(involves: 129S1/Sv)
|
blepharitis
|
J:48521
|
conjunctivitis
|
J:48521
|
Snrktm1.1Hxu/Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr)
|
brown adipose tissue inflammation
|
J:257980
|
white adipose tissue inflammation
|
J:257980
|
Snx10em1Ael/Snx10em1Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
osteomyelitis
|
J:289051
|
Snx10em2Ael/Snx10em2Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
osteomyelitis
|
J:289051
|
Socs1tm1Ayos/Socs1tm1Ayos Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
blepharitis
|
J:167922
|
conjunctivitis
|
J:167922
|
dermatitis
|
J:167922
|
Socs1tm1Kish/Socs1tm1Kish
(B6.129P2-Socs1tm1Kish)
|
liver inflammation
|
J:69472
|
Socs1tm1Kish/Socs1tm1Kish Stat1tm1Rds/Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
liver inflammation
|
J:69472
|
Socs1tm1Kish/Socs1tm1Kish Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
liver inflammation
|
J:69472
|
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
heart inflammation
|
J:51281
|
increased inflammatory response
|
J:72528
|
liver inflammation
|
J:51281
|
pancreas inflammation
|
J:51281
|
Socs1tm2Wehi/Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi)
|
glomerulonephritis
|
J:72528
|
increased incidence of corneal inflammation
|
J:72528
|
increased inflammatory response
|
J:72528
|
intestinal inflammation
|
J:72528
|
liver inflammation
|
J:72528
|
myocarditis
|
J:72528
|
myositis
|
J:72528
|
pancreas inflammation
|
J:72528
|
salivary gland inflammation
|
J:72528
|
skin inflammation
|
J:72528
|
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J)
|
liver inflammation
|
J:186227
|
Socs3tm1Robb/Socs3tm1Robb
(involves: C57BL/6)
|
increased susceptibility to induced arthritis
|
J:145513
|
Socs3tm1Wsa/Socs3tm2Wsa Tg(Vav1-cre)1Awr/0
(involves: C57BL/6)
|
increased inflammatory response
|
J:89785
|
liver inflammation
|
J:89785
|
lung inflammation
|
J:89785
|
peritoneal inflammation
|
J:89785
|
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J)
|
liver inflammation
|
J:219360
|
Sod1tm1Leb/Sod1tm1Leb
(involves: 129S7/SvEvBrd * C57BL/6)
|
blepharitis
|
J:219024
|
Meibomian gland inflammation
|
J:219024
|
Sod3tm1Mrkl/Sod3tm1Mrkl
(D1.129P2-Sod3tm1Mrkl)
|
autoimmune arthritis
|
J:106273
|
increased susceptibility to induced arthritis
|
J:106273
|
Sox2tm3(TK)Hoch/Sox2+
(involves: 129S4/SvJae * C57BL/6)
|
stomach inflammation
|
J:177655
|
tongue inflammation
|
J:177655
|
Sox17tm1Ysk/Sox17+
(involves: 129S1/Sv * C57BL/6)
|
liver inflammation
|
J:194071
|
Sox17tm1Ysk/Sox17+
(B6.129S1-Sox17tm1Ysk)
|
gallbladder inflammation
|
J:241569
|
liver inflammation
|
J:194071
|
Sox17tm2Sjm/Sox17+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
liver inflammation
|
J:241569
|
Sparctm1Hwe/Sparctm1Hwe
(involves: 129S/SvEv * C57BL/6J)
|
eye inflammation
|
J:52120
|
vitreous body inflammation
|
J:52120
|
Spata2tm1(KOMP)Vlcg/Spata2tm1(KOMP)Vlcg
(C57BL/6-Spata2tm1(KOMP)Vlcg)
|
increased inflammatory response
|
J:244164
|
Spdeftm1Shiv/Spdeftm1Shiv
(involves: 129S4/SvJae)
|
small intestinal inflammation
|
J:166876
|
stomach inflammation
|
J:166876
|
Spef2bgh/Spef2bgh
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/10J)
|
sinus inflammation
|
J:176695
|
Spink7em1Cya/Spink7em1Cya
(C57BL/6N-Spink7em1Cya/Cya)
|
increased susceptibility to induced colitis
|
J:310883
|
Spint1tm2.1Hk/Spint1tm2.1Hk Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to induced colitis
|
J:179937
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased incidence of corneal inflammation
|
J:213427
|
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
alveolitis
|
J:12830
|
interstitial pneumonia
|
J:12830
|
Spta1sph/Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
glomerulonephritis
|
J:44313
|
tubular nephritis
|
J:44313
|
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1)
|
glomerulonephritis
|
J:44313
|
tubular nephritis
|
J:44313
|
Sptbn4qv/Sptbn4qv
(either: (involves: BALB/c) or (involves: C57BL/10))
|
eye inflammation
|
J:167
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6)
|
skin inflammation
|
J:202388
|
Srctm1Sor/Srctm1Sor
(either: 129S7/SvEvBrd-Srctm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased inflammatory response
|
J:67040
|
periodontium inflammation
|
J:67040
|
Srxn1tm1Mtol/Srxn1tm1Mtol
(either: B6.129S2-Srxn1tm1Mtol or (involves: 129S2/SvPasCrl * C57BL/6))
|
increased susceptibility to endotoxin shock
|
J:199277
|
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6)
|
arteritis
|
J:162035
|
Ssial1NOD/Ssial1NOD
(involves: C57BL/6J * NOD)
|
periinsulitis
|
J:11442
|
salivary gland inflammation
|
J:75908
|
Ssial2NOD/?
(involves: C57BL/6J * NOD)
|
salivary gland inflammation
|
J:75908
|
Ssial3NOD/Ssial3NOD
(involves: C57BL/6J * NOD)
|
salivary gland inflammation
|
J:75908
|
Ssial4C57BL/6/Ssial4NOD
(involves: C57BL/6J * NOD)
|
salivary gland inflammation
|
J:75908
|
Ssial4NOD/Ssial4NOD
(involves: C57BL/6J * NOD)
|
salivary gland inflammation
|
J:75908
|
Sstr4tm1Szo/Sstr4tm1Szo
(B6.129P2-Sstr4tm1Szo)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:152015
|
Ssu72tm1Cwl/Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn)
|
liver inflammation
|
J:309624
|
St6gal1tm1Jlau/St6gal1tm1Jlau
(B6.129S4-St6gal1tm1Jlau)
|
peritoneal inflammation
|
J:140547
|
St6gal1tm1Jxm/St6gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
peritoneal inflammation
|
J:140547
|
St6galnac1em1Len/St6galnac1em1Len
(Not Specified)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:324883
|
St13em1Gwzh/St13em1Gwzh Tg(PRSS1/lacZ)#Gwzh/0
(Not Specified)
|
increased susceptibility to induced pancreatitis
|
J:345508
|
St14tm2Bug/St14tm3Bug Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)
|
lacrimal gland inflammation
|
J:213072
|
submandibular gland inflammation
|
J:213072
|
St14tm2Bug/St14tm3Bug Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * SJL)
|
colitis
|
J:153070
|
Stard7tm1a(EUCOMM)Wtsi/Stard7+
(involves: C57BL/6N)
|
dermatitis
|
J:242746
|
increased susceptibility to type I hypersensitivity reaction
|
J:242746
|
lung inflammation
|
J:242746
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
bronchiolitis
|
J:286237
|
lung inflammation
|
J:286237
|
peritoneal inflammation
|
J:286237
|
pleuritis
|
J:286237
|
Stat1tm1Rds/Stat1tm1Rds Stat3tm2Aki/Stat3tm2Aki Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
colitis
|
J:83280
|
Stat3tm1Desi/Stat3tm1Desi
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:77307
|
Stat3tm1Dlv/Stat3tm1Dlv Tg(Csf1r-icre)1Jwp/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
colitis
|
J:156593
|
Stat3tm1Flv/Stat3tm1Flv Tg(Tek-cre)1Xyfu/0
(involves: C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:86655
|
Stat3tm1Flv/Stat3tm1Flv Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6)
|
cecum inflammation
|
J:81973
|
colitis
|
J:81973
|
ileum inflammation
|
J:81973
|
intestinal inflammation
|
J:81973
|
liver inflammation
|
J:81973
|
Stat3tm1Xyfu/Stat3+ Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N)
|
increased susceptibility to endotoxin shock
|
J:86400
|
Stat3tm1Xyfu/Stat3tm1.1Xyfu Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N)
|
increased susceptibility to endotoxin shock
|
J:86400
|
Stat3tm2Aki/Stat3tm2Aki Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
colitis
|
J:83280
|
Stat3tm2Aki/Stat3tm2Aki Tg(KRT5-cre)1Tak/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
conjunctivitis
|
J:194832
|
dermatitis
|
J:194832
|
lacrimal gland inflammation
|
J:194832
|
Stat3tm2Aki/Stat3tm2Aki Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:87622
|
Stat3tm2Aki/Stat3tm2Aki Tlr4tm1Aki/Tlr4tm1Aki Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
colitis
|
J:83280
|
Stat3tm2Aki/Stat3tm2Aki Tnftm1Sek/Tnftm1Sek Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
colitis
|
J:83280
|
Stat4tm1Gru/Stat4tm1Gru Tg(Ins2-NP)25-3Olds/0
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
insulitis
|
J:107047
|
Stat6tm1Aki/Stat6tm1Aki
(C.129P2-Stat6tm1Aki Nfkbiztm1Aki)
|
skin inflammation
|
J:141704
|
Stat6tm1Aki/Stat6tm1Aki Tg(KRT14-CASP1)1Miz/0
(involves: 129P2/OlaHsd * C57BL/6)
|
dermatitis
|
J:78602
|
Stat6tm1Gru/Stat6+ Tg(Scgb1a1-Il13)2Eli/?
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
respiratory system inflammation
|
J:132385
|
Stia1NOD/ShiLtDoi/?
(involves: C57BL/6J * NOD/LtDoi)
|
increased inflammatory response
|
J:70882
|
Stia2C57BL/6J/Stia2C57BL/6J
(involves: C57BL/6J * NOD/LtDoi)
|
increased inflammatory response
|
J:70882
|
Stia2C57BL/6J/Stia2NOD/ShiLtDoi
(involves: C57BL/6J * NOD/LtDoi)
|
increased inflammatory response
|
J:70882
|
Stim1tm1Rao/Stim1tm1Rao Stim2tm1Rao/Stim2tm1Rao Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
blepharitis
|
J:133262
|
dermatitis
|
J:133262
|
Stim1tm3Ics/Stim1+
(involves: C57BL/6N)
|
myositis
|
J:277842
|
Sting1em1Jmin/Sting1+
(involves: C57BL/6N)
|
lung inflammation
|
J:251372
|
Stip1tm1.2Mamp/Stip1tm1.2Mamp
(involves: C57BL/6)
|
increased acute inflammation
|
J:201097
|
Stk3tm1.1Jav/Stk3tm1.1Jav Stk4tm1Kina/Stk4tm1Kina Tg(Nkx2-1-cre)2Sand/?
(involves: 129 * C57BL/6)
|
lung inflammation
|
J:197340
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR)
|
pancreas inflammation
|
J:134078
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp Tg(Sprr2f-cre)1Dcas/0
(involves: 129S6/SvEvTac * FVB/N)
|
peritoneal inflammation
|
J:158190
|
Stk36tm1Fjs/Stk36tm1Fjs
(involves: 129S1/Sv * C57BL/6)
|
rhinitis
|
J:116391
|
Stk36tm1Lex/Stk36tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased susceptibility to otitis media
|
J:185566
|
Sugcttm1.2Kald/Sugcttm1.2Kald
(B6.Cg-Sugcttm1.2Kald)
|
kidney inflammation
|
J:293423
|
white adipose tissue inflammation
|
J:293423
|
Sumf1Gt(RST760)Byg/Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
CNS inflammation
|
J:120146
|
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
lung inflammation
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
lung inflammation
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
interstitial pneumonia
|
J:144991
|
Swrl2NZB/Swrl2SWR
(involves: NZB * SWR)
|
glomerulonephritis
|
J:73097
|
Swrl2SWR/Swrl2SWR
(involves: NZB * SWR)
|
glomerulonephritis
|
J:73097
|
Sycntm1Rja/Sycntm1Rja
(involves: 129P2/OlaHsd)
|
increased susceptibility to induced pancreatitis
|
J:74654
|
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
glomerulonephritis
|
J:188422
|
Syne1tm1.1Mcn/Syne1tm1.1Mcn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL)
|
conjunctivitis
|
J:144757
|
Syt7tm1Nan/Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6)
|
increased inflammatory response
|
J:85201
|
myositis
|
J:85201
|
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
epididymis inflammation
|
J:213427
|
meningitis
|
J:213427
|
Syvn1tm1Tn/Syvn1+
(D1.Cg-Syvn1tm1Tn)
|
decreased susceptibility to induced arthritis
|
J:86009
|
Tacr1tm1Sph/Tacr1tm1Sph
(involves: 129P2/OlaHsd * C57BL/6)
|
joint inflammation
|
J:103700
|
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6)
|
glomerulonephritis
|
J:151757
|
liver inflammation
|
J:151757
|
lung inflammation
|
J:151757
|
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
|
decreased susceptibility to induced arthritis
|
J:301164
|
Tax1bp1tm1Ktj/Tax1bp1tm1Ktj
(B6.129P2-Tax1bp1tm1Ktj)
|
cardiovalvulitis
|
J:131849
|
skin inflammation
|
J:131849
|
Tbc1d23Gt(BA0556)Wtsi/Tbc1d23Gt(BA0556)Wtsi
(B6.129P2-Tbc1d23Gt(BA0556)Wtsi)
|
increased inflammatory response
|
J:181861
|
Tbk1tm1.1Lex/Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
increased susceptibility to endotoxin shock
|
J:166476
|
skin inflammation
|
J:166476
|
Tbx1tm1Bem/Tbx1+
(FVB.Cg-Tbx1tm1Bem)
|
increased susceptibility to otitis media
|
J:91664
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6)
|
respiratory system inflammation
|
J:73832
|
Tbx21tm1Glm/Tbx21tm1Glm
(C.129S6-Tbx21tm1Glm/J)
|
CNS inflammation
|
J:111932
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac)
|
increased susceptibility to induced colitis
|
J:141481
|
Tbxa2rtm1Sna/Tbxa2rtm1Sna
(B6.Cg-Tbxa2rtm1Sna)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Tcf7l2m1Btlr/Tcf7l2m1Btlr
(C57BL/6J-Tcf7l2m1Btlr)
|
increased susceptibility to induced colitis
|
J:267536
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi)
|
decreased susceptibility to induced arthritis
|
J:99107
|
increased incidence of corneal inflammation
|
J:132503
|
liver inflammation
|
J:135830
|
lung inflammation
|
J:121037
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
liver inflammation
|
J:105977
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:89695
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd)
|
colitis
|
J:37699
|
Tcratm1Mom/Tcratm1Mom
(B6.129S2-Tcratm1Mom)
|
colitis
|
J:135597
|
Tcratm1Mom/Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6)
|
colitis
|
J:15221
|
Tcratm1Mom/Tcratm1Mom Tcrgtm1.1Hish/Tcrgtm1.1Hish
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
colitis
|
J:135597
|
Tcratm1Mom/Tcratm1Mom Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
colitis
|
J:181257
|
increased inflammatory response
|
J:181257
|
myositis
|
J:181257
|
skin inflammation
|
J:181257
|
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c)
|
colitis
|
J:15221
|
Tcrbtm1Mom/Tcrbtm1Mom Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
colitis
|
J:15221
|
Tcrbtm1Mom/Tcrbtm1Mom Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)
|
skin inflammation
|
J:100506
|
Tcrdtm1Mom/Tcrdtm1Mom
(FVB.129P2-Tcrdtm1Mom)
|
dermatitis
|
J:75915
|
increased susceptibility to type IV hypersensitivity reaction
|
J:75915
|
Tcrdtm1Mom/Tcrdtm1Mom
(NOD.129P2-Tcrdtm1Mom)
|
dermatitis
|
J:75915
|
Tcrdtm1Mom/Tcrdtm1Mom Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Tdrd7nmf166/Tdrd7nmf166
(involves: C3H * C57BL/6J)
|
uveitis
|
J:169836
|
Terf1tm1.1Blas/Terf1tm1.1Blas Tg(KRT5-cre)1Tak/0
(involves: 129 * C3H * C57BL/6 * SJL)
|
skin inflammation
|
J:152077
|
Tet2Gt(AN0709)Wtsi/Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
liver inflammation
|
J:174052
|
Tet2Gt(AN0709)Wtsi/Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
liver inflammation
|
J:174052
|
Tff3tm1Dkpy/Tff3tm1Dkpy
(involves: 129S4/SvJae)
|
increased susceptibility to induced colitis
|
J:35882
|
Tg(Ace2-ACE2)1Cqin/0
(involves: ICR)
|
alveolitis
|
J:141460
|
interstitial pneumonia
|
J:141460,
J:287631
|
pyelitis
|
J:141460
|
submandibular gland inflammation
|
J:141460
|
Tg(Acta2-cre/ERT2)#Pcn/0 Tgfbr2tm1Karl/Tgfbr2tm1Karl Tg(H2-K-Fosl2,-EGFP)13Wag/0
(B6.Cg-Tgfbr2tm1Karl Tg(Acta2-cre/ERT2)#Pcn Tg(H2-K-Fosl2,-EGFP)13Wag)
|
lung inflammation
|
J:238723
|
Tg(ACTB-eGFP,-RAMP1)#Afru/0 Tg(Nes-cre)1Kln/0
(involves: C57BL/6J * SJL/J)
|
increased inflammatory response
|
J:120077
|
Tg(ACTB-Fpr2)#Jimw/0
(involves: FVB)
|
respiratory system inflammation
|
J:160074
|
Tg(Actb-Tnfsf4)1Nish/0
(B6.D2-Tg(Actb-Tnfsf4)1Nish)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:80214
|
Tg(Adipoq-Apol6)#Hsul/0
(C57BL/6J-Tg(Adipoq-Apol6)#Hsul)
|
white adipose tissue inflammation
|
J:344362
|
Tg(Adipoq-cre)1Evdr/0 Tg(CAG-Jmjd8)#Kaso/0
(involves: C57BL/6 * FVB/NJ)
|
white adipose tissue inflammation
|
J:319518
|
Tg(AGER)#Eca/0
(C57BL/6J-Tg(AGER)#Eca)
|
lung inflammation
|
J:205092
|
Tg(AGT)2-5Afu/0
(involves: C57BL/6)
|
heart inflammation
|
J:194606
|
Tg(Alb1-GP33/H2-Kb)1Hpi/0 Tg(Alb1-HBV)66Bri/0
(involves: C57BL/6 * C57BL/10 * DBA/2)
|
liver inflammation
|
J:162605
|
Tg(Alb1-GP33/H2-Kb)1Hpi/0 Tg(Alb1-HBV)66Bri/0 Tg(TcrLCMV)318Sdz/0
(involves: C57BL/6 * C57BL/10 * DBA/2)
|
liver inflammation
|
J:162605
|
Tg(Alb1-Ren)1Unc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
kidney inflammation
|
J:89252
|
Tg(Alb1-Ren)2Unc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
kidney inflammation
|
J:89252
|
Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J)
|
liver inflammation
|
J:223921
|
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6)
|
chronic liver inflammation
|
J:211984
|
Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA)
|
chronic liver inflammation
|
J:242582
|
Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh)
|
myocarditis
|
J:92579
|
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL)
|
liver inflammation
|
J:249664
|
Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2)
|
chronic liver inflammation
|
J:135124
|
liver inflammation
|
J:16979
|
myocarditis
|
J:135124
|
pancreas inflammation
|
J:135124
|
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh)
|
dermatitis
|
J:65036
|
folliculitis
|
J:65036
|
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(involves: C57BL/6)
|
dermatitis
|
J:135501
|
skin inflammation
|
J:135501
|
Tg(APOE-DGAT1)1Far/0
(involves: C57BL/6NHsd)
|
liver inflammation
|
J:124005
|
Tg(APOE-DGAT2)1Far/0
(involves: C57BL/6NHsd)
|
liver inflammation
|
J:124005
|
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA)
|
enthesitis
|
J:192371
|
Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/0
(involves: C57BL/6 * SJL)
|
brain inflammation
|
J:112949
|
Tg(ARR2/Pbsn-FGF8)3Prb/0
(involves: C57BL/6 * DBA/2)
|
increased inflammatory response
|
J:78918
|
prostate gland inflammation
|
J:78918
|
Tg(BLG-STAT5A)15Itb/0
(involves: FVB/N)
|
increased inflammatory response
|
J:80588
|
Tg(CAG-ACE2)AC70Ctkt/0
(either: (involves: BALB/c * C3H/HeJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6 * C57BL/6J))
|
interstitial pneumonia
|
J:117824
|
Tg(CAG-C1qtnf6)#Yiw/0
(involves: C57BL/6JJcl)
|
decreased susceptibility to induced arthritis
|
J:227217
|
Tg(CAG-cat,-Il18)#Thos/0 Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6)
|
interstitial pneumonia
|
J:147547
|
Tg(CAG-DPP4)4Yuzh/0
(C57BL/6-Tg(CAG-DPP4)4Yuzh)
|
brain inflammation
|
J:286175
|
kidney inflammation
|
J:286175
|
liver inflammation
|
J:286175
|
lung inflammation
|
J:286175
|
Tg(CAG-DPP4)52Ctkt/0
(involves: C3H/HeJ * C57BL/6J)
|
brain inflammation
|
J:227925
|
increased inflammatory response
|
J:227925
|
interstitial pneumonia
|
J:258199
|
lung inflammation
|
J:227925
|
Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
(involves: C57BL/6 * DBA/2)
|
myositis
|
J:142253
|
Tg(CAG-Lyn*)#Paau/0
(B6.Cg-Tg(CAG-Lyn*)#Paau)
|
skin inflammation
|
J:151886
|
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB)
|
lung inflammation
|
J:80609
|
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB)
|
lung inflammation
|
J:80609
|
Tg(CAG-NRIP1)51Row/0
(involves: FVB/N)
|
lung inflammation
|
J:175885
|
Tg(CAG-Pgam2)#Hiko/0
(involves: C57BL/6)
|
increased susceptibility to chemically induced skin inflammation
|
J:306793
|
Tg(CAG-PLA2G3)#aMurm/0
(Not Specified)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Tg(CAG-Ptafr)1Tksh/0
(B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc)
|
increased susceptibility to endotoxin shock
|
J:38639
|
Tg(CAG-SYVN1)1Tn/?
(D1.Cg-Tg(CAG-SYVN1)1Tn)
|
rheumatoid arthritis
|
J:86009
|
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-APPSwInd)107Dbo/0
(involves: C3H/HeJ * C57BL/6 * CBA)
|
CNS inflammation
|
J:109829
|
Tg(CD2-Ifngr2)2Pbro/?
(NOD.Cg-Tg(CD2-Ifngr2)2Pbro)
|
insulitis
|
J:81981
|
myositis
|
J:81981
|
ovary inflammation
|
J:81981
|
Tg(CD2-Ppp2ca)#Gct/0
(involves: C57BL/6J)
|
glomerulonephritis
|
J:184067
|
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6)
|
lacrimal gland inflammation
|
J:230700
|
lung inflammation
|
J:230700
|
salivary gland inflammation
|
J:230700
|
Tg(CD2-Stat6*V625A*T626A)78Mhk/0
(involves: C3H * C57BL/6)
|
dermatitis
|
J:160119
|
Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J)
|
peritoneal inflammation
|
J:123440
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
glomerulonephritis
|
J:217939
|
kidney inflammation
|
J:217939
|
liver inflammation
|
J:217939
|
lung inflammation
|
J:217939
|
skin inflammation
|
J:217939
|
Tg(Cd4-CD4)2362Litt/0 Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2 * SJL)
|
CNS inflammation
|
J:134764
|
Tg(Cd4-cre)1Cwi/0 Trmt61aem1Hbgl/Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J)
|
colitis
|
J:336736
|
Tg(CD4-HIV)F21380Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(CD4-HIV)F21388Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(CD4-HIV)F21407Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(CD4-HIV)F26605Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(CD4-HIV)F26622Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(CD4-HIV)F26990Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(CD4-HIV)F27011Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(CD4-HIV)F27367Pjo/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:78756
|
tubular nephritis
|
J:78756
|
Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:158594
|
lung inflammation
|
J:158594
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)
|
colitis
|
J:97554
|
glomerulonephritis
|
J:97554
|
increased inflammatory response
|
J:97554
|
liver inflammation
|
J:97554
|
lung inflammation
|
J:97554
|
pancreas inflammation
|
J:97554
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6)
|
colitis
|
J:134156
|
Tg(Cd68-BCL2)526Medz/0
(involves: 129 * C57BL/6)
|
increased inflammatory response
|
J:82809
|
Tg(Cd68-BCL2)535Medz/0
(involves: 129 * C57BL/6)
|
increased inflammatory response
|
J:82809
|
Tg(Cd74-Nlrc4*)1Kyas/0
(involves: C57BL/6N)
|
autoimmune arthritis
|
J:219652
|
dermatitis
|
J:219652
|
increased inflammatory response
|
J:219652
|
joint inflammation
|
J:219652
|
skin inflammation
|
J:219652
|
Tg(CD207-Dta)312Dhka/?
(FVB-Tg(CD207-Dta)312Dhka)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:113309
|
Tg(Cga-LHB/CGB)94Jhn/?
(involves: C57BL/6 * SJL)
|
pyelonephritis
|
J:55157
|
tubulointerstitial nephritis
|
J:55157
|
Tg(Ckm-APPSw)A2Lfa/0
(involves: C57BL/6 * SJL)
|
myositis
|
J:76338
|
Tg(Ckm-APPSw)A6Lfa/0
(involves: C57BL/6 * SJL)
|
myositis
|
J:76338
|
Tg(CKMM-tTA)A3Rhvh/0 Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl)
|
myositis
|
J:205907
|
Tg(Cma1-cre)ARoer/0 Tg(Kit*D814V)1Roer/0
(involves: C57BL/6)
|
colitis
|
J:169611
|
Tg(CMV-cre)1Cgn/0 Tg(Kit*D814V)1Roer/0
(involves: BALB/cJ * C57BL/6)
|
large intestinal inflammation
|
J:169611
|
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL)
|
pancreas inflammation
|
J:94953
|
Tg(Col1a1-FGF2*,-Sapphire)203Mmh/Tg(Col1a1-FGF2*,-Sapphire)203Mmh
(involves: FVB/N)
|
osteoarthritis
|
J:240777
|
Tg(Col2a1-cre/ERT2)1Dic/0 Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
(involves: 129 * C57BL/6)
|
osteoarthritis
|
J:271724
|
Tg(Col2a1-Mir140)#Asah/0
(C57BL/6-Tg(Col2a1-Mir140)#Asah)
|
decreased susceptibility to induced arthritis
|
J:160358
|
Tg(Col2a1-rtTA,tetO-COMP*)2Jath/0
(C57BL/6-Tg(Col2a1-rtTA,tetO-COMP*)2Jath)
|
increased inflammatory response
|
J:233238
|
Tg(Comp-tTA)#Yeli/0 Tg(tetO-DDR2)#Yeli/0
(Not Specified)
|
osteoarthritis
|
J:176308
|
Tg(Csf1r-Tnfsf15,-EGFP)#Targ/0
(involves: C57BL/6)
|
small intestinal inflammation
|
J:169462
|
Tg(CYP1A1-PPARD)#Jfoe/0
(involves: C57BL/6J * CBA)
|
skin inflammation
|
J:158907
|
Tg(DPP4)2Nnag/0
(B6.Cg-Tg(DPP4)2Nnag)
|
lung inflammation
|
J:286321
|
Tg(DUX4*)1Maar/?
(involves: C57BL/6J * CBA/J)
|
increased incidence of corneal inflammation
|
J:195481
|
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)
|
esophageal inflammation
|
J:180282
|
increased inflammatory response
|
J:180282
|
Tg(EIF1AX-Il31ra)1Jagr/0
(involves: C3H * C57BL/6)
|
conjunctivitis
|
J:91124
|
dermatitis
|
J:91124
|
Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * SJL)
|
pancreas inflammation
|
J:107545
|
Tg(Ela2a-Prss1*,-GFP)1Dbs/0
(C57BL/6-Tg(Ela2a-Prss1*,-GFP)1Dbs)
|
chronic pancreas inflammation
|
J:144663
|
increased susceptibility to induced pancreatitis
|
J:144663
|
Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6 * FVB)
|
pancreas inflammation
|
J:231759
|
Tg(Ela-KRAS*G12D)9Eps/0 Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: C57BL/6 * FVB)
|
pancreas inflammation
|
J:231759
|
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr)
|
interstitial pneumonia
|
J:145185
|
kidney inflammation
|
J:117018
|
lacrimal gland inflammation
|
J:145185
|
parotid gland inflammation
|
J:145185
|
salivary gland inflammation
|
J:117018,
J:145185
|
submandibular gland inflammation
|
J:145185
|
Tg(F2RL1)1Mslb/0
(involves: FVB/NCrl)
|
increased inflammatory response
|
J:79757
|
respiratory system inflammation
|
J:79757
|
Tg(Fabp4-Angptl2)5Yo/0
(involves: C57BL/6)
|
white adipose tissue inflammation
|
J:152387
|
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul)
|
white adipose tissue inflammation
|
J:344362
|
Tg(FCGR2A)11Mkz/0 Tg(PF4)#Zcy/0
(involves: C57BL/6 * SJL)
|
increased acute inflammation
|
J:72220
|
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz
(involves: C57BL/6 * SJL)
|
autoimmune arthritis
|
J:136516
|
glomerulonephritis
|
J:136516
|
increased susceptibility to induced arthritis
|
J:136516
|
interstitial pneumonia
|
J:136516
|
Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6)
|
interstitial pneumonia
|
J:288386
|
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0
(involves: C57BL/6NCrl)
|
increased inflammatory response
|
J:125295
|
increased susceptibility to type IV hypersensitivity reaction
|
J:125295
|
insulitis
|
J:125295
|
lung inflammation
|
J:125295
|
skin inflammation
|
J:125295
|
Tg(Gfap-Ifna1)12Ilc/0
(involves: BALB/c * C57BL/6J)
|
CNS inflammation
|
J:68811
|
meningoencephalitis
|
J:68811
|
Tg(Gfap-Ifna1)39Ilc/0
(involves: BALB/c * C57BL/6J)
|
CNS inflammation
|
J:68811
|
meningoencephalitis
|
J:68811
|
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP)
|
brain inflammation
|
J:113202
|
small intestinal inflammation
|
J:104241
|
Tg(Gfap-TNF*)K21Gkl/0
(involves: C57BL/6 * CBA)
|
CNS inflammation
|
J:106592
|
Tg(GFAP-tTA)78Pop/0 Tg(tetO-Ifng)184Pop/0
(B6.Cg-Tg(GFAP-tTA)78Pop Tg(tetO-Ifng)184Pop)
|
CNS inflammation
|
J:109838
|
Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr)
|
dermatitis
|
J:67478
|
Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay)
|
insulitis
|
J:117352
|
Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)
|
autoimmune arthritis
|
J:209872
|
heart inflammation
|
J:209872
|
joint inflammation
|
J:209872
|
kidney inflammation
|
J:209872
|
Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
|
autoimmune arthritis
|
J:209872
|
joint inflammation
|
J:209872
|
Tg(H2-Ea-Ins2)1Wehi/0
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)
|
salivary gland inflammation
|
J:100232
|
Tg(H2-Ead)5Lt/0
(NOD/ShiLt-Tg(H2-Ead)5Lt)
|
periinsulitis
|
J:36435
|
Tg(H2-Ead)12Lt/0
(NOD/ShiLt-Tg(H2-Ead)12Lt)
|
insulitis
|
J:36435
|
Tg(H2-K1-HLA-A*)28Mpla/0
(B10.Cg-Tg(H2-K1-HLA-A*)28Mpla)
|
choroid inflammation
|
J:67871
|
eye inflammation
|
J:67871
|
Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA)
|
dermatitis
|
J:138077
|
skin inflammation
|
J:138077
|
Tg(H2-K-Fosl2,-EGFP)13Wag/0
(B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag)
|
lung inflammation
|
J:238723
|
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs)
|
brain inflammation
|
J:149511
|
CNS inflammation
|
J:149511
|
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
glomerulonephritis
|
J:128016,
J:138762
|
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(C57BL/6-Tg(H2-L-IL6)46Kish)
|
glomerulonephritis
|
J:40405
|
Tg(HBB-Myc)#Cos/0
(involves: C57BL/6J * CBA/J)
|
kidney inflammation
|
J:276641
|
Tg(HIV)26Aln/0
(involves: FVB/N)
|
kidney inflammation
|
J:90297
|
myositis
|
J:90297
|
uveitis
|
J:136652
|
Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2)
|
CNS inflammation
|
J:134764
|
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(involves: C57BL/6 * C57BL/10Sn * SJL/J)
|
increased susceptibility to induced arthritis
|
J:108635
|
Tg(HTT*)NXwy/0
(involves: FVB/NJ)
|
CNS inflammation
|
J:219890
|
Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)
|
insulitis
|
J:131077
|
Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
insulitis
|
J:91865
|
Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V281)3Jwt)
|
insulitis
|
J:91865
|
Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6)
|
peritoneal inflammation
|
J:76574
|
Tg(Igh-V-CD40lg)#Tsub/0
(C57BL/6-Tg(Igh-V-CD40lg)#Tsub)
|
glomerulonephritis
|
J:128824
|
Tg(Igh-V-CD40lg)#Tsub/0
(involves: C57BL/6)
|
colitis
|
J:89855
|
glomerulonephritis
|
J:89855
|
Tg(IghH280)48Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs/J)
|
insulitis
|
J:274578
|
Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IgkH280)934Dvs/J)
|
insulitis
|
J:274578
|
Tg(ILK3mHEL)3Ccg/0 Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)
|
insulitis
|
J:78309
|
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
insulitis
|
J:209714
|
periinsulitis
|
J:209714
|
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)
|
insulitis
|
J:127015
|
Tg(Ins2-CD80)3B7Flv/?
(involves: C57BL/6 * CBA/Ca * NOD/Caj)
|
insulitis
|
J:26618
|
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
insulitis
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0
(involves: C57BL/6 * CBA/Ca)
|
periinsulitis
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
insulitis
|
J:93555
|
Tg(Ins2-cre)5Lt/Tg(Ins2-cre)5Lt
(NOD/ShiLt-Tg(Ins2-cre)5Lt)
|
insulitis
|
J:127015
|
Tg(Ins2-GAD2)1Lt/0
(NOD/ShiLt-Tg(Ins2-GAD2)1Lt)
|
insulitis
|
J:100251
|
Tg(Ins2-GAD2)2Lt/0
(NOD/ShiLt-Tg(Ins2-GAD2)2Lt)
|
insulitis
|
J:100251
|
Tg(Ins2-GP)#Psoh/0
(involves: C57BL/6)
|
insulitis
|
J:81285
|
Tg(Ins2-HA)165Bri/0 Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2)
|
insulitis
|
J:99756
|
Tg(Ins2-HA)165Bri/? Tg(TcraCl4,TcrbCl4)1Shrm/?
(involves: BALB/c * C57BL/6 * C57BL/10)
|
insulitis
|
J:99756
|
Tg(Ins2-Lta)#Flv/0
(involves: NOD)
|
insulitis
|
J:91820
|
kidney inflammation
|
J:91820
|
periinsulitis
|
J:91820
|
Tg(Ins2-Lta)#Flv/0
(involves: C57BL/6)
|
insulitis
|
J:91820
|
kidney inflammation
|
J:91820
|
periinsulitis
|
J:91820
|
Tg(Ins2-Lta)#Flv/0
(involves: C57BL/6 * CBA)
|
insulitis
|
J:127705
|
periinsulitis
|
J:127705
|
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA * NOD)
|
insulitis
|
J:91820
|
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA)
|
insulitis
|
J:91820
|
Tg(INS-Il10)#Sar/0
(involves: BALB/c)
|
pancreas inflammation
|
J:107927
|
periinsulitis
|
J:107927
|
Tg(ITGA2)1067Fmw/0 Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1067Fmw/0 Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1067Fmw/0 Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1070Fmw/0 Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1070Fmw/0 Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1070Fmw/0 Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1075Fmw/0 Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1075Fmw/0 Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA2)1075Fmw/0 Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0794Fmw/0 Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0794Fmw/0 Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0794Fmw/0 Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0844Fmw/0 Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0844Fmw/0 Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0844Fmw/0 Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0858Fmw/0 Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0858Fmw/0 Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGA5)0858Fmw/0 Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(Itgam-FCAR)83Rcmo/0
(involves: C57BL/6 * NOD)
|
glomerulonephritis
|
J:120534
|
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA)
|
dermatitis
|
J:30249
|
eye inflammation
|
J:30249
|
Tg(IVL-KLK5)#Hov/0
(involves: C57BL/6 * CBA)
|
erythroderma
|
J:210758
|
lymph node inflammation
|
J:210758
|
skin inflammation
|
J:210758
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
blood vessel inflammation
|
J:300960
|
brain inflammation
|
J:294084
|
bronchiolitis
|
J:302313
|
conjunctivitis
|
J:294084
|
cytokine storm
|
J:300960
|
interstitial pneumonia
|
J:300960,
J:302313
|
liver inflammation
|
J:300960
|
lung inflammation
|
J:294084,
J:302313
|
meningitis
|
J:294084,
J:302313
|
meningoencephalitis
|
J:300960,
J:296067
|
rhinitis
|
J:300960
|
Tg(Kit*D814V)1Roer/0 Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
colitis
|
J:169611
|
large intestinal inflammation
|
J:169611
|
small intestinal inflammation
|
J:169611
|
Tg(Kit*D814V)2Roer/0 Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
colitis
|
J:169611
|
large intestinal inflammation
|
J:169611
|
small intestinal inflammation
|
J:169611
|
Tg(Kit*D814V)3Roer/0 Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
colitis
|
J:169611
|
large intestinal inflammation
|
J:169611
|
Tg(KRT5-IKBKB)2Armz/0
(involves: C57BL/6 * DBA/2)
|
dermatitis
|
J:160072
|
Tg(KRT5-Nfkbia*)3Rto/0 Tg(Krt5-Tnfr1)#Rsab/0 Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
skin inflammation
|
J:208995
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO-Tfrc/EGFP/Ova)#Sfz/0 Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N)
|
respiratory system inflammation
|
J:199558
|
skin inflammation
|
J:199558
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N)
|
dermatitis
|
J:70670
|
skin inflammation
|
J:70670
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N)
|
conjunctivitis
|
J:100506
|
dermatitis
|
J:100506
|
Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR)
|
skin inflammation
|
J:90118
|
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Il13)1Tazh/0
(B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh)
|
dermatitis
|
J:150232
|
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-LMNA*G608G,-EGFP)VF1-07Maer/0
(involves: FVB/N)
|
periodontium inflammation
|
J:145312
|
skin inflammation
|
J:145312
|
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Tek)1Dmt/0
(involves: CD-1 * FVB/N)
|
skin inflammation
|
J:147438
|
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N)
|
dermatitis
|
J:70670
|
skin inflammation
|
J:70670
|
Tg(Krt14-Angptl2)1Yo/0
(C.Cg-Tg(Krt14-Angptl2)1Yo)
|
skin inflammation
|
J:152387,
J:181261
|
Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6)
|
dermatitis
|
J:78602,
J:79706
|
Tg(KRT14-cre)1Amc/0 Trpv3tm1.1Clph/Trpv3tm1.1Clph
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster)
|
erythroderma
|
J:164741
|
Tg(Krt14-Ifnk)#Cya/0
(C57BL/6N-Tg(Krt14-Ifnk)#Cya)
|
increased susceptibility to chemically induced skin inflammation
|
J:322130
|
Tg(KRT14-Il1f6)1Hblu/?
(involves: C57BL/6 * DBA/2)
|
skin inflammation
|
J:126327
|
Tg(KRT14-Il4)#Lsch/0
(involves: BALB/cBy * C57BL/6)
|
blepharitis
|
J:126285
|
conjunctivitis
|
J:126285
|
dermatitis
|
J:126285
|
skin inflammation
|
J:126285
|
Tg(KRT14-Il7)1Tsk/0
(FVB/N-Tg(KRT14-Il7)1Tsk)
|
blepharitis
|
J:42565
|
skin inflammation
|
J:42565
|
Tg(KRT14-Il7)1Tsk/Tg(KRT14-Il7)1Tsk
(FVB/N-Tg(KRT14-Il7)1Tsk)
|
skin inflammation
|
J:42565
|
Tg(KRT14-Il18)#Knak/0
(C57BL/6-Tg(KRT14-Il18)#Knak)
|
dermatitis
|
J:78602
|
Tg(Krt14-Rac1*G12V)#Mrnk/0
(involves: CBA/CaJ)
|
joint inflammation
|
J:237134
|
skin inflammation
|
J:237134
|
Tg(KRT14-VP16/NR1I2)13Sdub/?
(involves: C57BL/6)
|
dermatitis
|
J:258435
|
skin inflammation
|
J:258435
|
Tg(KRT18*R89C)22Rgo/0
(involves: FVB/N)
|
chronic liver inflammation
|
J:241700
|
Tg(KRT18*R89C)30Rgo/0
(involves: FVB/N)
|
chronic liver inflammation
|
J:241700
|
Tg(KRT18*R89C)50Rgo/0
(involves: FVB/N)
|
chronic liver inflammation
|
J:241700
|
Tg(KRT18-DPP4)3Pbmj/0
(involves: C57BL/6J * SJL/J)
|
brain inflammation
|
J:285467
|
interstitial pneumonia
|
J:286231
|
lung inflammation
|
J:286231,
J:285467
|
Tg(Lck-cre)548Jxm/? Tgfb1tm2.1Doe/Tgfb1tm2.1Doe
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)
|
increased inflammatory response
|
J:150024
|
lung inflammation
|
J:150024
|
salivary gland inflammation
|
J:150024
|
Tg(Lck-Il31)1Jagr/0
(involves: C3H * C57BL/6)
|
conjunctivitis
|
J:91124
|
dermatitis
|
J:91124
|
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:80214
|
lung inflammation
|
J:194882
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
colitis
|
J:129951
|
glomerulonephritis
|
J:129951
|
intestinal inflammation
|
J:128976
|
liver inflammation
|
J:129951
|
lung inflammation
|
J:129951
|
myositis
|
J:129951
|
small intestinal inflammation
|
J:120962
|
Tg(Lck-Tnfsf15,-EGFP)#Targ/0
(involves: C57BL/6)
|
small intestinal inflammation
|
J:169462
|
Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea)
|
glomerulonephritis
|
J:72982
|
liver inflammation
|
J:72982
|
lung inflammation
|
J:72982
|
Tg(Lck-VIPR2)1Ejg/0
(C57BL/6-Tg(Lck-VIPR2)1Ejg)
|
increased susceptibility to type I hypersensitivity reaction
|
J:127974
|
Tg(Ly6a-GCSAM)102AIsg/0
(involves: C57BL/6J * CBA)
|
increased inflammatory response
|
J:221238
|
Tg(Mbp-SNCA)1Ema/0
(involves: C57BL/6 * DBA/2)
|
brain inflammation
|
J:207162
|
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
thyroid gland inflammation
|
J:78309
|
Tg(MMTV-ENPP2)#Gbm/0
(FVB/N-Tg(MMTV-ENPP2)#Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR1)2Gbm/Tg(MMTV-LPAR1)2Gbm
(FVB/N-Tg(MMTV-LPAR1)2Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR1)7Gbm/Tg(MMTV-LPAR1)7Gbm
(FVB/N-Tg(MMTV-LPAR1)7Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR1)#Gbm/Tg(MMTV-LPAR1)#Gbm
(FVB/N-Tg(MMTV-LPAR1)#Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR2)3Gbm/Tg(MMTV-LPAR2)3Gbm
(FVB/N-Tg(MMTV-LPAR2)3Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR2)6Gbm/Tg(MMTV-LPAR2)6Gbm
(FVB/N-Tg(MMTV-LPAR2)6Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR2)#Gbm/Tg(MMTV-LPAR2)#Gbm
(FVB/N-Tg(MMTV-LPAR2)#Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR3)3Gbm/Tg(MMTV-LPAR3)3Gbm
(FVB/N-Tg(MMTV-LPAR3)3Gbm)
|
mastitis
|
J:149661
|
Tg(MMTV-LPAR3)#Gbm/Tg(MMTV-LPAR3)#Gbm
(FVB/N-Tg(MMTV-LPAR3)#Gbm)
|
mastitis
|
J:149661
|
Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J)
|
increased inflammatory response
|
J:182703
|
Tg(MSR1-Plau)1Ddi/0
(involves: C57BL/6 * SJL)
|
heart inflammation
|
J:101486
|
Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: FVB/N)
|
pancreas inflammation
|
J:76993
|
Tg(MT2A-TGFBR2)4Rser/0
(involves: C57BL/6 * DBA)
|
osteoarthritis
|
J:44579
|
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps)
|
liver inflammation
|
J:233146
|
Tg(Myh6*/tetO-Capn1)L3Gwd/0
(involves: FVB/N)
|
heart inflammation
|
J:133797
|
Tg(Myh6-BAG3*P209L)#Mswi/0
(involves: C57BL/6 * DBA/2)
|
heart inflammation
|
J:234278
|
Tg(Myh6-JUP*)1Dpju/0
(FVB/N-Tg(Myh6-JUP*)1Dpju)
|
heart inflammation
|
J:235770
|
Tg(Myh6-Tnf)1Brgi/?
(involves: C57BL/6J * SJL)
|
myocarditis
|
J:84829,
J:100006
|
Tg(Myh6-Tnf)2Brgi/?
(involves: C57BL/6J * SJL)
|
myocarditis
|
J:84829,
J:100006
|
Tg(Myh6-Tnnt2*R92Q)2Lnwd/0
(involves: C57BL/6)
|
heart inflammation
|
J:56911
|
Tg(Myh6-Tnnt2*R92Q)3Lnwd/0
(involves: C57BL/6)
|
heart inflammation
|
J:56911
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6 * CBA)
|
heart inflammation
|
J:131245
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6 * CBA)
|
myocarditis
|
J:81967
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-NOS2,-lacZ)240iMhus/0
(involves: C57BL/6 * CBA)
|
heart inflammation
|
J:132082
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-Spp1)5Gad/0
(involves: C57BL/6 * CBA)
|
heart inflammation
|
J:194810
|
myocarditis
|
J:194810
|
Tg(Pcp2-TBP*)69Hmhl/0
(involves: FVB/N)
|
brain inflammation
|
J:174239
|
Tg(Pim1-Il9)5Jcrd/0
(involves: BALB/c * FVB/N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:100568
|
Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:100568
|
Tg(PLP1*)4Rsj/0
(involves: CD-1)
|
CNS inflammation
|
J:161344
|
Tg(Prnp-ATXN7*92Q)6529Als/Y
(involves: C3H/HeJ * C57BL/6J)
|
colitis
|
J:135615
|
Tg(Prnp-Immt/SOD1*G93A)7Gmnf/Tg(Prnp-Immt/SOD1*G93A)7Gmnf
(involves: C57BL/6 * CBA * SJL)
|
dermatitis
|
J:177846
|
Tg(Prnp-ITM2B*)1Ruvi/Tg(Prnp-ITM2B*)1Ruvi Tg(Prnp-MAPT*P301L)#Ruvi/Tg(Prnp-MAPT*P301L)#Ruvi
(involves: C3HeB/FeJ * C57BL/6)
|
increased inflammatory response
|
J:197198
|
Tg(Prnp-MAPT*P301L)JNPL3Hlmc/?
(involves: C57BL/6 * DBA/2)
|
eye inflammation
|
J:63887
|
Tg(PRSS1/lacZ)#Gwzh/0
(Not Specified)
|
increased susceptibility to induced pancreatitis
|
J:345508
|
Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6)
|
lacrimal gland inflammation
|
J:141378
|
salivary gland inflammation
|
J:141378
|
Tg(RIP1-Tag)5Dh/?
(C3HeB/FeJ-Tg(RIP1-Tag)5Dh)
|
pancreas inflammation
|
J:80168
|
Tg(Scgb1a1-IL6)9Flv/0
(involves: C57BL/6 * CBA)
|
lung inflammation
|
J:128762,
J:156430
|
Tg(Scgb1a1-Il13)2Eli/?
(involves: C57BL/6 * CBA)
|
respiratory system inflammation
|
J:53612
|
Tg(Scgb1a1-Il17a)3Cdon/0
(C57BL/6-Tg(Scgb1a1-Il17a)3Cdon)
|
lung inflammation
|
J:112600
|
Tg(Scgb1a1-Il17f,GFP)1Cdon/?
(C57BL/6-Tg(Scgb1a1-Il17f,GFP)1Cdon)
|
lung inflammation
|
J:136279
|
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-EGFR*T790M*L858R)19Kkw/0
(involves: 129 * C57BL/6 * FVB/N)
|
interstitial pneumonia
|
J:122849
|
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-IL1B)KBry/0
(involves: 129 * C57BL/6)
|
lung inflammation
|
J:107601,
J:130523
|
Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1*)1Eli/0
(involves: C57BL/6)
|
lung inflammation
|
J:92469
|
Tg(Scgb1a1-Scnn1b)6608Bouc/0
(involves: C3H * C57BL/6)
|
bronchitis
|
J:91139
|
Tg(Scgb1a1-Scnn1b)6608Bouc/0
(B6.Cg-Tg(Scgb1a1-Scnn1b)6608Bouc)
|
respiratory system inflammation
|
J:191673
|
Tg(Scgb1a1-Scnn1b)6608Bouc/0
(C.Cg-Tg(Scgb1a1-Scnn1b)6608Bouc)
|
respiratory system inflammation
|
J:191673
|
Tg(SERPINA1*E342K)#Slcw/0
(involves: C57BL/6 * ICR)
|
liver inflammation
|
J:149132
|
Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * ICR)
|
liver inflammation
|
J:90305
|
Tg(SFTPC-Il18)AThos/0
(B6N.Cg-Tg(SFTPC-Il18)AThos)
|
lung inflammation
|
J:147547
|
Tg(SFTPC-rtTA)2Jaw/0 Tg(tetO-CTGF)#Swu/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
lung inflammation
|
J:171151
|
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: C57BL/6 * SJL)
|
lung inflammation
|
J:97297
|
Tg(SFTPC-Tnf)2Pva/0
(involves: C57BL/6 * DBA/2)
|
alveolitis
|
J:28120
|
interstitial pneumonia
|
J:28120
|
Tg(Sirt1)ASrn/?
(involves: C57BL/6 * CBA)
|
increased susceptibility to endotoxin shock
|
J:137868
|
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
CNS inflammation
|
J:110437
|
Tg(Stat3*)9199Alau/0
(involves: C57BL/6)
|
increased inflammatory response
|
J:210877
|
increased susceptibility to endotoxin shock
|
J:210877
|
intestinal inflammation
|
J:210877
|
Tg(SV40-KLK7)1010Teg/0
(involves: C57BL/6J * CBA)
|
dermatitis
|
J:75714
|
Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57L * DBA/2 * SJL)
|
seborrheic dermatitis
|
J:95380
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6)
|
blepharitis
|
J:83278
|
CNS inflammation
|
J:83278
|
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
insulitis
|
J:52940
|
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: C57BL/6 * NOD * SJL)
|
insulitis
|
J:137009
|
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
chronic joint inflammation
|
J:36815
|
glomerulonephritis
|
J:36815
|
kidney inflammation
|
J:36815
|
rheumatoid arthritis
|
J:36815
|
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp)
|
liver inflammation
|
J:72817
|
Tg(TcraTcrbNY4.1)1Pesa/0
(NOD.Cg-Tg(TcraTcrbNY4.1)1Pesa)
|
insulitis
|
J:108768
|
Tg(TcraTcrbNY8.3)1Pesa/?
(involves: C57BL/6 * NOD * SJL)
|
pancreas inflammation
|
J:44202
|
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J)
|
increased susceptibility to induced arthritis
|
J:134111
|
Tg(TcrbBL17)1Lmor/Tg(TcrbBL17)1Lmor
(involves: DBA/1J * SWR/J)
|
increased susceptibility to induced arthritis
|
J:134111
|
Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
thyroid gland inflammation
|
J:78309
|
Tg(Tek-Jam3)1Maal/?
(B6.Cg-Tg(Tek-Jam3)1Maal)
|
lung inflammation
|
J:99020
|
peritoneal inflammation
|
J:99020
|
Tg(Tek-Tnf*)5382Mcla/0
(B6.Cg-Tg(Tek-Tnf*)5382Mcla)
|
chronic liver inflammation
|
J:71622
|
kidney inflammation
|
J:71622
|
lung inflammation
|
J:71622
|
Tg(Tek-tTA)1Dmt/0 Tg(tetO-Tek)1Dmt/0
(involves: CD-1)
|
skin inflammation
|
J:96718,
J:137745
|
Tg(TetOp-Polb/tTA)2Sbl/0
(B6.Cg-Tg(TetOp-Polb/tTA)2Sbl)
|
glomerulonephritis
|
J:152481
|
Tg(Tgfa)1Efu/0
(Not Specified)
|
ear inflammation
|
J:65045
|
Tg(THY1-APP)2Somm/0
(involves: C57BL/6J * DBA/2)
|
brain inflammation
|
J:44603
|
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2)
|
brain inflammation
|
J:44603
|
Tg(Thy1-MAPT*P301S)2541Godt/Tg(Thy1-MAPT*P301S)2541Godt
(involves: C57BL/6J * CBA/Ca)
|
eye inflammation
|
J:108870
|
Tg(Tk1-DPP4)27Ysj/0
(involves: C57BL/6 * FVB/N)
|
lung inflammation
|
J:290259
|
Tg(Tlr7)1Boll/0
(involves: C57BL/6)
|
glomerulonephritis
|
J:127600
|
liver inflammation
|
J:127600
|
X/Tg(Tlr7)6Boll
(involves: C57BL/6)
|
glomerulonephritis
|
J:127600
|
liver inflammation
|
J:127600
|
lung inflammation
|
J:127600
|
Tg(TNF)197Gkl/0
(involves: C57BL/6 * CBA)
|
autoimmune arthritis
|
J:97992,
J:92576
|
Tg(TNF)197Gkl/0 Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129 * C57BL/6 * CBA)
|
autoimmune arthritis
|
J:92470
|
Tg(TNF)3647Gkl/0
(involves: C57BL/6 * CBA)
|
autoimmune arthritis
|
J:190204
|
Tg(Tnf)6074Gkl/0
(involves: C57BL/6 * CBA)
|
brain inflammation
|
J:106592
|
Tg(Tnf)6074Gkl/0 Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
CNS inflammation
|
J:106592
|
Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
kidney inflammation
|
J:73711
|
salivary gland inflammation
|
J:73711
|
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
glomerulonephritis
|
J:113556
|
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma
(involves: C57BL/6 * DBA/2)
|
kidney inflammation
|
J:178227
|
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: BALB/c * C57BL/6J * DBA/2)
|
skin inflammation
|
J:98545
|
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: C57BL/6J * DBA/2)
|
skin inflammation
|
J:98545
|
Tg(Umod*C147W)958Lura/0
(involves: FVB)
|
kidney inflammation
|
J:161532
|
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J)
|
glomerulonephritis
|
J:88565
|
Tg(Vil1-cre)997Gum/? Tlr4lps-del/Tlr4lps-del Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * C57BL/10ScN * SJL)
|
large intestinal inflammation
|
J:229155
|
Tg(Vil1-cre)997Gum/? Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * SJL/J)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:229155
|
large intestinal inflammation
|
J:229155
|
Tg(Vil-SLC3A2)HEMerl/0
(involves: FVB/N)
|
colitis
|
J:173946
|
increased susceptibility to induced colitis
|
J:173946
|
Tg(VIM-Tag)3Pau/0
(either: (involves: C57BL/6 * CBA * SJL/J) or (involves: C57BL/6 * SJL/J))
|
glomerulonephritis
|
J:92226
|
Tgm3Btlr/Tgm3Btlr
(C57BL/6J-Tgm3Btlr)
|
increased susceptibility to induced colitis
|
J:265197
|
Tgfatm1Ard/Tgfatm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of corneal inflammation
|
J:4606
|
Tgfawa1/Tgfawa1
(Not Specified)
|
conjunctivitis
|
J:13115
|
keratoconjunctivitis
|
J:13115
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1)
|
brain inflammation
|
J:2892
|
conjunctivitis
|
J:2892
|
diaphragmitis
|
J:2892
|
eye inflammation
|
J:2892
|
heart inflammation
|
J:2892
|
lacrimal gland inflammation
|
J:2892
|
liver inflammation
|
J:2892
|
lung inflammation
|
J:2892
|
myositis
|
J:2892
|
pancreas inflammation
|
J:2892
|
salivary gland inflammation
|
J:2892
|
skin inflammation
|
J:2892
|
stomach inflammation
|
J:2892
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * BALB/c * CF-1)
|
heart inflammation
|
J:69346
|
liver inflammation
|
J:69346
|
lung inflammation
|
J:69346
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129S2-Tgfb1tm1Doe)
|
heart inflammation
|
J:69346
|
liver inflammation
|
J:69346
|
Tgfb1tm1Doe/Tgfb1tm2.1Doe Tg(Lck-cre)548Jxm/?
(involves: 129S2/SvPas * 129S6/SvEvTac * Black Swiss * BALB/c * C57BL/6 * CBA)
|
lung inflammation
|
J:150024
|
salivary gland inflammation
|
J:150024
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
(involves: 129S6/SvEvTac * C57BL/6)
|
heart inflammation
|
J:120085
|
liver inflammation
|
J:120085
|
lung inflammation
|
J:120085
|
pancreas inflammation
|
J:120085
|
stomach inflammation
|
J:120085
|
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv)
|
atrial endocarditis
|
J:50848
|
increased inflammatory response
|
J:50848
|
interstitial pneumonia
|
J:50848
|
lymph node inflammation
|
J:50848
|
myocarditis
|
J:50848
|
pancreas inflammation
|
J:50848
|
pericarditis
|
J:50848
|
phlebitis
|
J:50848
|
salivary gland inflammation
|
J:50848
|
Tgfb1tm1Rif/Tgfb1tm1Rif
(either: (involves: 129) or (involves: 129S/SvEv * C57BL/6))
|
cecum inflammation
|
J:142353
|
heart inflammation
|
J:142353
|
increased inflammatory response
|
J:142353
|
large intestinal inflammation
|
J:142353
|
lung inflammation
|
J:142353
|
proctitis
|
J:142353
|
small intestinal inflammation
|
J:142353
|
stomach inflammation
|
J:142353
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
liver inflammation
|
J:148747
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD)
|
increased inflammatory response
|
J:196160
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)
|
pancreas inflammation
|
J:196160
|
Tgfbr2tm1Karl/Tgfbr2tm1Karl Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
eye inflammation
|
J:77844
|
increased inflammatory response
|
J:77844
|
liver inflammation
|
J:77844
|
pancreas inflammation
|
J:77844
|
stomach inflammation
|
J:77844
|
Tgif1tm1.1Caw/Tgif1tm1.1Caw
(B6.129S-Tgif1tm1.1Caw)
|
increased susceptibility to otitis media
|
J:198238
|
Thbdtm1Wlr/Thbdtm1Wlr
(B6.129S2-Thbdtm1Wlr)
|
increased susceptibility to endotoxin shock
|
J:111502
|
Thbdtm2.1Emc/Thbdtm2.1Emc
(involves: 129/Sv * BALB/c * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:118000
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
lung inflammation
|
J:46182,
J:48446
|
pancreas inflammation
|
J:48446
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
lacrimal gland inflammation
|
J:153126
|
Thbs1tm1Hyn/Thbs1tm1Hyn Thbs2tm1Bst/Thbs2tm1Bst
(involves: 129T2/SvEms * 129X1/SvJ)
|
lung inflammation
|
J:78876
|
thnh/thnh
(NOD.Cg-H2b thnh/J)
|
folliculitis
|
J:142872
|
Tia1tm1Andp/Tia1tm1Andp
(C.129S2-Tia1tm1Andp)
|
increased susceptibility to endotoxin shock
|
J:88770
|
Tia1tm1Andp/Tia1tm1Andp
(B6.Cg-Tia1tm1Andp)
|
autoimmune arthritis
|
J:88443
|
Tia1tm1Andp/Tia1tm1Andp Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Tia1tm1Andp Zfp36tm1Pjb)
|
autoimmune arthritis
|
J:88443
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
myocarditis
|
J:169158
|
TigarGt(EUCE0047g05)Hmgu/TigarGt(EUCE0047g05)Hmgu
(involves: 129P2/OlaHsd)
|
increased susceptibility to induced colitis
|
J:198650
|
Tigartm1.1Khv/Tigartm1.1Khv Tg(CMV-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL)
|
increased susceptibility to induced colitis
|
J:198650
|
Timp1tm1Pds/Timp1tm1Pds
(involves: 129S4/SvJae * C57BL/6)
|
lung inflammation
|
J:112941
|
Timp3tm1Osya/Timp3tm1Osya
(B6.129P2-Timp3tm1Osya)
|
aortitis
|
J:193744
|
Timp3tm1Rkho/Timp3tm1Rkho
(B6.129-Timp3tm1Rkho)
|
liver inflammation
|
J:92948
|
Tinf2tm2.2Tdl/Tinf2+
(involves: BALB/cJ * C57BL/6)
|
dermatitis
|
J:207367
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor)
|
kidney inflammation
|
J:117491
|
Tk1tm1Vnd/Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6)
|
arteritis
|
J:101669
|
liver inflammation
|
J:101669
|
lung inflammation
|
J:101669
|
thyroid gland inflammation
|
J:101669
|
Tktl1tm1Arte/Tktl1tm1Arte
(C57BL/6-Tktl1tm1Arte)
|
increased susceptibility to induced colitis
|
J:171154
|
Tlr2tm1Aki/Tlr2tm1Aki
(NOD.129P2-Tlr2tm1Aki)
|
insulitis
|
J:124334
|
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir)
|
increased susceptibility to induced colitis
|
J:165105
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv)
|
heart inflammation
|
J:119967
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
increased susceptibility to induced arthritis
|
J:96356
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
liver inflammation
|
J:135830
|
lung inflammation
|
J:96680
|
Tlr4tm1Aki/Tlr4tm1Aki
(C.129P2-Tlr4tm1Aki)
|
decreased susceptibility to induced arthritis
|
J:178054
|
Tlr5tm1Aki/Tlr5tm1Aki
(involves: 129P2/OlaHsd)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:229155
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to induced colitis
|
J:158055
|
increased susceptibility to induced pancreatitis
|
J:158055
|
lung inflammation
|
J:111778
|
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
liver inflammation
|
J:324448
|
lung inflammation
|
J:324448
|
lymph node inflammation
|
J:324448
|
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
glomerulonephritis
|
J:324448
|
increased inflammatory response
|
J:324448
|
liver inflammation
|
J:324448
|
lung inflammation
|
J:324448
|
lymph node inflammation
|
J:324448
|
pancreas inflammation
|
J:324448
|
salivary gland inflammation
|
J:324448
|
Tlr8tm1Vlcg/Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg)
|
glomerulonephritis
|
J:165267
|
Tlr9m6Btlr/Tlr9m6Btlr
(C57BL/6J-Tlr9m6Btlr)
|
increased susceptibility to induced colitis
|
J:155728
|
Tmem30atm1.1Xjz/Tmem30atm1.1Xjz Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA)
|
liver inflammation
|
J:249038
|
Tmem79ma/Tmem79ma
(involves: C57BL/6JJcl * CBA/CaGr)
|
dermatitis
|
J:202316
|
Tmem79ma/Tmem79ma
(B6.CBACaGr-Tmem79ma/J)
|
blepharitis
|
J:202453
|
dermatitis
|
J:202453
|
skin inflammation
|
J:202453
|
Tmem178tm1Lex/Tmem178tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:228311
|
Tmem219tm1(KOMP)Vlcg/Tmem219tm1(KOMP)Vlcg Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
lung inflammation
|
J:236976
|
Tmem241em1Blsg/Tmem241em1Blsg
(involves: C57BL/6J)
|
lung inflammation
|
J:344360
|
Tmem258tm1.1(KOMP)Vlcg/Tmem258+
(involves: C57BL/6NTac)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:240635
|
increased susceptibility to induced colitis
|
J:240635
|
Tmprss2tm1(KOMP)Vlcg/Tmprss2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
lung inflammation
|
J:214427
|
Tmprss2tm2.1(ETV1)Sho/Tmprss2tm2.1(ETV1)Sho
(involves: C57BL/6 * DBA/2)
|
prostate gland inflammation
|
J:212219
|
Tnbs1SJL/J/?
(involves: C57BL/6J * SJL/J)
|
increased susceptibility to induced colitis
|
J:82095
|
Tnbs2SJL/J/?
(involves: C57BL/6J * SJL/J)
|
increased susceptibility to induced colitis
|
J:82095
|
TnfBpsm1/Tnf+
(involves: C57BL/6)
|
aortic valve inflammation
|
J:226052
|
mitral valve inflammation
|
J:226052
|
rheumatoid arthritis
|
J:226052
|
TnfBpsm1/Tnf+
(C.Cg-TnfBpsm1)
|
aortic valve inflammation
|
J:226052
|
cardiovalvulitis
|
J:226052
|
mitral valve inflammation
|
J:226052
|
TnfBpsm1/TnfBpsm1
(involves: C57BL/6)
|
accelerated temporomandibular joint osteoarthritis
|
J:226052
|
aortic valve inflammation
|
J:226052
|
mitral valve inflammation
|
J:226052
|
rheumatoid arthritis
|
J:226052
|
Tnfem4Boui/Tnf+
(C57BL/6-Tnfem4Boui)
|
autoimmune arthritis
|
J:306876
|
cardiovalvulitis
|
J:306876
|
colitis
|
J:306876
|
esophageal inflammation
|
J:306876
|
ileum inflammation
|
J:306876
|
Tnfem5Boui/Tnf+ Tnfrsf1atm1Mak/Tnfrsf1a+
(involves: 129S2/SvPas * C57BL/6)
|
autoimmune arthritis
|
J:306876
|
cardiovalvulitis
|
J:306876
|
colitis
|
J:306876
|
Tnftm1Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:54056
|
rheumatoid arthritis
|
J:54056
|
Tnftm1Ljo/Tnftm1Ljo
(B6.129S1-Tnftm1Ljo)
|
lung inflammation
|
J:127028
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv * C57BL/6)
|
skin inflammation
|
J:127028
|
Tnftm2.1Gkl/Tnftm2.1Gkl Tg(Fabp1-cre)1Jig/0
(involves: 129S/SvEv * FVB/N)
|
ileum inflammation
|
J:204557
|
large intestinal inflammation
|
J:204557
|
small intestinal inflammation
|
J:204557
|
Tnftm2.1Gkl/Tnftm2.1Gkl Tg(Lck-cre)I57Jxm/0
(involves: 129S/SvEv * ICR)
|
small intestinal inflammation
|
J:108572
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6)
|
autoimmune arthritis
|
J:92307,
J:136667
|
ileum inflammation
|
J:204922
|
intestinal inflammation
|
J:136667
|
rheumatoid arthritis
|
J:54056
|
small intestinal inflammation
|
J:92307,
J:54056,
J:204922
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6 * SPRET/Ei)
|
autoimmune arthritis
|
J:92307
|
small intestinal inflammation
|
J:92307
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
small intestinal inflammation
|
J:108572
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6 * CBA)
|
autoimmune arthritis
|
J:131930
|
Tnftm2Gkl/Tnf+
(B6.129S-Tnftm2Gkl/Jarn)
|
ileum inflammation
|
J:131978,
J:145626
|
Tnftm2Gkl/Tnf+ Tnfrsf1atm2Gkl/Tnfrsf1atm2Gkl Tg(Col6a1-cre)1Gkl/?
(involves: 129S/SvEv * C57BL/6 * CBA)
|
autoimmune arthritis
|
J:131930
|
small intestinal inflammation
|
J:131930
|
Tnftm2Gkl/Tnf+ Tnfrsf1btm1.1Gkl/Tnfrsf1btm1.1Gkl Tg(Col6a1-cre)1Gkl/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA)
|
joint inflammation
|
J:264147
|
Tnftm2Gkl/Tnf+ Tnfrsf1btm1.2Gkl/Tnfrsf1btm1.2Gkl
(involves: 129S/SvEv * C57BL/6 * C57BL/6J)
|
aortic valve inflammation
|
J:264147
|
autoimmune arthritis
|
J:264147
|
Tnftm2Gkl/Tnf+ Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
rheumatoid arthritis
|
J:54056
|
small intestinal inflammation
|
J:54056
|
Tnftm2Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6)
|
cardiovalvulitis
|
J:226052
|
rheumatoid arthritis
|
J:54056
|
small intestinal inflammation
|
J:54056
|
Tnfaip3m1Apb/Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb)
|
CNS inflammation
|
J:324062
|
uterus inflammation
|
J:324062
|
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum/0
(B6.Cg-Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum)
|
increased susceptibility to induced colitis
|
J:163410
|
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl Tnfrsf1atm1Mak/Tnfrsf1atm1Mak Tg(Vil1-cre)997Gum/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
increased susceptibility to induced colitis
|
J:163410
|
Tnfaip3tm1Ama/Tnfaip3tm1Ama
(Not Specified)
|
increased inflammatory response
|
J:92931
|
intestinal inflammation
|
J:92931
|
joint inflammation
|
J:92931
|
kidney inflammation
|
J:92931
|
liver inflammation
|
J:92931
|
Tnfaip3tm1Homy/Tnfaip3tm1Homy Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
liver inflammation
|
J:212681
|
lung inflammation
|
J:212681
|
Tnfaip3tm3.1Ama/Tnfaip3tm3.1Ama
(C57BL/6J-Tnfaip3tm3.1Ama)
|
increased susceptibility to induced colitis
|
J:203160
|
Tnfaip3tm4.1Ama/Tnfaip3tm4.1Ama
(C57BL/6J-Tnfaip3tm4.1Ama)
|
increased susceptibility to induced colitis
|
J:203160
|
Tnfaip8Gt(IST13629C1)Tigm/Tnfaip8Gt(IST13629C1)Tigm
(involves: C57BL/6N)
|
increased susceptibility to induced colitis
|
J:223320
|
Tnfaip8Gt(IST13629C1)Tigm/Tnfaip8Gt(IST13629C1)Tigm Tnfaip8l1em1Huwa/Tnfaip8l1em1Huwa
(involves: C57BL/6 * C57BL/6N)
|
colitis
|
J:342074
|
Tnfaip8l1em1Huwa/Tnfaip8l1em1Huwa
(C57BL/6-Tnfaip8l1em1Huwa)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:342074
|
increased susceptibility to induced colitis
|
J:342074
|
Tnfaip8l2tm1Yhcn/Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn)
|
increased susceptibility to endotoxin shock
|
J:139785
|
intestinal inflammation
|
J:139785
|
liver inflammation
|
J:139785
|
lung inflammation
|
J:139785
|
lymph node inflammation
|
J:139785
|
Tnfrsf1atm1.1Gkl/Tnfrsf1a+
(involves: 129/Sv * C57BL/6)
|
liver inflammation
|
J:92470
|
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6)
|
liver inflammation
|
J:92470
|
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129/Sv * C57BL/6)
|
liver inflammation
|
J:92470
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:92307
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
lung inflammation
|
J:120174
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:120707
|
osteomyelitis
|
J:58851
|
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
glomerulonephritis
|
J:180054
|
Tnfrsf1atm1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm1Rsie)
|
increased susceptibility to endotoxin shock
|
J:160543
|
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm2.1Rsie)
|
increased susceptibility to endotoxin shock
|
J:160543
|
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(involves: 129S6/SvEvTac)
|
increased susceptibility to endotoxin shock
|
J:160543
|
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased inflammatory response
|
J:45147
|
lung inflammation
|
J:120174
|
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD)
|
periinsulitis
|
J:64051
|
Tnfrsf9em1Ygch/Tnfrsf9em1Ygch
(NOD/ShiLtDvs-Tnfrsf9em1Ygch)
|
insulitis
|
J:208927
|
Tnfrsf9em2Ygch/Tnfrsf9em2Ygch
(NOD/ShiLtDvs-Tnfrsf9em2Ygch)
|
insulitis
|
J:208927
|
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
glomerulonephritis
|
J:82331
|
kidney inflammation
|
J:82331
|
liver inflammation
|
J:82331
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
liver inflammation
|
J:87620
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
increased susceptibility to induced arthritis
|
J:82145
|
Tnfsf13tm1Pod/Tnfsf13tm1Pod
(B6.Cg-Tnfsf13tm1Pod)
|
decreased susceptibility to induced arthritis
|
J:141374
|
Tnfsf15tm1Hluo/Tnfsf15tm1Hluo
(D1LacJ.129(B6)-Tnfsf15tm1Hluo)
|
decreased susceptibility to induced arthritis
|
J:207029
|
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:180054
|
Tnip1m1Btlr/Tnip1m1Btlr
(C57BL/6J-Tnip1m1Btlr)
|
increased susceptibility to induced colitis
|
J:265175
|
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:176826
|
Tns1tm1Efu/Tns1tm1Efu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
tubulointerstitial nephritis
|
J:39202
|
Tns2nph/Tns2nph
(involves: ICR)
|
glomerulonephritis
|
J:108691
|
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
conjunctivitis
|
J:133892
|
dermatitis
|
J:133892
|
increased inflammatory response
|
J:133892
|
Tomm5Gt(OST44663)Lex/Tomm5Gt(OST44663)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
lung inflammation
|
J:186382
|
Top3btm1Jcw/Top3btm1Jcw
(involves: 129S6/SvEvTac * C57BL/6)
|
dermatitis
|
J:69405
|
glomerulonephritis
|
J:69405
|
increased inflammatory response
|
J:69405
|
pancreas inflammation
|
J:69405
|
stomach inflammation
|
J:69405
|
Tpsab1m1/Tpsab1m1 Tpsb2tm1(cre)Adch/Tpsb2tm1(cre)Adch
(B6.Cg-Tpsb2tm1(cre)Adch Tpsab1m1)
|
decreased susceptibility to induced arthritis
|
J:142880
|
Tpsb2tm1.1Mfg/Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg)
|
decreased susceptibility to induced arthritis
|
J:142880
|
Traf3ip2adjm/Traf3ip2adjm
(KOR-Traf3ip2adjm)
|
dermatitis
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(A.KOR-Traf3ip2adjm)
|
dermatitis
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(B6.KOR-Traf3ip2adjm)
|
dermatitis
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(C.KOR-Traf3ip2adjm)
|
dermatitis
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(AK.KOR-Traf3ip2adjm)
|
dermatitis
|
J:162859
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129/Sv * BALB/c)
|
increased inflammatory response
|
J:93923
|
respiratory system inflammation
|
J:93923
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix)
|
blepharitis
|
J:138560
|
glomerulonephritis
|
J:138560
|
increased inflammatory response
|
J:138560
|
kidney inflammation
|
J:138560
|
lacrimal gland inflammation
|
J:138560
|
parotid gland inflammation
|
J:138560
|
stomatitis
|
J:138560
|
submandibular gland inflammation
|
J:138560
|
Traf4tm1Lind/Traf4tm1Lind
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:74252
|
Traf4tm2Lind/Traf4tm2Lind
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
lung inflammation
|
J:74252
|
Trafd1tm1Ayos/Trafd1tm1Ayos
(involves: 129 * C57BL/6J)
|
increased susceptibility to endotoxin shock
|
J:144594
|
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N)
|
increased susceptibility to endotoxin shock
|
J:242126
|
Treml1tm1Mcvic/Treml1tm1Mcvic
(C57BL/6-Treml1tm1Mcvic)
|
increased susceptibility to endotoxin shock
|
J:150578
|
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
bronchiolitis
|
J:220965
|
glomerulonephritis
|
J:220965
|
heart inflammation
|
J:220965
|
increased inflammatory response
|
J:220965
|
lacrimal gland inflammation
|
J:220965
|
pancreas inflammation
|
J:220965
|
salivary gland inflammation
|
J:220965
|
tubulointerstitial nephritis
|
J:220965
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd)
|
heart inflammation
|
J:202757
|
myocarditis
|
J:92264
|
skin inflammation
|
J:202757
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
dermatitis
|
J:181257
|
folliculitis
|
J:181257
|
glomerulonephritis
|
J:181257
|
increased inflammatory response
|
J:181257
|
kidney inflammation
|
J:181257
|
myocarditis
|
J:181257
|
myositis
|
J:181257
|
skin inflammation
|
J:181257
|
stomach inflammation
|
J:181257
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
heart inflammation
|
J:234263
|
increased inflammatory response
|
J:234263
|
kidney inflammation
|
J:234263
|
myositis
|
J:234263
|
stomach inflammation
|
J:234263
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6J)
|
dermatitis
|
J:243357
|
Trim8tm1Hbsh/Trim8tm1Hbsh
(involves: 129S6/SvEvTac)
|
increased susceptibility to endotoxin shock
|
J:251270
|
Trim21tm1Mwah/Trim21+
(C57BL/6-Trim21tm1Mwah)
|
dermatitis
|
J:151775
|
Trim21tm1Mwah/Trim21tm1Mwah
(C57BL/6-Trim21tm1Mwah)
|
dermatitis
|
J:151775
|
increased inflammatory response
|
J:151775
|
Trim58tm2313.1Arte/Trim58tm2313.1Arte Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to induced colitis
|
J:279270
|
Trim58tm2313.2Arte/Trim58tm2313.2Arte
(involves: BALB/cJ * C57BL/6N)
|
increased susceptibility to induced colitis
|
J:279270
|
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6)
|
increased inflammatory response
|
J:173271
|
liver inflammation
|
J:173271
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
adipose tissue inflammation
|
J:173271
|
increased inflammatory response
|
J:173271
|
liver inflammation
|
J:173271
|
lung inflammation
|
J:173271
|
Trp53inp1tm1Acar/Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to induced colitis
|
J:118867
|
large intestinal inflammation
|
J:118867
|
Trp63tm2Brd/Trp63+
(involves: 129S7/SvEvBrd)
|
kidney inflammation
|
J:100483
|
uterine cervix inflammation
|
J:100483
|
Trp73tm1Fmc/Trp73tm1Fmc
(involves: 129S4/SvJae)
|
conjunctivitis
|
J:60896
|
increased susceptibility to otitis media
|
J:60896
|
rhinitis
|
J:60896
|
sinus inflammation
|
J:60896
|
Trpm4tm1.1Mfre/Trpm4tm1.1Mfre
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
increased susceptibility to type I hypersensitivity reaction
|
J:118679
|
Trpm7tm1Agry/Trpm7+
(involves: 129)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:205665
|
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul)
|
kidney inflammation
|
J:154624
|
Trpv3Nh/Trpv3+
(involves: DS)
|
dermatitis
|
J:42153
|
Trpv3tm1.2Clph/Trpv3tm1.2Clph
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA)
|
erythroderma
|
J:164741
|
Trpv5Hcalc1/Trpv5+
(involves: C3H/HeH * C57BL/6J)
|
kidney inflammation
|
J:196612
|
Trpv5Hcalc1/Trpv5Hcalc1
(involves: C3H/HeH * C57BL/6J)
|
kidney inflammation
|
J:196612
|
Trpv5m1Btlr/Trpv5m1Btlr
(C57BL/6J-Trpv5m1Btlr)
|
increased susceptibility to induced colitis
|
J:192586
|
intestinal inflammation
|
J:192586
|
Tsc22d3tm1.2Efmd/Y
(Not Specified)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:201728
|
Tslptm1(KOMP)Vlcg/Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
respiratory system inflammation
|
J:187770
|
Tslptm1Mak/Tslptm1Mak
(B6.Cg-Tslptm1Mak)
|
colitis
|
J:175844
|
Ttc7fsn-Jic/Ttc7fsn-Jic
(C3.INT-Ttc7fsn-Jic)
|
liver inflammation
|
J:115742
|
Ttc7fsn/Ttc7fsn
(involves: A/J)
|
stomach inflammation
|
J:2777
|
Ttc39aos1em1Bcgen/Ttc39aos1em1Bcgen
(involves: C57BL/6N)
|
increased susceptibility to induced pancreatitis
|
J:307097
|
Ttc39aos1tm1Kaf/Ttc39aos1tm1Kaf
(C57BL/6-Ttc39aos1tm1Kaf)
|
increased susceptibility to endotoxin shock
|
J:234649
|
Ttll1Gt(OST372941)Lex/Ttll1Gt(OST372941)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to otitis media
|
J:186050
|
rhinitis
|
J:186050
|
Ttll1tm1Seto/Ttll1tm1Seto
(involves: 129S/SvEv * C57BL/6)
|
rhinosinusitis
|
J:161297
|
Ttnmdm/Ttnmdm
(Not Specified)
|
myositis
|
J:14016
|
Ttntm1.1Isrd/Ttntm1.1Isrd
(involves: 129S2/SvPas * C57BL/6)
|
myositis
|
J:165576
|
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J)
|
arteritis
|
J:119985
|
glomerulonephritis
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
arteritis
|
J:119985
|
glomerulonephritis
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
arteritis
|
J:309768
|
Tvp23bem3Eetr/Tvp23bem3Eetr
(C57BL/6J-Tvp23bem3Eetr)
|
increased susceptibility to induced colitis
|
J:340685
|
Tvp23bm1Btlr/Tvp23bm1Btlr
(C57BL/6J-Tvp23bm1Btlr)
|
increased susceptibility to induced colitis
|
J:340685
|
Tyk2E775K/Tyk2E775K
(B10.D1-H2q/SgJ)
|
decreased susceptibility to induced arthritis
|
J:69051
|
Tymptm1Akiy/Tymptm1Akiy Upp1tm1Akiy/Upp1tm1Akiy
(involves: 129X1/SvJ)
|
brain inflammation
|
J:78036
|
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd)
|
decreased susceptibility to induced arthritis
|
J:158811
|
U90926em1Dnkv/U90926em1Dnkv
(C57BL6/J-U90926em1Dnkv)
|
increased susceptibility to endotoxin shock
|
J:340649
|
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy)
|
liver inflammation
|
J:157049
|
lung inflammation
|
J:157049
|
Ube3bGt(RRJ142)Byg/Ube3bGt(RRJ142)Byg
(involves: 129P2/OlaHsd * CBA/Ca)
|
eye inflammation
|
J:203652
|
Ulk4tm1Lex/Ulk4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased susceptibility to otitis media
|
J:185566
|
maxillary sinus inflammation
|
J:185566
|
nasal inflammation
|
J:185566
|
Umodem1Duf/Umod+
(C57BL/6J-Umodem1Duf)
|
kidney inflammation
|
J:252597
|
Umodtm1.1Rvt/Umod+
(either: B6J.129-Umodtm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))
|
kidney inflammation
|
J:242593
|
Umodtm1.1Rvt/Umodtm1.1Rvt
(either: B6J.129-Umodtm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))
|
kidney inflammation
|
J:242593
|
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:174308
|
liver inflammation
|
J:174308
|
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli)
|
kidney inflammation
|
J:271949
|
Uoxtm1Bay/Uoxtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
tubulointerstitial nephritis
|
J:16490
|
Uri1tm1.1Ndj/Uri1tm1.1Ndj Albtm1(cre/ERT2)Mtz/Alb+
(B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj)
|
liver inflammation
|
J:217463
|
Usp13em1Nmw/Usp13em1Nmw
(B6.Cg-Usp13em1Nmw)
|
lung inflammation
|
J:285981
|
Usp18ity9/Usp18ity9
(involves: 129S1/SvImJ * C57BL/6)
|
increased susceptibility to endotoxin shock
|
J:163843
|
Usp25Gt(RRS805)Byg/Usp25Gt(RRS805)Byg
(involves: 129P2/OlaHsd)
|
lung inflammation
|
J:188557
|
Usp38em1Cya/Usp38em1Cya
(C57BL/6-Usp38em1Cya)
|
lung inflammation
|
J:321973
|
UvragTn(pb-Act-RFP)1.100107015-HRAZhu/UvragTn(pb-Act-RFP)1.100107015-HRAZhu
(involves: FVB/NJ)
|
heart inflammation
|
J:219546
|
Varc/Varc+
(C3H/HeJ-Varc/J)
|
increased susceptibility to otitis media
|
J:241135
|
Varc/Varc+
(C3OuJ.C3-Varc/Kjn)
|
increased susceptibility to otitis media
|
J:241135
|
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to induced colitis
|
J:130511
|
intestinal inflammation
|
J:107077
|
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
dermatitis
|
J:111828
|
Vdrtm2Ska/Vdrtm2Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
ear inflammation
|
J:111828
|
Vegfatm2Gne/Vegfatm2Gne Tg(SFTPC-cre)#Mliu/0
(involves: 129/Sv * ICR)
|
lung inflammation
|
J:158566
|
Vhltm1Jae/Vhltm1Jae Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased inflammatory response
|
J:107682
|
Viptm1Clw/Viptm1Clw
(involves: 129S/Sv * C57BL/6)
|
lung inflammation
|
J:132313
|
Vipr2tm1Ajh/Vipr2tm1Ajh
(B6.129P2-Vipr2tm1Ajh)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:72933
|
Vms1A/J/Vms1A/J
(involves: A/J * C57BL/10SnSg)
|
myocarditis
|
J:121574
|
Vps13btm1.2Ics/Vps13btm1.2Ics
(involves: C57BL/6N)
|
eye inflammation
|
J:296007
|
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased inflammatory response
|
J:222944
|
Vwftm1.1Geno/Vwf+
(involves: C57BL/6)
|
increased acute inflammation
|
J:250145
|
Vwftm1.1Geno/Vwftm1.1Geno
(involves: C57BL/6)
|
increased acute inflammation
|
J:250145
|
Wastm1Sbs/Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
colitis
|
J:48836
|
Wastm1Sbs/Wastm1Sbs
(129S6/SvEvTac-Wastm1Sbs/J)
|
glomerulonephritis
|
J:180407
|
Wastm1Sbs/Wastm1Sbs Wasltm2Sbs/Wasltm2Sbs Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
colitis
|
J:125309
|
Wasltm1.1Ttha/Wasltm1.1Ttha Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
dermatitis
|
J:271857
|
skin inflammation
|
J:271857
|
Wdr1Gt(XN462)Byg/Wdr1rede
(involves: 129P2/OlaHsd * C57BL/6)
|
ear inflammation
|
J:134092
|
skin inflammation
|
J:134092
|
Wdr1rede/Wdr1rede
(Not Specified)
|
increased inflammatory response
|
J:85113
|
Wdr1rede/Wdr1rede
(C57BL/6-Wdr1rede)
|
ear inflammation
|
J:134092
|
skin inflammation
|
J:134092
|
Wdr41m1Btlr/Wdr41m1Btlr
(C57BL/6J-Wdr41m1Btlr)
|
increased susceptibility to induced colitis
|
J:268243
|
Wdr83tm1Guwo/Wdr83+
(involves: C57BL/6)
|
kidney inflammation
|
J:153983
|
Wfdc2tm1.1Ohbo/Wfdc2tm1.1Ohbo
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
lung inflammation
|
J:282576
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6)
|
colitis
|
J:116168
|
glomerulonephritis
|
J:116168
|
interstitial pneumonia
|
J:116168
|
joint inflammation
|
J:116168
|
lung inflammation
|
J:116168
|
Wlstm1.1Arte/Wlstm1.1Arte Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
skin inflammation
|
J:202499
|
Wrntm1Led/Wrntm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
heart inflammation
|
J:106446
|
Wt1tm1Mlh/Wt1+
(involves: 129P2/OlaHsd * C57BL/6)
|
glomerulonephritis
|
J:135449
|
Wt1tm1Mlh/Wt1+
(129P2/OlaHsd-Wt1tm1Mlh)
|
glomerulonephritis
|
J:135449
|
Wt1tm1Mlh/Wt1+
(involves: 129P2/OlaHsd * C57BL/6 * MF1)
|
glomerulonephritis
|
J:135449
|
Wwc1tm1Arsc/Wwc1tm1Arsc Wwc2tm1.1Arte/Wwc2tm1.1Arte Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * C57BL/6J * DBA)
|
liver inflammation
|
J:305034
|
Wwtr1tm1Benj/Wwtr1tm1Benj
(129S6/SvEvTac-Wwtr1tm1Benj)
|
intestinal inflammation
|
J:125326
|
lung inflammation
|
J:125326
|
Wwtr1tm1Benj/Wwtr1tm1Benj
(129S-Wwtr1tm1Benj/J)
|
intestinal inflammation
|
J:156586
|
lung inflammation
|
J:156586
|
Wwtr1tm1Hku/Wwtr1tm1Hku
(involves: 129 * C57BL/6 * ICR)
|
alveolitis
|
J:164957
|
lung inflammation
|
J:164957
|
Wwtr1tm1Whun/Wwtr1tm1Whun
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
tubular nephritis
|
J:119488
|
Xbp1tm2Glm/Xbp1+ Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL)
|
small intestinal inflammation
|
J:188627
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Defa6-icre)1Rsb/0
(involves: 129S6/SvEvTac * C57BL/6)
|
small intestinal inflammation
|
J:206084
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL)
|
increased susceptibility to induced colitis
|
J:188627
|
small intestinal inflammation
|
J:188627
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
small intestinal inflammation
|
J:206084
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
small intestinal inflammation
|
J:206084
|
Xbp1tm2Glm/Xbp1tm2Glm Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
small intestinal inflammation
|
J:206084
|
Xbp1tm3Glm/Xbp1tm3Glm Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
small intestinal inflammation
|
J:188627
|
Xcl1tm1.1Dnax/Xcl1tm1.1Dnax
(either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6))
|
heart inflammation
|
J:176844
|
increased inflammatory response
|
J:176844
|
lacrimal gland inflammation
|
J:176844
|
liver inflammation
|
J:176844
|
salivary gland inflammation
|
J:176844
|
stomach inflammation
|
J:176844
|
Xdhtm1Fink/Xdhtm1Fink
(involves: 129X1/SvJ * C57BL/6J)
|
tubulointerstitial nephritis
|
J:166326
|
X/Yaa
(BXSB/MpJ)
|
glomerulonephritis
|
J:6235
|
X/Yaa
((NZW x SB)F1)
|
glomerulonephritis
|
J:7276
|
X/Yaa
(BXSB/MpJScr)
|
glomerulonephritis
|
J:10973
|
Yaa2BXSB/J/?
(involves: BXSB/J * C57BL/10Ola)
|
kidney inflammation
|
J:49868
|
Yaa3BXSB/J/?
(involves: BXSB/J * C57BL/10Ola)
|
kidney inflammation
|
J:49868
|
Yaa4BXSB/J/?
(involves: BXSB/J * C57BL/10Ola)
|
kidney inflammation
|
J:49868
|
YaailNZW/Ola/?
(involves: C57BL/6Ola * NZW/Ola)
|
glomerulonephritis
|
J:52110
|
Yap1M1Btlr/Yap1M1Btlr
(C57BL/6J-Yap1M1Btlr)
|
increased susceptibility to induced colitis
|
J:267549
|
Yap1tm1.1Dupa/Yap1tm1.1Dupa Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
increased susceptibility to induced colitis
|
J:165471
|
Yipf6M1Btlr/Y
(C57BL/6J-Yipf6M1Btlr/Mmucd)
|
colitis
|
J:187584
|
increased susceptibility to induced colitis
|
J:187584
|
Yipf6M1Btlr/Yipf6M1Btlr
(C57BL/6J-Yipf6M1Btlr/Mmucd)
|
colitis
|
J:187584
|
increased susceptibility to induced colitis
|
J:187584
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
chronic joint inflammation
|
J:86607
|
increased susceptibility to induced arthritis
|
J:154166
|
lung inflammation
|
J:86607
|
rheumatoid arthritis
|
J:86607
|
Zap70m1Saka/Zap70m1Saka Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: BALB/c * C57BL/6J * DBA/2J)
|
autoimmune arthritis
|
J:86607
|
Zap70m1Saka/Zap70tm1Dlo
(involves: 129P2/OlaHsd * BALB/c)
|
autoimmune arthritis
|
J:86607
|
Zap70m1Saka/Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c)
|
decreased susceptibility to induced arthritis
|
J:154166
|
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased inflammatory response
|
J:304105
|
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA)
|
bile duct inflammation
|
J:304105
|
liver inflammation
|
J:304105
|
Zdhhc2em1Eko/Zdhhc2em1Eko
(C57BL/6-Zdhhc2em1Eko)
|
decreased susceptibility to chemically induced skin inflammation
|
J:303593
|
Zfp14tm1Xch/Zfp14+
(involves: C57BL/6)
|
chronic pancreas inflammation
|
J:331393
|
increased inflammatory response
|
J:331393
|
Zfp14tm1Xch/Zfp14tm1Xch
(involves: C57BL/6)
|
chronic pancreas inflammation
|
J:331393
|
increased inflammatory response
|
J:331393
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(Not Specified)
|
autoimmune arthritis
|
J:33986
|
conjunctivitis
|
J:33986
|
dermatitis
|
J:33986
|
heart inflammation
|
J:33986
|
liver inflammation
|
J:33986
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
autoimmune arthritis
|
J:88443
|
blood vessel inflammation
|
J:214114
|
Zfp36tm2.1Pjb/Zfp36tm2.1Pjb
(involves: C57BL/6)
|
decreased susceptibility to induced arthritis
|
J:229078
|
Zfp36tm4.1Pjb/Zfp36tm4.1Pjb Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
alveolitis
|
J:188677
|
autoimmune arthritis
|
J:188677
|
increased inflammatory response
|
J:188677
|
increased susceptibility to endotoxin shock
|
J:188677
|
Zfp148tm1.1Jmer/Zfp148tm1.1Jmer Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased inflammatory response
|
J:198847
|
Zfp148tm1Djl/Zfp148tm1Djl
(involves: 129)
|
increased susceptibility to induced colitis
|
J:107441
|
Zfp871tm1a(EUCOMM)Wtsi/Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd)
|
liver inflammation
|
J:317166
|
Zfp950Gt(ROSA)76Sor/Zfp950Gt(ROSA)76Sor
(involves: 129S4/SvJaeSor)
|
kidney inflammation
|
J:117491
|
Zmynd10tm1(KOMP)Wtsi/Zmynd10tm1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
lung inflammation
|
J:261915
|
Zranb1em1Shios/Zranb1em1Shios
(involves: C57BL/6)
|
increased susceptibility to colitis induced morbidity/mortality
|
J:333468
|